WO2021063735A1 - Nouveaux dérivés pyridines bicycliques - Google Patents

Nouveaux dérivés pyridines bicycliques Download PDF

Info

Publication number
WO2021063735A1
WO2021063735A1 PCT/EP2020/076363 EP2020076363W WO2021063735A1 WO 2021063735 A1 WO2021063735 A1 WO 2021063735A1 EP 2020076363 W EP2020076363 W EP 2020076363W WO 2021063735 A1 WO2021063735 A1 WO 2021063735A1
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
alkyl
crc
case
formula
Prior art date
Application number
PCT/EP2020/076363
Other languages
English (en)
Inventor
Georg Christoph RUDOLF
Michael Seet
Bernd Mueller
Wassilios Grammenos
Benjamin Juergen MERGET
Andreas Koch
Nadine RIEDIGER
Christine WIEBE
Thomas Grote
Jan Klaas Lohmann
Christian Harald WINTER
Anja Weber
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of WO2021063735A1 publication Critical patent/WO2021063735A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Definitions

  • the present invention relates to the use of pyridine compounds and the N-oxides and the salts thereof as fungicides as well to new pyridine compounds.
  • the invention also relates to the composition comprising at least one compound I, to the method for combating phytopathogenic fungi and to the seed coated with at least one compound of the formula I.
  • the present invention relates to the use of the compound of the formula I
  • Q is O or S
  • X is O or S
  • R 1 is in each case independently selected from hydrogen, halogen, CN, CrC 6 -alkyl, C 1 -C 6 - halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, 0-CrC 6 -alkyl, 0-C 2 -C 6 -alkenyl, 0-C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, wherein the acyclic and cyclic moieties of R 1 are unsubstituted or substituted by one to six groups R 1a which independently of one another are selected from: halogen, CN, CrC 6 -alkyl, CrC 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkeny
  • R 2 is in each case independently selected from hydrogen, halogen, CN, CrC 6 -alkyl, C 1 -C 6 - halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl, 0-CrC 6 -alkyl, 0-C 2 -C 6 -alkenyl, 0-C 2 -C 6 -alkynyl, C 3 -C 6 -cycloalkyl, wherein the acyclic and cyclic moieties of R 2 are unsubstituted or substituted by one to six groups R 2a which independently of one another are selected from: halogen, CN, CrC 6 -alkyl, CrC 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkeny
  • R 3 is in each case independently selected from hydrogen, halogen, CN, CrC6-alkyl, C 1 -C 6 - halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl C 3 -C 6 -cycloalkyl, wherein the acyclic and cyclic moieties of R 3 are unsubstituted or substituted by one to six groups R 3a which independently of one another are selected from: halogen, CN, CrC 6 -alkyl, CrC 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 - alkynyl, C 2 -C 6 -halogenalkynyl, 0-CrC 6 -alkyl,
  • R 4 is in each case independently selected from hydrogen, halogen, CN, CrC 6 -alkyl, C 1 -C 6 - halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -halogenalkynyl C 3 -C 6 -cycloalkyl, wherein the acyclic and cyclic moieties of R 4 are unsubstituted or substituted by one to six groups R 4a which independently of one another are selected from: halogen, CN, CrC 6 -alkyl, CrC 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, C2-C6- alkynyl, C2-C6-halogenalkynyl, 0-CrC 6 -alkyl, 0-C 2 -C 6 -alken
  • Y is in each case independently selected from CrC 6 -alkyl, C2-C6-alkenyl, C2-C6-alkynyl, Ci- C 6 -halogenalkyl, C2-C6-alkenyl, C2-C6-halogenalkenyl, 0-CrC 6 -alkyl, 0-C 2 -C 6 -alkenyl, O- C2-C6-alkynyl, N(R 5 )-Ci-C 6 -alkyl, N(R 5 )C2-C6-alkenyl, N(R 5 ) C2-C6-alkynyl; the acyclic and cyclic moieties of Y are unsubstituted or substituted by one to eight groups Y a
  • R ' is in each case independently selected from hydrogen, CrC 6 -alkyl, C2-C6-alkenyl, C2-C6- alkynyl, wherein the acyclic moieties of R are unsubstituted or substituted by one to six groups
  • R R independently of one another are selected from: halogen, CN, 0-CrC 6 -alkyl, C3-C6-cycloalkyl, 0-C 3 -C 6 -cycloalkyl, phenyl, phenoxy; wherein the acyclic and cyclic moieties of R R are unsubstituted or substituted by one to six groups selected from halogen, CN, CrC 6 -alkyl, CrC 6 -halogenalkyl, C3-C6-cycloalkyl, 0-CrC 6 -alkyl, 0-CrC 6 -halogenalkyl;
  • the present invention relates to use of the compounds of formula I
  • the N-oxides may be prepared from the inventive compounds according to conventional oxidation methods, e. g. by treating compounds I with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(11), 1892-903, 1995); or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-8, 1981) or oxone (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001).
  • the oxidation may lead to pure mono-N-oxides or to a mixture of different N-oxides, which can be separated by conventional methods such as chromatography.
  • Agriculturally acceptable salts of the compounds of the formula I encompass especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of the compounds I.
  • Suitable cations are thus in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, of the transition metals, preferably manganese, copper, zinc and iron, and also the ammonium ion which, if desired, may be substituted with one to four CrC4-alkyl substituents and/or one phenyl or benzyl substituent, preferably diisopropylammonium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(Ci-C4- alkyl)sulfonium, and
  • Anions of acceptable acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting a compound I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.
  • Stereoisomers of the formula I can exist as one or more stereoisomers.
  • the various stereoisomers include enantiomers, diastereomers, atropisomers arising from restricted rotation about a single bond of asymmetric groups and geometric isomers. They also form part of the subject matter of the present invention.
  • one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers.
  • the compounds of the invention may be present as a mixture of stereoisomers, e.g. a racemate, individual stereoisomers, or as an optically active form.
  • the embodiments of the intermediates obtained during preparation of compounds I correspond to the embodiments of the compounds of formula I.
  • the term “ compounds I” refers to compounds of the formula I.
  • C n -C m indicates the number of carbon atoms possible in each case in the substituent or substituent moiety in question.
  • halogen refers to fluorine, chlorine, bromine and iodine.
  • Ci-C 6 -alkyl refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms, e.g. methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2- methylpropyl, 1 , 1 -di methylethyl , pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl,
  • C2-C4-alkyl refers to a straight-chained or branched alkyl group having 2 to 4 carbon atoms, such as ethyl, propyl (n-propyl), 1-methylethyl (iso-propoyl), butyl, 1-methylpropyl (sec.-butyl), 2-methylpropyl (iso-butyl), 1 , 1 -dimethylethyl (tert.-butyl).
  • Ci-C 6 -halogenalkyl refers to an alkyl group having 1 or 6 carbon atoms as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above.
  • Ci-C2-halogenalkyl groups such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1- fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-
  • CrC 6 -alkoxy refers to a straight-chain or branched alkyl group having 1 to 6 carbon atoms which is bonded via an oxygen, at any position in the alkyl group.
  • Examples are “C1-C4- alkoxy” groups, such as methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-methyhprop- oxy, 2-methylpropoxy or 1,1-dimethylethoxy.
  • Ci-C 6 -halogenalkoxy refers to a Ci-C 6 -alkoxy radical as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above.
  • Examples are "Ci-C4-halogenalkoxy” groups, such as OCH2F, OCHF2, OCF 3 , OCH2CI, OCHCI2, OCCI 3 , chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy,
  • C2-C6-alkenyl refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and a double bond in any position.
  • Examples are “C2-C4-alkenyl” groups, such as ethenyl, 1-propenyl, 2-propenyl (allyl), 1-methylethenyl, 1-butenyl, 2-butenyl,
  • C2-C6-halogenalkenyl refers to an alkyl group having 2 or 6 carbon atoms as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above.
  • C2-C6-alkenyloxy refers to a straight-chain or branched alkenyl group having 2 to 6 carbon atoms which is bonded via an oxygen, at any position in the alkenyl group. Examples are “C2-C4-alkenyloxy” groups.
  • C2-C6-alkynyl refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and containing at least one triple bond.
  • Examples are "C2-C4- alkynyl” groups, such as ethynyl, prop-1-ynyl, prop-2-ynyl (propargyl), but-1-ynyl, but-2-ynyl, but-3-ynyl , 1 -methyl-prop-2-ynyl .
  • C2-C6-halogenalkynyl refers to an alkyl group having 2 or 6 carbon atoms as defined above, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as mentioned above.
  • C2-C6-alkynyloxy refers to a straight-chain or branched alkynyl group having 2 to 6 carbon atoms which is bonded via an oxygen, at any position in the alkynyl group. Examples are “C2-C4-alkynyloxy” groups.
  • C3-C6-cycloalkyl refers to monocyclic saturated hydrocarbon radicals having 3 to 6 carbon ring members, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl. Accordingly, a saturated three-, four-, five-, six-, seven-, eight-, nine or ten-membered carbocyclyl or carbo- cycle is a "C3-Cio-cycloalkyl".
  • C3-C6-cycloalkenyl refers to a monocyclic partially unsaturated 3-, 4- 5- or 6- membered carbocycle having 3 to 6 carbon ring members and at least one double bond, such as cyclopentenyl, cyclopentadienyl, cyclohexadienyl. Accordingly, a partially unsaturated three-, four-, five-, six-, seven-, eight-, nine or ten-membered carbocyclyl or carbocycle is a "C3-C10- cycloalkenyl".
  • C3-C8-cycloalkyl-Ci-C4-alkyl refers to alkyl having 1 to 4 carbon atoms (as defined above), whereAccording to one hydrogen atom of the alkyl radical is replaced by a cycloalkyl radical having 3 to 8 carbon atoms (as defined above).
  • saturated or partially unsaturated three-, four-, five-, six-, seven-, eight-, nine or ten- membered heterocyclyl or heterocycle, wherein the heterocyclyl or heterocycle contains 1 , 2, 3 or 4 heteroatoms selected from N, O and S is to be understood as meaning both saturated and partially unsaturated heterocycles, wherein the ring member atoms of the heterocycle include besides carbon atoms 1 , 2, 3 or 4 heteroatoms independently selected from the group of O, N and S.
  • a 3- or 4-membered saturated heterocycle which contains 1 or 2 heteroatoms from the group consisting of O, N and S as ring members such as oxirane, aziridine, thiirane, oxetane, azetidine, thiethane, [1,2]dioxetane, [1 ,2]dithietane, [1,2]diazetidine; and a 5- or 6-membered saturated or partially unsaturated heterocycle which contains 1, 2 or 3 heteroatoms from the group consisting of O, N and S as ring members such as 2- tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3- pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl, 3-isothiazolidinyl,
  • substituted refers to substitued with 1, 2, 3 or up to the maximum possible number of substituents.
  • 5-or 6-membered heteroaryl or “5-or 6-membered heteroaromatic” refers to aromatic ring systems incuding besides carbon atoms, 1, 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S, for example, a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan- 2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4
  • Q is O.
  • Q is S.
  • Z is N.
  • Z is CR 2 .
  • X is O.
  • X is S.
  • R 1 is H, halogen, CrC 6 -alkyl or CrC 6 -halogenalkyl, in particular H, F, Cl, CH 3 , C2H5, CF 3 more specifically H, CH 3 , F or Cl most preferred H, F or Cl, especially R 1 is hydrogen.
  • R 1 Particularly preferred embodiments of R 1 according to the invention are in Table P1 below, wherein each line of lines P1-1 to P1-13 corresponds to one particular embodiment of the invention. Thereby, for every R 1 that is present in the inventive compounds, these specific embodiments and preferences apply independently of the meaning of any other R 1 that may be present in the ring:
  • R 2 is selected from the group consisting of H, halogen, CrC 6 -alkyl, CrC 6 -halogenalkyl, -0-CrC 6 -alkyl, 0-CrC 6 -halogenalkyl, in particular H, F, Cl, CHs, C2H5, CFs, CH 2 F, CHF 2 , OCH3, OC 2 H 5 , OCHF 2 more specifically H, CH 3 , CH 2 F,
  • R 2 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.
  • R 2 is H.
  • R 2 is F.
  • R 2 is Cl
  • R 2 is Br
  • R 2 is CrC 6 -alkyl, in particular CrC4-alkyl, such as CH 3 . or C 2 H5, in particular CH 3 or CH 2 CH 3 .
  • R 2 is CrC 6 -halogenalkyl, in particular C1-C4- halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF 3 CH 2 , CCI 3 CH 2 or CF 2 CHF 2 .
  • R 2 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C4-alkynyl or C 2 -C4-halogenalkynyl, such as CECH, CH 2 CECH, CECCI, CH 2 CECCI, or CC CECCI.
  • R 2 is 0-CrC 6 -alkyl, in particular C1-C4- alkyl, more specifically Ci-C 2 -alkoxy.
  • R 2 is such as OCH 3 or OCH 2 CH 3 .
  • R 2 is 0-C 2 -C 6 -alkenyl in particular C 2 - C4-alkenyl, more specifically C 2 -C 3 -alkenyl.
  • R 2 is 0-C 2 -C 6 -alkynyl, in particular C 2 - C 6 -alkynyl, in particular C 2 -C4-alkynyl, more specifically C 2 -C 3 -alkynyl.
  • R 2 is such as 0-CH 2 - CECH.
  • R 2 is 0-CrC 6 -halogenalkyl, in particular OCF 3 , OCCI 3 , OFCH 2 , OCICH 2 , OF 2 CH, OC CH, OCF 3 CH 2 , OCCI 3 CH 2 or OCF 2 CHF 2 , more specifically OCF 3 , OF 2 CH, OFCH 2.
  • R 2 is C 3 -C 6 -cycloalkyl, in particular cyclopropyl.
  • R 2 is C 3 -C 6 -halogencycloalkyl.
  • R 2a is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 2,2-F 2 -cyclopropyl, 2,2-CI 2 -cyclopropyl .
  • R 2 Particularly preferred embodiments of R 2 according to the invention are in Table P2 below, wherein each line of lines P2-1 to P2-24 corresponds to one particular embodiment of the invention, wherein P2-1 to P2-24 are also in any combination with one another a preferred embodiment of the present invention.
  • the connection point to the carbon atom, to which R 2 is bound is marked with “#” in the drawings.
  • R 3 is selected from the group consisting of H, halogen, CrC6-alkyl, CrC6-halogenalkyl, in particular H, F, Cl, CH3, C2H5, CF3, CH2F, CHF2, OCH3, more specifically H, CH3, CH2F, CF2H, CF3, most preferred H.
  • R 3 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.
  • R 3 is H.
  • R 3 is F.
  • R 3 is Cl
  • R 3 is Br.
  • R 3 is CrC6-alkyl, in particular CrC 4 -alkyl, such as CH3 or C2H5, in particular CH3 or CH2CH3.
  • R 3 is CrC6-halogenalkyl, in particular C1-C4- halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2 or CF 2 CHF 2 .
  • R 3 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C4-alkynyl or C 2 -C4-halogenalkynyl, such as CECH, CH 2 CECH, CECCI, CH 2 CECCI, or CC CECCI.
  • R 3 is C3-C6-cycloalkyl, in particular cyclopropyl.
  • R 3 is C3-C6-halogencycloalkyl.
  • R 3a is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 2,2-F 2 -cyclopropyl, 2,2-CI 2 -cyclopropyl .
  • R 3 Particularly preferred embodiments of R 3 according to the invention are in Table P3 below, wherein each line of lines P3-1 to P3-24 corresponds to one particular embodiment of the invention, wherein P3-1 to P3-24 are also in any combination with one another a preferred embodiment of the present invention.
  • the connection point to the carbon atom, to which R 3 is bound is marked with “#” in the drawings.
  • R 4 is selected from the group consisting of H, halogen, CrC 6 -alkyl, CrC 6 -halogenalkyl, in particular H, F, Cl, CH 3 , C 2 Hs, CF 3 , CH 2 F, CHF 2 , OCH 3 , more specifically H, CH 3 , CH 2 F, CF 2 H, CF 3 , most preferred H.
  • R 4 is halogen, in particular F, Cl, Br or I, more specifically F, Cl or Br, in particular F or Cl.
  • R 4 is H.
  • R 4 is F.
  • R 4 is Cl
  • R 4 is Br.
  • R 4 is CrC 6 -alkyl, in particular CrC4-alkyl, such as CH 3 or C2H5, in particular CH 3 or CH2CH 3 .
  • R 4 is CrC 6 -halogenalkyl, in particular C1-C4- halogenalkyl, such as CF 3 , CCI 3 , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF3CH2, CCI3CH2 or CF 2 CHF 2 .
  • R 4 is C2-C6-alkynyl or C2-C6-halogenalkynyl, in particular C2-C4-alkynyl or C2-C4-halogenalkynyl, such as CECH, CFhCECH, CECCI, CH 2 CECCI, or CC CECCI.
  • R 4 is C3-C6-cycloalkyl, in particular cyclopropyl.
  • R 4 is C3-C6-halogencycloalkyl.
  • R 4a is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 2,2-F 2 -cyclopropyl, 2,2-Cl 2 -cyclopropyl .
  • R 4 Particularly preferred embodiments of R 4 according to the invention are in Table P4 below, wherein each line of lines P3-1 to P3-24 corresponds to one particular embodiment of the invention, wherein P3-1 to P3-24 are also in any combination with one another a preferred embodiment of the present invention.
  • the connection point to the carbon atom, to which R 4 is bound is marked with “#” in the drawings.
  • Y is in each case independently selected from CrC 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, Ci- C 6 -halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, 0-CrC 6 -alkyl, 0-C 2 -C 6 -alkenyl, O-C 2 -C 6 - alkynyl, N(R 5 )-CrC 6 -alkyl, N(R 5 )C 2 -C 6 -alkenyl, N(R 5 ) C 2 -C 6 -alkynyl.
  • Y is in each case independently selected from CrC6-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 - alkynyl, CrC6-halogenalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -halogenalkenyl, N(R 5 )-CrC6-alkyl, N(R 5 )C 2 - C6-alkenyl, N(R 5 ) C 2 -C 6 -alkynyl.
  • Y is in each case independently selected from CrC6-alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 - alkynyl, Ci-C6-halogenalkyl.
  • Y is in each case independently selected from CrC6-alkyl, C 2 -C 6 -alkynyl, C 1 -C 6 - halogenalkyl, N(R 5 )-Ci-C6-alkyl.
  • Y is in each case independently selected CrC 3 -alkyl, C 3 -alkynyl, N(R 5 )-Ci-C 2 -alkyl.
  • Y a is in each case independently selected from halogen, CN, CrCs-alkyl, C 2 -Cs-alkenyl, Ci- Cs-halogenalkyl, C 2 -Cs-halogenalkenyl, phenyl; the acyclic and cyclic moieties of Y a are unsubstituted or substituted by one to six groups Y b
  • Y b is in each case independently selected from halogen, CN, CrCs-alkyl, CrCs-halogenalkyl, phenyl.
  • R ' is in each case independently selected from hydrogen, CrC 6 -alkyl, C2-C6-alkenyl, C2-C6- alkynyl, wherein the acyclic moieties of R are unsubstituted or substituted by one to six groups
  • R R independently of one another are selected from: halogen, CN, 0-CrC 6 -alkyl, C3-C6-cycloalkyl, 0-C 3 -C 6 -cycloalkyl, phenyl, phenoxy; wherein the acyclic and cyclic moieties of R R are unsubstituted or substituted by one to six groups selected from halogen, CN, CrC 6 -alkyl, CrC 6 -halogenalkyl, C3-C6-cycloalkyl, 0-CrC 6 -alkyl, 0-CrC 6 -halogenalkyl;
  • R 5 is H, CrC 6 -alkyl, phenyl, CH2- phenyl, wherein the acyclic and cyclic moieties of R 5 are unsubstituted or substituted by one to six groups R 5a which independently of one another are selected from: halogen, phenyl; and wherein the phenyl is unsubstituted or substituted by one to six halogen.
  • R 5 is, CH 3 , C2H5, phenyl, CH2- phenyl, wherein the acyclic and cyclic moieties of R 5 are unsubstituted or substituted by one to six groups R 5a which independently of one another are selected from: halogen, phenyl; and wherein the phenyl is unsubstituted or substituted by one to six halogen.
  • R 5 is H, CH 3 , C2H5, phenyl, CH2- phenyl, , wherein the acyclic and cyclic moieties of R 5 are unsubstituted or substituted by one to six groups R 5a which independently of one another are selected from: halogen.
  • R 5 is H. According to one embodiment of formula I, R 5 is CN. According to still another embodiment of formula I, R 5 is CrC 6 -alkyl, such as CH3, C2H5, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl, tert-butyl, n-pentyl or i-pentyl. Most preferably is i-propyl, i-butyl, tert-butyl .
  • R 5 is CrC 6 -halogenalkyl, in particular C1-C4- halogenalkyl, such as CF 3 , CC , FCH 2 , CICH 2 , F 2 CH, CI 2 CH, CF 3 CH 2 , CHF 2 CH 2 , CCI 3 CH 2 or CF 2 CHF 2 .
  • R 5 is C 3 -C 6 -cycloalkyl, in particular cyclopropyl.
  • R 5 is C 3 -C 6 -halogencycloalkyl.
  • R 5 is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 2,2-F 2 -cyclopropyl, 2,2-CI 2 -cyclopropyl .
  • R 5 is C 2 -C 6 -alkynyl or C 2 -C 6 -halogenalkynyl, in particular C 2 -C4-alkynyl or C 2 -C4-halogenalkynyl, such as CECH, CH 2 CECH, CECCI, CH 2 CECCI, or CC CECCI.
  • R 5 is 0-CrC 6 -alkanyl in particular C 2 - C4-alkanyl, more specifically Ci-C 2 -alkanyl.
  • R 5 is such as OCH 3 , OC 2 H5.
  • R 5 is 0-C 2 -C 6 -alkenyl in particular C 2 - C4-alkenyl, more specifically C 2 -C 3 -alkenyl.
  • R 5 is 0-C 2 -C 6 -alkynyl, in particular C 2 - C 6 -alkynyl, in particular C 2 -C4-alkynyl, more specifically C 2 -C 3 -alkynyl.
  • R 3 is such as 0CH 2 CECH,
  • R 5 is C 3 -C 6 -cycloalkyl, in particular cyclopropyl, cyclopentyl and cyclohexyl.
  • R 5 is CH 2 -C 3 -C 6 -cycloalkyl, in particular CH 2 - cyclopropyl, CH 2 -cyclopentyl and CH 2 -cyclohexyl.
  • R 5 is C 3 -C 6 -halogencycloalkyl.
  • R 5 is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 2,2-F 2 -cyclopropyl, 2,2-CI 2 -cyclopropyl .
  • R 5 is a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-4
  • 1.2.4-thiadiazol-5-yl preferred are pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl,
  • R 5 is a 6-membered heteroaryl such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl, preferred are pyridin-2-yl, pyridin-3-yl, pyridin-4-yl.
  • R 5 Particularly preferred embodiments of R 5 according to the invention are in Table P5 below, wherein each line of lines P5-1 to P5-107 corresponds to one particular embodiment of the invention, wherein P5-1 to P5-107 are also in any combination with one another a preferred embodiment of the present invention.
  • the connection point to the carbon atom, to which R 5 is bound is marked with “#” in the drawings.
  • R 8 is phenyl, phenoxy, cyclopentyl or cyclohexyl. According to one embodiment of formula I, R 8 is CrC 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl. According to still another embodiment of formula I, R 8 is H.
  • R 8 is CrC 6 -alkyl, in particular CrC 4 -alkyl, such as CH 3 . or C 2 H 5 , in particular CH 3 or CH 2 CH 3 .
  • R 8 is C 2 -C 6 -alkynyl in particular C 2 -C 4 - alkynyl or C 2 -C 4 -halogenalkynyl, such as CECH, ChhCECH.
  • R 8 is 0-CrC 6 -alkyl, in particular C1-C4- alkyl, more specifically Ci-C2-alkoxy.
  • R 2 is such as OCH3 or OCH2CH3.
  • R 8 is 0-C 2 -C 6 -alkenyl in particular C2- C4-alkenyl, more specifically C2-C3-alkenyl.
  • R 8 is 0-C 2 -C 6 -alkynyl, in particular C2- C 6 -alkynyl, in particular C2-C4-alkynyl, more specifically C2-C3-alkynyl.
  • R 2 is such as O-CH2- CECH.
  • R 8 is C3-Cio-cycloalkyl, in particular cyclopropyl, cyclopentyl and cyclohexyl.
  • R 8 is C3-C6-halogencycloalkyl.
  • R 8 is fully or partially halogenated cyclopropyl, such as 1-F-cyclopropyl, 1-CI- cyclopropyl, 2,2-F 2 -cyclopropyl, 2,2-Cl 2 -cyclopropyl.
  • R 8 is a 5-membered heteroaryl such as pyrrol-1 -yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-4
  • 1.2.4-thiadiazol-5-yl preferred are pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl,
  • R 8 is a 6-membered heteroaryl such as pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1 ,3,5-triazin-2-yl and 1 ,2,4-triazin-3-yl, preferred are pyridin-2-yl, pyridin-3-yl, pyridin-4-yl.
  • R 8 Particularly preferred embodiments of R 8 according to the invention are in Table P8 below, wherein each line of lines P8-1 to P8-94 corresponds to one particular embodiment of the invention, wherein P8-1 to P8-94 are also in any combination with one another a preferred embodiment of the present invention.
  • the connection point to the carbon atom, to which R 8 is bound is marked with “#” in the drawings.
  • the invention relates to compounds of the formula IA,
  • R 5 and R 8 are not H.
  • the invention relates to compounds of the formula I as defined above and
  • Y is C(Y a1 Y a2 ), N(R 5 );
  • the invention relates to compounds of the formula I as defined above and
  • Y is C(Y a1 Y a2 )-C(Y a3 Y a4 ), N(R 5 )-C(Y a3 Y a4 ), C(Y a1 Y a2 )-0;
  • the invention relates to compounds of the formula I as defined above and Y C(Y a1 Y a2 )-C(Y a3 Y a4 )-0, C(Y a1 Y a2 )-CH 2 -CoC;
  • Preferred embodiments of the present invention are the following compounds I.C-1, I.C-2, I.C-3, I.C-4; compounds I.D-1, I.D-2, I.D-3, I.D-4.
  • substituents Y and R 8 are independently as defined above or preferably defined herein:
  • Table 1b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4 in which Y is C(Y a1 Y a2 ), R 8 is cyclo-C3H5 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C-1.1 b.X-1 to I.C-1.1b.
  • X-188 I.C-2.1 b.X-1 to I.C-2.1b.X-188, I.C-3.1b.X-1 to I.C-3.1b.X-188, I.C-4.1b.X-1 to I.C-4.1b. X-188; I.D-1.1b.X-1 to I . D-1.1 b.X-188, I.D-2.1b.X-1 to I.D-2.1b.X-188, I.D-3.1b.X-1 to I.D-3.1b. X-188, I.D-4.1b.X-1 to I.D-4.1b.X-188).
  • Table 2b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclo-C ⁇ and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.2b.X-1 to I.C-1 2b. X-188, I.C-2.2b.X-1 to I.C-2.2b.X-188, I.C-3.2b.X-1 to I.C-3.2b.X-188, I.C-
  • Table 3b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclo-CsHgand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.3b.X-1 to I.C-1 3b. X-188, I.C-2.3b.X-1 to I.C-2.3b.X-188, I.C-3.3b.X-1 to I.C-3.3b.X-188, I.C-
  • Table 4b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclo-CeHn and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.4b.X-1 to I.C-1 4b. X-188, I.C-2.4b.X-1 to I.C-2.4b.X-188, I.C-3.4b.X-1 to I.C-3.4b.X-188, I.C-
  • Table 5b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is ⁇ and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.5b.X-1 to I.C-1 5b.X-188, I.C-2.5b.X-1 to I.C-2.5b.X-188, I.C-3.5b.X-1 to I.C-3.5b.X-188, I.C- 4.5b.X-1 to I.C-4.5b.X-188; I.D-1.5b.X-1 to I.D-1.5b.X-188, I.D-2.5b.X-1 to I.D-2.5b.X-188, I.D- 3.5b.X-1 to I.D-
  • Table 6b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is CeF and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table X (compounds I.C-1 6b.X-1 to I.C-1 6b.X-188, I.C-2.6b.X-1 to I.C-2.6b.X-188, I.C-3.6b.X-1 to I.C-3.6b.X-188, I.C-4.6b.X-1 to I.C-4.6b.
  • Table 7b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2-F-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C-1 39b. X- 1 to I.C-1 39b.
  • Table 8b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3-F-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C-1 8b.X-1 to I.C-1 8b.X-188, I.C-2.8b.X-1 to I.C-2.8b.X-188, I.C-3.8b.X-1 to I.C-3.8b.X-188, I.C-4.8b.X-1 to I.C-4.8b.X-188; I.D-1.8b.X-1 to I.D-1.8b.X-188, I.D-2.8b.X-1 to I.D-2.8b.X-188, I.D-3.8b.X-1 to I.
  • Table 9b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 4-F-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C-1 8b.X-1 to I.C-1 8b.X-188, I.C-2.8b.X-1 to I.C-2.8b.X-188, I.C-3.8b.X-1 to I.C-3.8b.X-188, I.C-4.8b.X-1 to I.C-4.8b.X-188; I.D-1.8b.X-1 to I.D-1.8b.X-188, I.D-2.8b.X-1 to I.D-2.8b.X-188, I.D-3.8b.X-1 to I.
  • Table 10b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 each individual compound corresponds in each case to one line of Table X (compounds I.C-1.10b. X- 1 to I.C-1.10b.
  • Table 11b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3-CI-C 6 FUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.11b.
  • Table 12b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 4-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.12b.
  • Table 13b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2-OCH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.13b.X-1 to I.C-1.13b.X-188, I.C-2.13b.X-1 to I.C-2.13b.X-188, I.C-3.13b.X-1 to I.C-3.13b.X- 188, I.C-4.13b.
  • Table 14b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3-OCH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.14b.
  • Table 15b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 4-OCH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.15b.
  • Table 16b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2-OCHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.16b.
  • Table 17b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3-OCHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.17b.
  • Table 18b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ),R 8 is 4-OCHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.18b.
  • Table 19b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.19b.
  • Table 20b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.20b.X-1 to I.C-1.20b.X-188, I.C-2.20b.X-1 to I.C-2.20b.X-188, I.C-3.20b.X-1 to I.C-3.20b.X- 188, I.C-4.20b.X-1 to I.C-4.20b.X-188; I.D-1.20b.X-1 to I.D-1.20b.X-188, I.D-2.20b.X-1 to I.D- 2.20b.
  • Table 21b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 4-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.21b.X-1 to I.C-1.21b.X-188, I.C-2.21b.X-1 to I.C-2.21b.X-188, I.C-3.21b.X-1 to I.C-3.21b.X- 188, I.C-4.21b.X-1 to I.C-4.21b.X-188; I.D-1.21b.X-1 to I.D-1.21b.X-188, I.D-2.21b.X-1 to I.D- 2.21b.
  • Table 22b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2-CF 3 -CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.22b.
  • Table 23b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3-CF 3 -CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.23b.
  • Table 24b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 4-CF 3 -CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.24b.
  • Table 25b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,3-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.25b.
  • Table 26b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,4-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.26b.
  • Table 27b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,5-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.27b.
  • Table 28b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,6-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.28b.X-1 to I.C-1.28b.X-188, I.C-2.28b.X-1 to I.C-2.28b.X-188, I.C-3.28b.X-1 to I.C-3.28b.X- 188, I.C-4.28b.
  • Table 29b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3,4-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.29b.
  • Table 30b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3,5-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.30b.
  • Table 31b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,3-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.31b.
  • Table 32b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,4-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.32b.
  • Table 33b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,5-Cl 2 -C 6 H 3 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.33b.
  • Table 34b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,6-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table (compounds I.C- 1.34b.
  • Table 35b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3,4-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.35b.
  • Table 36b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3,5-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X ((compounds I.C- 1.36b.X-1 to I.C-1.36b.X-188, I.C-2.36b.X-1 to I.C-2.36b.X-188, I.C-3.36b.X-1 to I.C-3.36b.X- 188, I.C-4.36b.
  • Table 37b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,3-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.37b.
  • Table 38b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.39b.
  • Table 39b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.39b.
  • Table 40b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 2,6-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.40b.
  • Table 41b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.41b.
  • Table 42b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is 3,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.42b.
  • Table 43b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.43b.X-1 to I.C-1.43b.X-188, I.C-2.43b.X-1 to I.C-2.43b.X-188, I.C-3.43b.X-1 to I.C-3.43b.X- 188, I.C-4.43b.X-1 to I.C-4.43b.X-188; I.D-1 43b.X-1 to I.D-1.43b.X-188, I.D-2.43b.X-1 to I.D- 2.43b.X-188, I.D-3.43
  • Table 44b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclo-pent-(1)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.44b.X-1 to I.C-1.44b.X-188, I.C-2.44b.X-1 to I.C-2.44b.X-188, I.C-3.44b.X-1 to I.C-3.44b.X- 188, I.C-4.44b.
  • Table 45b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclopent-(2)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.45b.
  • Table 46b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclo-pent-(3)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.46b.
  • Table 47b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclohex-(1)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.47b.
  • Table 48b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclohex-(2)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.48b.
  • Table 49b Compounds of the formula I.C-1 , I.C-2, I.C-3, I.C-4; I.D-1 , I.D-2, I.D-3, I.D-4, in which Y is C(Y a1 Y a2 ), R 8 is cyclohex-(3)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table X (compounds I.C- 1.49b.
  • Preferred embodiments of the present invention are the following compounds I.E-1 , I.E-2, I.E-3, I.E-4; compounds I.F-1 , I.F-2, I.F-3, I.F-4.
  • the substituents R 8 and Y are independently as defined above or preferably defined herein:
  • preference is given to the compounds of the compounds I.E-1 , I.E-2, I.E-3, I.E-4; compounds I.F-1 , I.F-2, I.F-3, I.F-4, that are compiled in the Tables 1c to 49c.
  • Each of the groups mentioned for a substituent in the tables is furthermore per se, independently of the combination in which it is mentioned, a particularly preferred aspect of the substituent in question.
  • Table 1c Compounds of the formula I.E-1, I.E-2, I.E-3, I.E-4; I.F-1 , I.F-2, I.F-3, I.F-4 in which Y NR 5 , R 8 is cyclo-C3H5 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.1c.Y-1 to I.E-1.1c.Y-12, I.E-2.1c.Y-1 to I.E- 2.1C.Y-12, I.E-3.1C.Y-1 to I.E-3.1C.Y-12, I.E-4.1C.Y-1 to I.E-4.1C.Y-12; I.F-1.1c.
  • R 8 is cyclo-C H and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.2c.Y-1 to I.E-1.2c.Y-12, I.E-2.2c.Y-1 to I.E- 2.2c. Y-12, LE-3.2c.Y-1 to LE-3.2c.Y-12, LE-4.2c.Y-1 to LE-4.2c.Y-12; I.F-1.2c. Y-1 to LF-1.2c.Y- 12, LF-2.2c.Y-1 to LF-2.2c.Y-12, LF-3.2c.Y-1 to LF-3.2c.Y-12, LF-4.2c.Y-1 to LF-4.2c.Y-12).
  • R 8 is cyclo-CsHgand the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.3c.Y-1 to I.E-1.3c.Y-12, I.E-2.3c.Y-1 to I.E- 2.3c. Y-12, LE-3.3c.Y-1 to LE-3.3c.Y-12, LE-4.3c.Y-1 to LE-4.3c.Y-12; I.F-1.3c. Y-1 to LF-1.3c.Y- 12, LF-2.3c.Y-1 to LF-2.3c.Y-12, LF-3.3c.Y-1 to LF-3.3c.Y-12, LF-4.3c.Y-1 to LF-4.3c.Y-12).
  • R 8 is cyclo-C 6 Hii and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.4c. Y-1 to I.E-1.4c.Y-12, I.E-2.4c.Y-1 to I.E- 2.4c. Y-12, LE-3.4c.Y-1 to LE-3.4c.Y-12, LE-4.4c.Y-1 to LE-4.4c.Y-12; I.F-1.4c.
  • Y NR 5 , R 8 is and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.5c.Y-1 to I.E-1.5c.Y-12, I.E-2.5c.Y-1 to I.E- 2.5c. Y-12, LE-3.5c.Y-1 to LE-3.5c.Y-12, LE-4.5c.Y-1 to LE-4.5c.Y-12; I.F-1.5c. Y-1 to LF-1.5c.Y- 12, LF-2.5c.Y-1 to LF-2.5c.Y-12, LF-3.5c.Y-1 to LF-3.5c.Y-12, LF-4.5c.Y-1 to LF-4.5c.Y-12).
  • Y NR 5 , R 8 is CeHsand the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.6c.Y-1 to I.E- 1.6c. Y-12, LE-2.6c.Y-1 to LE-2.6c.Y-12, LE-3.6c.Y-1 to LE-3.6c.Y-12, LE-4.6c.Y-1 to LE-4.6c.Y- 12; I.F-1.6c. Y-1 to I.F-1.6c. Y-12, LF-2.6c.Y-1 to LF-2.6c.Y-12, LF-3.6c.Y-1 to LF-3.6c.Y-12, I.F- 4.6c. Y-1 to LF-4.6c.Y-12).
  • Y NR 5 , R 8 is 2-F-CeH 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 39c.Y-1 to I.E-1 39c.Y-12, I.E-2.39c.Y-1 to LE-2.39c.Y-12, LE-3.39c.Y-1 to LE-3.39c.Y-12, LE-4.39c.Y-1 to LE-4.39c.Y-12; I.F-1 39c. Y-1 to I.F-1.39c.
  • Y NR 5 , R 8 is 3-F-CeH 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.8c.Y-1 to I.E-1.8c.Y-12, I.E-2.8c.Y-1 to I.E- 2.8c. Y-12, LE-3.8c.Y-1 to LE-3.8c.Y-12, LE-4.8c.Y-1 to LE-4.8c.Y-12; I.F-1.8c. Y-1 to LF-1.8c.Y- 12, LF-2.8c.Y-1 to LF-2.8c.Y-12, LF-3.8c.Y-1 to LF-3.8c.Y-12, LF-4.8c.Y-1 to LF-4.8c.Y-12).
  • R 8 is 4-F-CeH 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.8c.Y-1 to I.E-1.8c.Y-12, I.E-2.8c.Y-1 to I.E- 2.8c. Y-12, LE-3.8c.Y-1 to LE-3.8c.Y-12, LE-4.8c.Y-1 to LE-4.8c.Y-12; I.F-1.8c. Y-1 to LF-1.8c.Y- 12, LF-2.8c.Y-1 to LF-2.8c.Y-12, LF-3.8c.Y-1 to LF-3.8c.Y-12, LF-4.8c.Y-1 to LF-4.8c.Y-12).
  • Table 10c Compounds of the formula I.E-1, I.E-2, I.E-3, I.E-4; I.F-1 , I.F-2, I.F-3, I.F-4, in which Y NR 5 , R 8 is 2-CI-C 6 H 4 and the meaning for R 5 each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.10c.Y-1 to I.E-1.10c.Y-12, I.E-2.10c.Y-1 to I.E- 2.10C.Y-12, I.E-3.10C.Y-1 to I.E-3.10C.Y-12, I.E-4.10C.Y-1 to I.E-4.10C.Y-12; I.F-1 10c.
  • Y NR 5 , R 8 is 3-CI-C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.11c.Y-1 to I.E-1.11c.Y-12, I.E-2.11c.Y-1 to I.E-2.11c. Y-12, I.E-3.1 lc.Y-1 to I.E-3.11c. Y-12, I.E-4.11c.Y-1 to I.E-4.11c. Y-12; I.F-1.11c. Y-1 to I.F-1.11c. Y-12, I.F-2.11c. Y-1 to I.F-2.11c. Y-12, I.F-3.11c. Y-1 to I.F-3.11c. Y-12, I.F-4.11c. Y-1 to I.F-4.1 lc.Y-12).
  • R 8 is 4-CI-C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.12c.Y-1 to I.E-1.12c.Y-12, I.E-2.12c.Y-1 to I.E-2.12c. Y-12, I.E-3.12C.Y-1 to I.E-3.12C.Y-12, I.E-4.12C.Y-1 to I.E-4.12c. Y-12; I.F-1 12c. Y-1 to I.F-1.12c. Y-12, I.F-2.12c. Y-1 to I.F-2.12C.Y-12, I.F-3.12C.Y-1 to I.F-3.12c. Y-12, I.F-4.12C.Y-1 to I.F-4.12C.Y-12).
  • R 8 is 2-OCH 3 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.13c.Y-1 to I.E-1.13c.Y-12, I.E-2.13c.Y-1 to I.E-2.13c. Y-12, I.E-3.13C.Y-1 to I.E-3.13C.Y-12, I.E-4.13C.Y-1 to I.E-4.13c. Y-12; I.F-1 13c. Y-1 to I.F-1.13c. Y-12, I.F-2.13c. Y-1 to I.F-2.13c. Y-12, I.F-3.13C.Y-1 to I.F-3.13c. Y-12, I.F-4.13C.Y-1 to I.F-4.13C.Y-12).
  • Y NR 5 , R 8 is 3-OCH 3 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.14c.Y-1 to I.E-1.14c.Y-12, I.E-2.14c.Y-1 to I.E-2.14c. Y-12, I.E-3.14C.Y-1 to I.E-3.14C.Y-12, I.E-4.14C.Y-1 to I.E-4.14c. Y-12; I.F-1 14c. Y-1 to I.F-1.14c. Y-12, I.F-2.14c. Y-1 to I.F-2.14C.Y-12, I.F-3.14C.Y-1 to I.F-3.14C.Y-12, I.F-4.14C.Y-1 to I.F-4.14C.Y-12).
  • Y NR 5 , R 8 is 4-OCH 3 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.15c.Y-1 to I.E-1.15c.Y-12, I.E-2.15c.Y-1 to I.E-2.15c. Y-12, I.E-3.15C.Y-1 to I.E-3.15C.Y-12, I.E-4.15C.Y-1 to I.E-4.15c. Y-12; I.F-1 15c. Y-1 to I.F-1.15c. Y-12, I.F-2.15c. Y-1 to I.F-2.15c. Y-12, I.F-3.15C.Y-1 to I.F-3.15c. Y-12, I.F-4.15C.Y-1 to I.F-4.15C.Y-12).
  • R 8 is 2-OCHF 2 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.16c.Y-1 to I.E-1.16c.Y-12, I.E-2.16c.Y-1 to I.E-2.16c. Y-12, I.E-3.16C.Y-1 to I.E-3.16C.Y-12, I.E-4.16C.Y-1 to I.E-4.16c. Y-12; I.F-1 16c. Y-1 to I.F-1.16c. Y-12, I.F-2.16c. Y-1 to I.F-2.16C.Y-12, I.F-3.16C.Y-1 to I.F-3.16c. Y-12).
  • Y NR 5 , R 8 is 3-OCHF 2 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.17c.Y-1 to I.E-1.17c.Y-12, I.E-2.17c.Y-1 to I.E-2.17c. Y-12, I.E-3.17C.Y-1 to I.E-3.17C.Y-12, I.E-4.17C.Y-1 to I.E-4.17c. Y-12; I.F-1 17c. Y-1 to I.F-1.17c. Y-12, I.F-2.17c. Y-1 to I.F-2.17c.
  • Y NR 5 ,R 8 is 4-OCHF 2 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.18c.Y-1 to I.E-1.18c.Y-12, I.E-2.18c.Y-1 to I.E-2.18C.Y-12, I.E-3.18C.Y-1 to I.E-3.18C.Y-12, I.E-4.18C.Y-1 to I.E-4.18C.Y-12; I.F-1 18c. Y-1 to I.F-1.18c. Y-12, I.F-2.18c. Y-1 to I.F-2.18c. Y-12, I.F-3.18C.Y-1 to I.F-3.18c. Y-12, I.F-4.18C.Y-1 to I.F-4.18C.Y-12).).
  • Y NR 5 , R 8 is 2-CH 3 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.19c.Y-1 to I.E-1.19c.Y-12, I.E-2.19c.Y-1 to I.E-2.19c. Y-12, I.E-3.19C.Y-1 to I.E-3.19C.Y-12, I.E-4.19C.Y-1 to I.E-4.19c. Y-12; I.F-1 19c. Y-1 to I.F-1.19c. Y-12, I.F-2.19c. Y-1 to I.F-2.19c. Y-12, I.F-3.19C.Y-1 to I.F-3.19c. Y-12, I.F-4.19C.Y-1 to I.F-4.19C.Y-12).
  • Y NR 5 , R 8 is 3-CH 3 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 20c.Y-1 to I.E-1 20c.Y-12, I.E-2.20c.Y-1 to I.E-2.20C.Y-12, I.E-3.20C.Y-1 to I.E-3.20C.Y-12, I.E-4.20C.Y-1 to I.E-4.20C.Y-12; I.F-1 20c. Y-1 to I.F-1.20c.
  • Y NR 5 , R 8 is 4-CH 3 -C 6 H 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.21c.Y-1 to I.E-1.21c.Y-12, I.E-2.21c.Y-1 to I.E-2.21C.Y-12, I.E-3.21C.Y-1 to I.E-3.21C.Y-12, I.E-4.21C.Y-1 to I.E-4.21C.Y-12; I.F-1 21c. Y-1 to I.F-1.21c.
  • R 8 is 2-CF 3 -CeH 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 22c.Y-1 to I.E-1 22c.Y-12, I.E-2.22c.Y-1 to I.E-2.22C.Y-12, I.E-3.22C.Y-1 to I.E-3.22C.Y-12, I.E-4.22C.Y-1 to I.E-4.22C.Y-12; I.F-1 22c. Y-1 to I.F-1.22c.
  • Y NR 5 , R 8 is 3-CF 3 -CeH 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 23c.Y-1 to I.E-1 23c.Y-12, I.E-2.23c.Y-1 to I.E-2.23C.Y-12, I.E-3.23C.Y-1 to I.E-3.23C.Y-12, I.E-4.23C.Y-1 to I.E-4.23C.Y-12; I.F-1 23c. Y-1 to I.F-1.23c.
  • Y NR 5 , R 8 is 4-CF 3 -CeH 4 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 24c.Y-1 to I.E-1 24c.Y-12, I.E-2.24c.Y-1 to I.E-2.24C.Y-12, I.E-3.24C.Y-1 to I.E-3.24C.Y-12, I.E-4.24C.Y-1 to I.E-4.24C.Y-12; I.F-1 24c. Y-1 to I.F-1.24c.
  • Y NR 5 , R 8 is 2,3-F 2 -CeH 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 25c.Y-1 to I.E-1 25c.Y-12, I.E-2.25c.Y-1 to I.E-2.25C.Y-12, I.E-3.25C.Y-1 to I.E-3.25C.Y-12, I.E-4.25C.Y-1 to I.E-4.25C.Y-12; I.F-1 25c. Y-1 to I.F-1.25c.
  • Y NR 5 , R 8 is 2,4-F 2 -CeH 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 26c.Y-1 to I.E-1 26c.Y-12, I.E-2.26c.Y-1 to I.E-2.26C.Y-12, I.E-3.26C.Y-1 to I.E-3.26C.Y-12, I.E-4.26C.Y-1 to I.E-4.26C.Y-12; I.F-1 26c. Y-1 to I.F-1.26c.
  • Y NR 5 , R 8 is 2,5-F 2 -CeH 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 27c.Y-1 to I.E-1 27c.Y-12, I.E-2.27c.Y-1 to I.E-2.27C.Y-12, I.E-3.27C.Y-1 to I.E-3.27C.Y-12, I.E-4.27C.Y-1 to I.E-4.27C.Y-12; I.F-1 27c. Y-1 to I.F-1.27c.
  • Y NR 5 , R 8 is 2,6-F 2 -CeH 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 28c.Y-1 to I.E-1 28c.Y-12, I.E-2.28c.Y-1 to I.E-2.28C.Y-12, I.E-3.28C.Y-1 to I.E-3.28C.Y-12, I.E-4.28C.Y-1 to I.E-4.28C.Y-12; I.F-1 28c. Y-1 to I.F-1.28c.
  • Y NR 5 , R 8 is 3,4-F 2 -CeH 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 29c.Y-1 to I.E-1 29c.Y-12, I.E-2.29c.Y-1 to I.E-2.29C.Y-12, I.E-3.29C.Y-1 to I.E-3.29C.Y-12, I.E-4.29C.Y-1 to I.E-4.29C.Y-12; I.F-1 29c. Y-1 to I.F-1.29c.
  • Y NR 5 , R 8 is 3,5-F 2 -CeH 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 30c.Y-1 to I.E-1 30c.Y-12, I.E-2.30c.Y-1 to I.E-2.30C.Y-12, I.E-3.30C.Y-1 to I.E-3.30C.Y-12, I.E-4.30C.Y-1 to I.E-4.30C.Y-12; I.F-1 30c. Y-1 to I.F-1.30c.
  • Y NR 5 , R 8 is 2,3-Cl 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.31c.Y-1 to I.E-1.31c.Y-12, I.E-2.31c.Y-1 to I.E-2.31C.Y-12, I.E-3.31C.Y-1 to I.E-3.31C.Y-12, I.E-4.31C.Y-1 to I.E-4.31C.Y-12; I.F-1 31c. Y-1 to I.F-1.31c.
  • Y NR 5 , R 8 is 2,4-Cl 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 32c.Y-1 to I.E-1 32c.Y-12, I.E-2.32c.Y-1 to I.E-2.32C.Y-12, I.E-3.32C.Y-1 to I.E-3.32C.Y-12, I.E-4.32C.Y-1 to I.E-4.32C.Y-12; I.F-1 32c. Y-1 to I.F-1.32c.
  • Y NR 5 , R 8 is 2,5-Cl 2 -C 6 H 3 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 33c.Y-1 to I.E- 1.33C.Y-12, I.E-2.33C.Y-1 to I.E-2.33C.Y-12, I.E-3.33C.Y-1 to I.E-3.33C.Y-12, I.E-4.33C.Y-1 to I.E-4.33C.Y-12; I.F-1 33c. Y-1 to I.F-1 33c. Y-12, I.F-2.33c. Y-1 to I.F-2.33C.Y-12, I.F-3.33C.Y-1 to I.F-3.33C.Y-12, I.F-4.33C.Y-1 to I.F-4.33c. Y-12).
  • R 8 is 2,6-Cl 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table (compounds I.E-1.34c.Y-1 to I.E-1 34c.Y-12, I.E-2.34c.Y-1 to I.E- 2.34c. Y-12, I.E-3.34C.Y-1 to I.E-3.34C.Y-12, I.E-4.34C.Y-1 to I.E-4.34C.Y-12; I.F-1 34c. Y-1 to I.F- 1.34c.
  • Y NR 5 , R 8 is 3,4-Cl 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 35c.Y-1 to I.E-1 35c.Y-12, I.E-2.35c.Y-1 to I.E-2.35C.Y-12, I.E-3.35C.Y-1 to I.E-3.35C.Y-12, I.E-4.35C.Y-1 to I.E-4.35C.Y-12; I.F-1 35c. Y-1 to I.F-1.35c.
  • Y NR 5 , R 8 is 3,5-Cl 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y ((compounds I.E-1 36c.Y-1 to I.E-1.36c.Y-12, I.E-2.36c.Y-1 to I.E-2.36C.Y-12, I.E-3.36C.Y-1 to I.E-3.36C.Y-12, I.E-4.36C.Y-1 to I.E-4.36C.Y-12; I.F-1 36c. Y-1 to I.F-1.36c.
  • Y NR 5 , R 8 is 2,3-(CH 3 ) 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 37c.Y-1 to I.E-1 37c.Y-12, I.E-2.37c.Y-1 to I.E-2.37C.Y-12, I.E-3.37C.Y-1 to I.E-3.37C.Y-12, I.E-4.37C.Y-1 to I.E-4.37C.Y-12; I.F-1 37c. Y-1 to I.F-1.37c.
  • Y NR 5 , R 8 is 2,4-(CH 3 ) 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 39c.Y-1 to I.E-1 39c.Y-12, I.E-2.39c.Y-1 to I.E-2.39C.Y-12, I.E-3.39C.Y-1 to I.E-3.39C.Y-12, I.E-4.39C.Y-1 to I.E-4.39C.Y-12; I.F-1 39c. Y-1 to I.F-1.39c.
  • Y NR 5 , R 8 is 2,5-(CH 3 ) 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 39c.Y-1 to I.E-1 39c.Y-12, I.E-2.39c.Y-1 to I.E-2.39C.Y-12, I.E-3.39C.Y-1 to I.E-3.39C.Y-12, I.E-4.39C.Y-1 to I.E-4.39C.Y-12; I.F-1 39c. Y-1 to I.F-1.39c.
  • Y NR 5 , R 8 is 2,6-(CH 3 ) 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 40c.Y-1 to I.E-1 40c.Y-12, I.E-2.40c.Y-1 to I.E-2.40C.Y-12, I.E-3.40C.Y-1 to I.E-3.40C.Y-12, I.E-4.40C.Y-1 to I.E-4.40C.Y-12; I.F-1 40c. Y-1 to I.F-1.40c.
  • Table 41c Compounds of the formula I.E-1, I.E-2, I.E-3, I.E-4; I.F-1 , I.F-2, I.F-3, I.F-4, in which Y NR 5 , R 8 is 3,4-(CH 3 ) 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.41c.Y-1 to I.E-1.41c.Y-12, I.E-2.41c.Y-1 to I.E-2.41C.Y-12, I.E-3.41C.Y-1 to I.E-3.41C.Y-12, I.E-4.41C.Y-1 to I.E-4.41C.Y-12; I.F-1 41c.
  • Y NR 5 , R 8 is 3,5-(CH 3 ) 2 -C 6 H 3 and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 42c.Y-1 to I.E-1 42c.Y-12, I.E-2.42c.Y-1 to I.E-2.42C.Y-12, I.E-3.42C.Y-1 to I.E-3.42C.Y-12, I.E-4.42C.Y-1 to I.E-4.42C.Y-12; I.F-1 42c. Y-1 to I.F-1.42c.
  • Y NR 5 , R 8 is and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 43c.Y-1 to I.E-1 43c.Y-12, I.E-2.43c.Y-1 to I.E-2.43C.Y-12, I.E-3.43C.Y-1 to I.E-3.43C.Y-12, I.E-4.43C.Y-1 to I.E-4.43C.Y-12; I.F-1 43c. Y-1 to I.F-1.43c.
  • R 8 is cyclo-pent-(1)-en and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.44c.Y-1 to I.E-1.44c.Y-12, I.E-2.44c. Y-1 to I.E-2.44C.Y-12, I.E-3.44C.Y-1 to I.E-3.44C.Y-12, I.E-4.44C.Y-1 to I.E-4.44C.Y-12; I.F-1.44c. Y-1 to I.F-1.44c.
  • Y NR 5 , R 8 is cyclopent-(2)-en and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 45c.Y-1 to I.E-1 45c.Y-12, I.E-2.45c.Y-1 to I.E-2.45C.Y-12, I.E-3.45C.Y-1 to I.E-3.45C.Y-12, I.E-4.45C.Y-1 to I.E-4.45C.Y-12; I.F-1 45c. Y-1 to I.F-1.45c.
  • R 8 is cyclo-pent-(3)-en and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1.46c.Y-1 to I.E-1.46c.Y-12, I.E-2.46c. Y-1 to I.E-2.46C.Y-12, I.E-3.46C.Y-1 to I.E-3.46C.Y-12, I.E-4.46C.Y-1 to I.E-4.46C.Y-12; I.F-1.46c. Y-1 to I.F-1.46c.
  • R 8 is cyclohex-(1)-en and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 47c.Y-1 to I.E-1 47c.Y-12, I.E-2.47c.Y-1 to I.E-2.47C.Y-12, I.E-3.47C.Y-1 to I.E-3.47C.Y-12, I.E-4.47C.Y-1 to I.E-4.47C.Y-12; I.F-1 47c. Y-1 to I.F-1.47c.
  • R 8 is cyclohex-(2)-en and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 48c.Y-1 to I.E-1 48c.Y-12, I.E-2.48c.Y-1 to I.E-2.48C.Y-12, I.E-3.48C.Y-1 to I.E-3.48C.Y-12, I.E-4.48C.Y-1 to I.E-4.48C.Y-12; I.F-1 48c.
  • Table 49c Compounds of the formula I.E-1, I.E-2, I.E-3, I.E-4; I.F-1, I.F-2, I.F-3, I.F-4, in which Y NR 5 , R 8 is cyclohex-(3)-en and the meaning for R 5 for each individual compound corresponds in each case to one line of Table Y (compounds I.E-1 49c.Y-1 to I.E-1 49c.Y-12, I.E-2.49c.Y-1 to LE-2.49c.Y-12, LE-3.49c.Y-1 to LE-3.49c.Y-12, LE-4.49c.Y-1 to LE-4.49c.Y-12; I.F-1 49c. Y-1 to I.F-1.49c.
  • Preferred embodiments of the present invention are the following compounds I.G-1, I.G-2, I.G-3, I.G-4; compounds I.H-1, I.H-2, I.H-3, I.H-4.
  • substituents Y and R 8 are independently as defined above or preferably defined herein:
  • Table 1d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4 in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclo-CsHs and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.1d.Z-1 to I.G-1.1d.Z-1504, I.G-2.1d.Z-1 to I.G-2.1d.Z-1504, I.G-3.1d.Z-1 to I.G-3.1d.Z-1504, I.G-4.1d.Z-1 to I.G-4.1d.Z-1504; I.H-1.1d.Z-1 to I .
  • Table 2d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclo-C ⁇ and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.2d.Z-1 to I.G-1 2d.Z-1504, I.G-2.2d.Z-1 to I.G-2.2d.Z-1504, I.G-3.2d.Z-1 to I.G-3.2d.
  • Table 3d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclo-CsHgand the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.3d.Z-1 to I.G-1.3d.Z-1504, I.G-2.3d.Z-1 to I.G-2.3d.Z-1504, I.G-3.3d.Z-1 to I.G-3.3d.
  • Z-1504 I.G-4.3d.Z-1 to I.G-4.3d.Z-1504; I.H-1.3d.Z-1 to I.H-1.3d.Z-1504, I.H-2.3d.Z-1 to I.H-2.3d. Z-1504, I.H-3.3d.Z-1 to I.H-3.3d.Z-1504, I.H-4.3d.Z-1 to I.H-4.3d.Z-1504).
  • Table 4d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclo-CeHn and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.4d.Z-1 to I.G-1 4d.Z-1504, I.G-2.4d.Z-1 to I.G-2.4d.Z-1504, I.G-3.4d.Z-1 to I.
  • G-3.4d. Z-1504 I.G-4.4d.Z-1 to I.G-4.4d.Z-1504; I.H-1.4d.Z-1 to I.H-1.4d.Z-1504, I.H-2.4d.Z-1 to I. H-2.4d. Z-1504, I.H-3.4d.Z-1 to I.H-3.4d.Z-1504, I.H-4.4d.Z-1 to I.H-4.4d.Z-1504).
  • Table 5d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is ⁇ and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.5d.Z-1 to I.G-1.5d.Z-1504, I.G-2.5d.Z-1 to I.G-2.5d.Z-1504, I.G-3.5d.Z-1 to I.G-3.5d.Z-1504, I.G-4.5d.Z-1 to I.G-4.5d.Z-1504; I.H-1.5d.Z-1 to I.H-1.5d.Z-1504, I.H-2.5d.Z-1 to I.H-2.5d.Z-1504,
  • Table 6d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is C 6 H 5 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table X (compounds I.G- 1.6d.Z-1 to I.G-1.6d.Z-1504, I.G-2.6d.Z-1 to I.G-2.6d.Z-1504, I.G-3.6d.Z-1 to I.G-3.6d.Z-1504, I.G-4.6d.Z-1 to I.G-4.6d.Z-1504; I.H-1.6d.Z-1 to I.H-1.6d.Z-1504, I.H-2.6d.Z-1 to I.H-2.6d.Z- 1504, I.H-3.6d.Z-1 to I
  • Table 7d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2-F-C 6 H 4 and the meaning for the combination Y A1 , Y A2 ,
  • Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.39d.Z-1 to I.G-1.39d.Z-1504, I.G-2.39d.Z-1 to I.G-2.39d.Z-1504, I.G-3.39d.Z- 1 to I.G-3.39d.Z-1504, I.G-4.39d.Z-1 to I.G-4.39d.Z-1504; I.H-1.39d.Z-1 to I.H-1.39d.Z-1504, I.H-2.39d.Z-1 to I.H-2.39d.Z-1504, I.H-3.39d.Z-1 to I.H-3.39d.Z-1504, I.H-4.39d.Z-1 to I.H- 4.39d.Z-1504).
  • Table 8d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3-F-C 6 H 4 and the meaning for the combination Y A1 , Y A2 ,
  • Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.8d.Z-1 to I.G-1.8d.Z-1504, I.G-2.8d.Z-1 to I.G-2.8d.Z-1504, I.G-3.8d.Z-1 to I.G-3.8d.Z-1504, I.G-4.8d.Z-1 to I.G-4.8d.Z-1504; I.H-1.8d.Z-1 to I.H-1.8d.Z-1504, I.H-2.8d.Z-1 to I.H-2.8d.Z-1504, I.H-3.8d.Z-1 to I.H-3.8d.Z-1504, I.H-4.8d.Z-1 to I.H-4.8d.Z-1504).
  • Table 9d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 4-F-C 6 H 4 and the meaning for the combination Y A1 , Y A2 ,
  • Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.8d.Z-1 to I.G-1.8d.Z-1504, I.G-2.8d.Z-1 to I.G-2.8d.Z-1504, I.G-3.8d.Z-1 to I.G-3.8d.Z-1504, I.G-4.8d.Z-1 to I.G-4.8d.Z-1504; I.H-1.8d.Z-1 to I.H-1.8d.Z-1504, I.H-2.8d.Z-1 to I.H-2.8d.Z-1504, I.H-3.8d.Z-1 to I.H-3.8d.Z-1504, I.H-4.8d.Z-1 to I.H-4.8d.Z-1504).
  • Table 10d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2-CI-CeH 4 and the meaning for the combination of Y a1 and Y a2 each individual compound corresponds in each case to one line of Table X (compounds I.G- 1.10d.Z-1 to I.G-1.10d.Z-1504, I.G-2.10d.Z-1 to I.G-2.10d.Z-1504, I.G-3.10d.Z-1 to I.G-3.10d.Z- 1504, I.G-4.10d.Z-1 to I.G-4.10d.Z-1504; I .
  • H-1.10d.Z-1 to I.H-1.10d.Z-1504 I.H-2.10d.Z-1 to I.H-2.10d.Z-1504, I.H-3.10d.Z-1 to I.H-3.10d.Z-1504, I.H-4.10d.Z-1 to I.H-4.10d.Z-1504).
  • Table 11d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3-CI-CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.11 d.Z-1 to I .G-1.11 d.Z-1504, I.G-2.11d.Z-1 to I.G-2.11d.Z-1504, I.G-3.11d.Z- 1 to I.G-3.11d.Z-1504, I.G-4.11d.Z-1 to I.G-4.11d.Z-1504; I.H-1.11d.Z-1 to I . H-1.11 d.Z-1504,
  • Table 12d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 4-CI-CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.12d.Z-1 to I.G-1.12d.Z-1504, I.G-2.12d.Z-1 to I.G-2.12d.Z-1504, I.G-3.12d.Z- 1 to I.G-3.12d.Z-1504, I.G-4.12d.Z-1 to I.G-4.12d.Z-1504; I .
  • H-1.12d.Z-1 to I.H-1.12d.Z-1504 I.H-2.12d.Z-1 to I.H-2.12d.Z-1504, I.H-3.12d.Z-1 to I.H-3.12d.Z-1504, I.H-4.12d.Z-1 to I.H- 4.12d.Z-1504).
  • Table 13d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I. H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2-OCH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.13d.Z-1 to I.G-1.13d.Z-1504, I.G-2.13d.Z-1 to I.G-2.13d.Z-1504, I.G-3.13d.Z- 1 to I.G-3.13d.
  • Table 14d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I. H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3-OCH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.14d.Z-1 to I.G-1.14d.Z-1504, I.G-2.14d.Z-1 to I.G-2.14d.Z-1504, I.G-3.14d.Z- 1 to I.
  • Table 15d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I. H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 4-OCH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.15d.Z-1 to I.G-1.15d.Z-1504, I.G-2.15d.Z-1 to I.G-2.15d.Z-1504, I.G-3.15d.Z- 1 to I.
  • Table 16d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I. H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2-OCHF 2 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.16d.Z-1 to I.G-1.16d.Z-1504, I.G-2.16d.Z-1 to I.G-2.16d.Z-1504, I.G-3.16d.Z- 1 to I.
  • Table 17d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I. H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3-OCHF 2 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.17d.Z-1 to I.G-1.17d.Z-1504, I.G-2.17d.Z-1 to I.G-2.17d.Z-1504, I.G-3.17d.Z- 1 to I.
  • Table 18d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I. H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y A4 ),R 8 is 4-OCHF 2 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.18d.Z-1 to I.G-1.18d.Z-1504, I.G-2.18d.Z-1 to I.G-2.18d.Z-1504, I.G-3.18d.Z- 1 to I.
  • Table 19d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2-CH 3 -C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.19d.Z-1 to I.G-1.19d.Z-1504, I.G-2.19d.Z-1 to I.G-2.19d.Z-1504, I.G-3.19d.Z- 1 to I.G-3.19d.Z-1504, I.G-4.19d.Z-1 to I.G-4.19d.Z-1504; I .
  • Table 20d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3-CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.20d.Z-1 to I.G-1.20d.Z-1504, I.G-2.20d.Z-1 to I.G-2.20d.Z-1504, I.G-3.20d.Z- 1 to I.G-3.20d.Z-1504, I.G-4.20d.Z-1 to I.G-4.20d.Z-1504; I.H-1.20d.Z-1 to I.H-1.20d.Z-1504, I.H
  • Table 21d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 4-CH 3 -C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.21d.Z-1 to I.G-1.21d.Z-1504, I.G-2.21d.Z-1 to I.G-2.21d.Z-1504, I.G-3.21d.Z- 1 to I.G-3.21d.Z-1504, I.G-4.21d.Z-1 to I.G-4.21d.Z-1504; I.H-1.21d.Z-1 to I.H-1.21d.Z-1504, I.H
  • Table 22d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2-CF 3 -C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.22d.Z-1 to I.G-1.22d.Z-1504, I.G-2.22d.Z-1 to I.G-2.22d.Z-1504, I.G-3.22d.Z- 1 to I.G-3.22d.Z-1504, I.G-4.22d.Z-1 to I.G-4.22d.Z-1504; I.H-1.22d.Z-1 to I.H-1.22d.Z-1504, I.H
  • Table 23d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3-CF 3 -C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.23d.Z-1 to I.G-1.23d.Z-1504, I.G-2.23d.Z-1 to I.G-2.23d.Z-1504, I.G-3.23d.Z- 1 to I.G-3.23d.
  • Table 24d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 4-CF 3 -C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.24d.Z-1 to I.G-1.24d.Z-1504, I.G-2.24d.Z-1 to I.G-2.24d.Z-1504, I.G-3.24d.Z- 1 to I.
  • G-3.24d. Z-1504 I.G-4.24d.Z-1 to I.G-4.24d.Z-1504; I.H-1.24d.Z-1 to I.H-1.24d.Z-1504, I.H-2.24d.Z-1 to I.H-2.24d.Z-1504, I.H-3.24d.Z-1 to I.H-3.24d.Z-1504, I.H-4.24d.Z-1 to I.H- 4.24d.Z-1504).
  • Table 25d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,3-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.25d.Z-1 to I.G-1.25d.Z-1504, I.G-2.25d.Z-1 to I.G-2.25d.Z-1504, I.G-3.25d.Z- 1 to I.
  • G-3.25d. Z-1504 I.G-4.25d.Z-1 to I.G-4.25d.Z-1504; I.H-1.25d.Z-1 to I.H-1.25d.Z-1504, I.H-2.25d.Z-1 to I.H-2.25d.Z-1504, I.H-3.25d.Z-1 to I.H-3.25d.Z-1504, I.H-4.25d.Z-1 to I.H- 4.25d.Z-1504).
  • Table 26d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,4-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.26d.Z-1 to I.G-1.26d.Z-1504, I.G-2.26d.Z-1 to I.G-2.26d.Z-1504, I.G-3.26d.Z- 1 to I.G-3.26d.Z-1504, I.G-4.26d.Z-1 to I.G-4.26d.Z-1504; I.H-1.26d.Z-1 to I.H-1.26d.Z-1504, I
  • Table 27d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,5-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.27d.Z-1 to I.G-1.27d.Z-1504, I.G-2.27d.Z-1 to I.G-2.27d.Z-1504, I.G-3.27d.Z- 1 to I.G-3.27d.Z-1504, I.G-4.27d.Z-1 to I.G-4.27d.Z-1504; I.H-1.27d.Z-1 to I.H-1.27d.Z-1504, I
  • Table 28d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,6-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.28d.Z-1 to I.G-1.28d.Z-1504, I.G-2.28d.Z-1 to I.G-2.28d.Z-1504, I.G-3.28d.Z- 1 to I.G-3.28d.Z-1504, I.G-4.28d.Z-1 to I.G-4.28d.Z-1504; I.H-1.28d.Z-1 to I.H-1.28d.Z-1504, I
  • Table 29d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3,4-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.29d.Z-1 to I.G-1.29d.Z-1504, I.G-2.29d.Z-1 to I.G-2.29d.Z-1504, I.G-3.29d.Z- 1 to I.G-3.29d.Z-1504, I.G-4.29d.Z-1 to I.G-4.29d.Z-1504; I.H-1.29d.Z-1 to I.H-1.29d.Z-1504, I
  • Table 30d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3,5-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.30d.Z-1 to I.G-1.30d.Z-1504, I.G-2.30d.Z-1 to I.G-2.30d.Z-1504, I.G-3.30d.Z- 1 to I.G-3.30d.Z-1504, I.G-4.30d.Z-1 to I.G-4.30d.Z-1504; I.H-1.30d.Z-1 to I.H-1.30d.Z-1504, I.
  • Table 31d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,3-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.31d.Z-1 to I.G-1.31d.Z-1504, I.G-2.31d.Z-1 to I.G-2.31d.Z-1504, I.G-3.31d.Z- 1 to I.G-3.31d.Z-1504, I.G-4.31d.Z-1 to I.G-4.31d.Z-1504; I.H-1.31d.Z-1 to I.H-1.31d.Z-1504,
  • Table 32d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,4-CI 2-C6H3 and the meaning for the combination Y A1 ,
  • Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.32d.Z-1 to I.G-1.32d.Z-1504, I.G-2.32d.Z-1 to I.G-2.32d.Z-1504, I.G-3.32d.Z- 1 to I.G-3.32d.Z-1504, I.G-4.32d.Z-1 to I.G-4.32d.Z-1504; I.H-1.32d.Z-1 to I.H-1.32d.Z-1504, I.H-2.32d.Z-1 to I.H-2.32d.Z-1504, I.H-3.32d.Z-1 to I.H-3.32d.Z-1504, I.H-4.32d.Z-1 to I.H- 4.32d.Z-1504).
  • Table 33d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,5-Cl 2 -C 6 H 3 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.33d.Z-1 to I.G-1.33d.Z-1504, I.G-2.33d.Z-1 to I.G-2.33d.Z-1504, I.G-3.33d.Z- 1 to I.G-3.33d.
  • Table 34d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,6-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table (compounds I.G-1.34d.Z-1 to I.G-1.34d.Z-1504, I.G-2.34d.Z-1 to I.G-2.34d.Z-1504, I.G-3.34d.Z- 1 to I.
  • G-3.34d. Z-1504 I.G-4.34d.Z-1 to I.G-4.34d.Z-1504; I.H-1.34d.Z-1 to I.H-1.34d.Z-1504, I.H-2.34d.Z-1 to I.H-2.34d.Z-1504, I.H-3.34d.Z-1 to I.H-3.34d.Z-1504, I.H-4.34d.Z-1 to I.H- 4.34d.Z-1504).
  • Table 35d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3,4-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.35d.Z-1 to I.G-1.35d.Z-1504, I.G-2.35d.Z-1 to I.G-2.35d.Z-1504, I.G-3.35d.Z- 1 to I.
  • G-3.35d. Z-1504 I.G-4.35d.Z-1 to I.G-4.35d.Z-1504; I.H-1.35d.Z-1 to I.H-1.35d.Z-1504, I.H-2.35d.Z-1 to I.H-2.35d.Z-1504, I.H-3.35d.Z-1 to I.H-3.35d.Z-1504, I.H-4.35d.Z-1 to I.H- 4.35d.Z-1504).
  • Table 36d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3,5-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X ((compounds I.G-1.36d.Z-1 to I.G-1.36d.Z-1504, I.G-2.36d.Z-1 to I.G-2.36d.Z-1504, I.G- 3.36d.Z-1 to I.
  • G-3.36d. Z-1504 I.G-4.36d.Z-1 to I.G-4.36d.Z-1504; I.H-1.36d.Z-1 to I.H-1.36d.Z- 1504, I.H-2.36d.Z-1 to I.H-2.36d.Z-1504, I.H-3.36d.Z-1 to I.H-3.36d.Z-1504, I.H-4.36d.Z-1 to I.H- 4.36d.Z-1504).
  • Table 37d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,3-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.37d.Z-1 to I.G-1.37d.Z-1504, I.G-2.37d.Z-1 to I.G-2.37d.Z-1504, I.G-3.37d.Z- 1 to I.
  • G-3.37d. Z-1504 I.G-4.37d.Z-1 to I.G-4.37d.Z-1504; I.H-1.37d.Z-1 to I.H-1.37d.Z-1504, I.H-2.37d.Z-1 to I.H-2.37d.Z-1504, I.H-3.37d.Z-1 to I.H-3.37d.Z-1504, I.H-4.37d.Z-1 to I.H- 4.37d.Z-1504).
  • Table 38d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,4-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.39d.Z-1 to I.G-1.39d.Z-1504, I.G-2.39d.Z-1 to I.G-2.39d.Z-1504, I.G-3.39d.Z- 1 to I.
  • G-3.39d. Z-1504 I.G-4.39d.Z-1 to I.G-4.39d.Z-1504; I.H-1.39d.Z-1 to I.H-1.39d.Z-1504, I.H-2.39d.Z-1 to I.H-2.39d.Z-1504, I.H-3.39d.Z-1 to I.H-3.39d.Z-1504, I.H-4.39d.Z-1 to I.H- 4.39d.Z-1504).
  • Table 39d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,5-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.39d.Z-1 to I.G-1.39d.Z-1504, I.G-2.39d.Z-1 to I.G-2.39d.Z-1504, I.G-3.39d.Z- 1 to I.G-3.39d.Z-1504, I.G-4.39d.Z-1 to I.G-4.39d.Z-1504; I.H-1.39d.Z-1 to I.H-1.39d.Z
  • Table 40d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 2,6-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.40d.Z-1 to I.G-1.40d.Z-1504, I.G-2.40d.Z-1 to I.G-2.40d.Z-1504, I.G-3.40d.Z- 1 to I.G-3.40d.Z-1504, I.G-4.40d.Z-1 to I.G-4.40d.Z-1504; I.H-1.40d.Z-1 to I.H-1.40d.Z
  • Table 41d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3,4-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.41d.Z-1 to I.G-1.41d.Z-1504, I.G-2.41d.Z-1 to I.G-2.41d.Z-1504, I.G-3.41d.Z- 1 to I.G-3.41d.Z-1504, I.G-4.41d.Z-1 to I.G-4.41d.Z-1504; I.H-1.41d.Z-1 to I.H-1.41d.Z
  • Table 42d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 3,5-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.42d.Z-1 to I.G-1.42d.Z-1504, I.G-2.42d.Z-1 to I.G-2.42d.Z-1504, I.G-3.42d.Z- 1 to I.G-3.42d.Z-1504, I.G-4.42d.Z-1 to I.G-4.42d.Z-1504; I.H-1.42d.Z-1 to I.H-1.42d.Z-15
  • Table 43d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in and the meaning for the combination Y A1 , g A2 g A3 anc
  • g A4 f or gg ⁇ individual compound corresponds in each case to one line of Table X (compounds I.G-1.43d.Z-1 to I.G-1.43d.Z-1504, I.G-2.43d.Z-1 to I.G-2.43d.Z-1504, I.G-3.43d.Z- 1 to I.G-3.43d.Z-1504, I.G-4.43d.Z-1 to I.G-4.43d.Z-1504; I.H-1.43d.Z-1 to I.H-1.43d.Z-1504, I.H-2.43d.Z-1 to I.H-2.43d.Z-1504, I.H-3.43d.Z-1 to I
  • Table 44d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclo-pent-(1)-en and the meaning for the combination Y A1 g A 2 g A3 anc
  • individual compound corresponds in each case to one line of Table X (compounds I.G-1.44d.Z-1 to I.G-1.44d.Z-1504, I.G-2.44d.Z-1 to I.G-2.44d.Z-1504, I.G- 3.44d.Z-1 to I.G-3.44d.Z-1504, I.G-4.44d.Z-1 to I.G-4.44d.Z-1504; I.H-1.44d.Z-1 to I.H-1.44d
  • Table 45d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclopent-(2)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.45d.Z-1 to I.G-1.45d.Z-1504, I.G-2.45d.Z-1 to I.G-2.45d.Z-1504, I.G-3.45d.Z- 1 to I.G-3.45d.Z-1504, I.G-4.45d.Z-1 to I.G-4.45d.Z-1504; I.H-1.45d.Z-1 to I.H-1.45d.Z-1504, I.H-2
  • Table 46d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclo-pent-(3)-en and the meaning for the combination Y A1 g A 2 g A3 anc
  • Table 47d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclohex-(1)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.47d.Z-1 to I.G-1.47d.Z-1504, I.G-2.47d.Z-1 to I.G-2.47d.Z-1504, I.G-3.47d.Z- 1 to I.G-3.47d.Z-1504, I.G-4.47d.Z-1 to I.G-4.47d.Z-1504; I.H-1.47d.Z-1 to I.H-1.47d.Z-1504, I.H
  • Table 48d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclohex-(2)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.48d.Z-1 to I.G-1.48d.Z-1504, I.G-2.48d.Z-1 to I.G-2.48d.Z-1504, I.G-3.48d.Z- 1 to I.G-3.48d.Z-1504, I.G-4.48d.Z-1 to I.G-4.48d.Z-1504; I.H-1.48d.Z-1 to I.H-1.48d.Z-1504, I.H
  • Table 49d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is cyclohex-(3)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.49d.Z-1 to I.G-1.49d.Z-1504, I.G-2.49d.Z-1 to I.G-2.49d.Z-1504, I.G-3.49d.Z- 1 to I.G-3.49d.Z-1504, I.G-4.49d.Z-1 to I.G-4.49d.Z-1504; I.H-1.49d.Z-1 to I.H-1.49d.Z-1504, I.H
  • Table 1d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4 in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is O-cyclo-CsHs and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.1 d ' .Z-1 to I.G-1.1d ' .Z-1504, I.G-2.1d ' .Z-1 to I.G-2.1d ' .Z-1504, I.G-3.1d ' .Z-1 to I.G-3.1d ' .Z-1504, I.G-4.1d ' .Z-1 to I.G-4.1d ' .Z-1504; I.H-1.1d ' .
  • Table 2d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclo-C 4 H 7 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.2d ' .Z-1 to I.G-1.2d ' .Z-1504, I.G-2.2d ' .Z-1 to I.G-2.2d ' .Z-1504, I.G-3.2d ' .Z-1 to I.G-3.2d ' .
  • Table 3d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is O-cyclo-CsHgand the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.3d ' .Z-1 to I.G-1.3d ' .Z-1504, I.G-2.3d ' .Z-1 to I.G-2.3d ' .Z-1504, I.G-3.3d ' .Z-1 to I.G-3.3d ' .
  • Table 4d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is O-cyclo-CeHn and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.4d ' .Z-1 to I.G-1.4d ' .Z-1504, I.G-2.4d ' .Z-1 to I.G-2.4d ' .Z-1504, I.G-3.4d ' .Z-1 to I.
  • Table 7d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is O-2-F-C6H4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.39d ' .Z-1 to I.G-1.39d ' .Z-1504, I.G-2.39d ' .Z-1 to I.G-2.39d ' .Z-1504, I.G- 3.39d ' .Z-1 to I.G-3.39d ' .Z-1504, I.G-4.39d ' .Z-1 to I.G-4.39d ' .Z-1504; I.
  • Table 8d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3-F-CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.8d ' .Z-1 to I.G-1.8d ' .Z-1504, I.G-2.8d ' .Z-1 to I.G-2.8d ' .Z-1504, I.G-3.8d ' .Z-1 to I.G-3.8d ' .Z-1504, I.G-4.8d ' .Z-1 to I.G-4.8d ' .Z-1504; I.H-1.8d ' '
  • Table 9d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is O-4-F-C6H4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.8d ' .Z-1 to I.G-1.8d ' .Z-1504, I.G-2.8d ' .Z-1 to I.G-2.8d ' .Z-1504, I.G-3.8d ' .Z-1 to I.G-3.8d ' .Z-1504, I.G-4.8d ' .Z-1 to I.G-4.8d ' .Z-1504; I.H-1.8d ' .
  • Table 10d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 each individual compound corresponds in each case to one line of Table X (compounds I.G-1.10d ' .Z-1 to I.G-1.10d ' .Z-1504, I.G-2.10d ' .Z-1 to I.G-2.10d ' .Z-1504, I.G-3.10d ' .Z-1 to I.G- 3.10d ' .Z-1504, I.G-4.10d ' .Z-1 to I.G-4.10d ' .Z-1504; I.H-1.10d ' .
  • Table 11d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3-CI-C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.11d ' .Z-1 to I.G-1.11d ' .Z-1504, I.G-2.11d ' .Z-1 to I.G-2.11d ' .Z-1504, I.G- 3.11d ' .Z-1 to I.G-3.11d ' .Z-1504, I.G-4.11d ' .Z-1 to I.G-4.11d ' .Z-1504; I.
  • Table 12d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-4-CI-C 6 H 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.12d ' .Z-1 to I.G-1.12d ' .Z-1504, I.G-2.12d ' .Z-1 to I.G-2.12d ' .Z-1504, I.G- 3.12d ' .Z-1 to I.G-3.12d ' .Z-1504, I.G-4.12d ' .Z-1 to I.G-4.12d ' .Z-1504; I.
  • Table 13d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2-0CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.13d ' .Z-1 to I.G-1.13d ' .Z-1504, I.G-2.13d ' .Z-1 to I.G-2.13d ' .Z-1504, I.G- 3.13d ' .
  • Table 14d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3-0CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.14d ' .Z-1 to I.G-1.14d ' .Z-1504, I.G-2.14d ' .Z-1 to I.G-2.14d ' .Z-1504, I.G- 3.14d ' .Z-1 to I.
  • Table 15d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-4-0CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.15d ' .Z-1 to I.G-1.15d ' .Z-1504, I.G-2.15d ' .Z-1 to I.G-2.15d ' .Z-1504, I.G- 3.15d ' .Z-1 to I.
  • Table 16d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2-0CHF 2 -CeH 4 and the meaning for the combination g L ⁇ g A 2 g A3 anc
  • individual compound corresponds in each case to one line of Table X (compounds I.G-1.16d ' .Z-1 to I.G-1.16d ' .Z-1504, I.G-2.16d ' .Z-1 to I.G-2.16d ' .Z-1504, I.G-3.16d ' .Z-1 to I.G-3.16d ' .Z-1504, I.G-4.16d ' .Z-1 to I.G-4.16d
  • Table 17d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3-0CHF 2 -C 6 H 4 and the meaning for the combination Y A1 g A 2 g A3 anc
  • individual compound corresponds in each case to one line of Table X (compounds I.G-1.17d ' .Z-1 to I.G-1.17d ' .Z-1504, I.G-2.17d ' .Z-1 to I.G-2.17d ' .Z-1504, I.G-3.17d ' .Z-1 to I.G-3.17d ' .Z-1504, I.G-4.17d ' .Z-1 to I.G-4.17d
  • Table 18d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y A4 ),R 8 is 0-4-0CHF 2 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.18d ' .Z-1 to I.G-1.18d ' .Z-1504, I.G-2.18d ' .Z-1 to I.G-2.18d ' .Z-1504, I.G- 3.18d ' .Z-1 to I.G-3.18d ' .Z-1504, I.G-4.18d ' .Z-1 to I.G-4.18d ' .Z-15
  • Table 19d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2-CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.19d ' .Z-1 to I.G-1.19d ' .Z-1504, I.G-2.19d ' .Z-1 to I.G-2.19d ' .Z-1504, I.G- 3.19d ' .Z-1 to I.G-3.19d ' .Z-1504, I.G-4.19d ' .Z-1 to I.G-4.19d ' .Z-1504;
  • Table 20d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3-CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.20d ' .Z-1 to I.G-1.20d ' .Z-1504, I.G-2.20d ' .Z-1 to I.G-2.20d ' .Z-1504, I.G- 3.20d ' .Z-1 to I.G-3.20d ' .Z-1504, I.G-4.20d ' .Z-1 to I.G-4.20d ' .Z-1504
  • Table 21d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-4-CH 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.21d ' .Z-1 to I.G-1.21d ' .Z-1504, I.G-2.21d ' .Z-1 to I.G-2.21d ' .Z-1504, I.G- 3.21d ' .Z-1 to I.G-3.21d ' .Z-1504, I.G-4.21d ' .Z-1 to I.G-4.21d ' .Z-1504
  • Table 22d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2-CF 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.22d ' .Z-1 to I.G-1.22d ' .Z-1504, I.G-2.22d ' .Z-1 to I.G-2.22d ' .Z-1504, I.G- 3.22d ' .Z-1 to I.G-3.22d ' .Z-1504, I.G-4.22d ' .Z-1 to I.G-4.22d ' .Z-1504;
  • Table 23d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3-CF 3 -C 6 H 4 and the meaning for the combination Y A1 , Y A2 y A3 anc
  • Table 24d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-4-CF 3 -CeH 4 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.24d ' .Z-1 to I.G-1.24d ' .Z-1504, I.G-2.24d ' .Z-1 to I.G-2.24d ' .Z-1504, I.G- 3.24d ' .Z-1 to I.
  • Table 25d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,3-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.25d ' .Z-1 to I.G-1.25d ' .Z-1504, I.G-2.25d ' .Z-1 to I.G-2.25d ' .Z-1504, I.G- 3.25d ' .Z-1 to I.
  • Table 26d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,4-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.26d ' .Z-1 to I.G-1.26d ' .Z-1504, I.G-2.26d ' .Z-1 to I.G-2.26d ' .Z-1504, I.G- 3.26d ' .Z-1 to I.
  • Table 27d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,5-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.27d ' .Z-1 to I.G-1.27d ' .Z-1504, I.G-2.27d ' .Z-1 to I.G-2.27d ' .Z-1504, I.G- 3.27d ' .Z-1 to I.
  • Table 28d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,6-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.28d ' .Z-1 to I.G-1.28d ' .Z-1504, I.G-2.28d ' .Z-1 to I.G-2.28d ' .Z-1504, I.G- 3.28d ' .Z-1 to I.
  • Table 29d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3,4-F 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.29d ' .Z-1 to I.G-1.29d ' .Z-1504, I.G-2.29d ' .Z-1 to I.G-2.29d ' .Z-1504, I.G- 3.29d ' .Z-1 to I.
  • Table 30d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3,5-F 2 -C 6 H 3 and the meaning for the combination Y A1 , Y A2 y A3 anc
  • Table 31d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,3-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.31d ' .Z-1 to I.G-1.31d ' .Z-1504, I.G-2.31d ' .Z-1 to I.G-2.31d ' .Z-1504, I.G- 3.31d ' .Z-1 to I.G-3.31d ' .Z-1504, I.G-4.31d ' .Z-1 to I.G-4.31d ' .Z
  • Table 32d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,4-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.32d ' .Z-1 to I.G-1.32d ' .Z-1504, I.G-2.32d ' .Z-1 to I.G-2.32d ' .Z-1504, I.G- 3.32d ' .Z-1 to I.G-3.32d ' .Z-1504, I.G-4.32d ' .Z-1 to I.G-4.32d ' .Z
  • Table 33d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,5-Cl 2 -CeH 3 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.33d ' .Z-1 to I.G-1.33d ' .Z-1504, I.G-2.33d ' .Z-1 to I.G-2.33d ' .Z-1504, I.G- 3.33d ' .Z-1 to I.G-3.33d ' .
  • Table 34d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,6-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table (compounds I.G-1.34d ' .Z-1 to I.G-1.34d ' .Z-1504, I.G-2.34d ' .Z-1 to I.G-2.34d ' .Z-1504, I.G- 3.34d ' .Z-1 to I.
  • Table 35d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3,4-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.35d ' .Z-1 to I.G-1.35d ' .Z-1504, I.G-2.35d ' .Z-1 to I.G-2.35d ' .Z-1504, I.G- 3.35d ' .Z-1 to I.
  • Table 36d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3,5-Cl 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X ((compounds I.G-1.36d ' .Z-1 to I.G-1.36d ' .Z-1504, I.G-2.36d ' .Z-1 to I.G-2.36d ' .Z-1504, I.G- 3.36d ' .Z-1 to I.G-3.36d ' .Z-1504, I.G-4.36d ' .Z-1 to I.G-4.36d ' .
  • Table 37d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,3-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination Y A1 g A 2 g A3 anc
  • Table 38d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,4-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.39d ' .Z-1 to I.G-1.39d ' .Z-1504, I.G-2.39d ' .Z-1 to I.G-2.39d ' .Z-1504, I.G-3.39d ' .Z-1 to I.G-3.39d ' .Z-1504, I.G-4.39d ' .Z-1 to I.G-4.39d '
  • Table 39d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,5-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1.39d ' .Z-1 to I.G-1.39d ' .Z-1504, I.G-2.39d ' .Z-1 to I.G-2.39d ' .Z-1504, I.G-3.39d ' .Z-1 to I.G-3.39d ' .Z-1504, I.G-4.39d ' .Z-1 to I.G-4.39d '
  • Table 40d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-2,6-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 40d ' .Z-1 to I.G-1.40d ' .Z-1504, I.G-2.40d ' .Z-1 to I.G-2.40d ' .Z-1504, I.G-3.40d ' .Z-1 to I.G-3.40d ' .Z-1504, I.G-4.40d ' .Z-1 to I.G-4.40d '
  • Table 41d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3,4-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 41d ' .Z-1 to I.G-1.41d ' .Z-1504, I.G-2.41d ' .Z-1 to I.G-2.41d ' .Z-1504, I.G-3.41d ' .Z-1 to I.G-3.41d ' .Z-1504, I.G-4.41d ' .Z-1 to I.G-4.41d '
  • Table 42d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-3,5-(CH 3 ) 2 -CeH 3 and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 42d ' .Z-1 to I.G-1.42d ' .Z-1504, I.G-2.42d ' .Z-1 to I.G-2.42d ' .Z-1504, I.G-3.42d ' .Z-1 to I.G-3.42d ' .Z-1504, I.G-4.42d ' .Z-1 to I.G-4.42d '
  • Table 43d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is O- and the meaning for the combination Y A1 , Y A2 y A3 anc
  • Table 44d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclo-pent-(1)-en and the meaning for the combination Y A1 g A 2 g A3 anc
  • Table 45d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclopent-(2)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 45d ' .Z-1 to I.G-1.45d ' .Z-1504, I.G-2.45d ' .Z-1 to I.G-2.45d ' .Z-1504, I.G-3.45d ' .Z-1 to I.G-3.45d ' .Z-1504, I.G-4.45d ' .Z-1 to I.G-4.45d ' .Z-1504; I.H
  • Table 46d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclo-pent-(3)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 46d ' .Z-1 to I.G-1.46d ' .Z-1504, I.G-2.46d ' .Z-1 to I.G-2.46d ' .Z-1504, I.G-3.46d ' .Z-1 to I.G-3.46d ' .Z-1504, I.G-4.46d ' .Z-1 to I.G-4.46d ' .Z-1504; I.
  • Table 47d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclohex-(1)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 47d ' .Z-1 to I.G-1.47d ' .Z-1504, I.G-2.47d ' .Z-1 to I.G-2.47d ' .Z-1504, I.G-3.47d ' .Z-1 to I.G-3.47d ' .Z-1504, I.G-4.47d ' .Z-1 to I.G-4.47d ' .Z-1504; I.
  • Table 48d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclohex-(2)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 48d ' .Z-1 to I.G-1.48d ' .Z-1504, I.G-2.48d ' .Z-1 to I.G-2.48d ' .Z-1504, I.G-3.48d ' .Z-1 to I.G-3.48d ' .Z-1504, I.G-4.48d ' .Z-1 to I.G-4.48d ' .Z-1504; I.
  • Table 49d Compounds of the formula I.G-1, I.G-2, I.G-3, I.G-4; I.H-1 , I.H-2, I.H-3, I.H-4, in which Y is C(Y A1 Y A2 )-C(Y A3 Y M ), R 8 is 0-cyclohex-(3)-en and the meaning for the combination Y A1 , Y A2 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table X (compounds I.G-1 49d ' .Z-1 to I.G-1.49d ' .Z-1504, I.G-2.49d ' .Z-1 to I.G-2.49d ' .Z-1504, I.G-3.49d ' .Z-1 to I.G-3.49d ' .Z-1504, I.G-4.49d ' .Z-1 to I.G-4.49d ' .Z-1504; I.
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.3d “ .Z-1 to I.G-1.3d “ .Z-1504, I.G-2.3d “ .Z-1 to I.G-2.3d “ .Z-1504, I.G- 3.3d “ .Z-1 to I.G-3.3d “ . Z-1504, I.G-4.3d “ .Z-1 to I.G-4.3d “ .Z-1504; I.H-3d “ .Z-1 to I.H-1.3d “ .Z- 1504, I.H-2.3d “ .
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.5d “ . Z-1 to I.G-1.5d “ . Z-1504, I.G-2.5d “ . Z-1 to I.G-2.5d “ . Z-1504, I.G- 3.5d “ .Z-1 to I. G-3.5d “ . Z-1504, I.G-4.5d “ .Z-1 to I.G-4.5d; I.H-5d " .Z-1 to I.H-1.5d " .Z-1504, I.H- 2.5d " .Z-1 to I. H-2.5d “ . Z-1504, I.H-3.5d “ .Z-1 to I.H-3.5d ” .Z-1504, I.H-4.5d “ .Z-1 to I.H-4.5d “ .Z- 1504).
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.15d “ .Z-1 to I.G-1.15d ” .Z-1504, I.G-2.15d ” .Z-1 to I.G-2.15d “ .Z-1504, I.G- 3.15d “ .Z-1 to I. G-3.15d “ . Z-1504, I.G-4.15d “ .Z-1 to I.G-4.15d “ .Z-1504; I.H-15d " .Z-1 to I.H- 1 15d ” .
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.24d “ .Z-1 to I.G-1 24d “ .Z-1504, I.G-2.24d “ .Z-1 to I.G-2.24d “ .Z-1504, I.G- 3.24d “ .Z-1 to I. G-3.24d “ .
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.35d “ .Z-1 to I.G-1.35d “ .Z-1504, I.G-2.35d “ .Z-1 to I.G-2.35d “ .Z-1504, I.G- 3.35d “ .Z-1 to I.G-3.35d “ .Z-1504, I.G-4.35d “ .Z-1 to I.G-4.35d “ .Z-1504; I.H-35d “ .Z-1 to I.H- 1.35d " .Z-1504, I.H-2.35d “ .Z-1 to I.H-2.35d “ .Z-1504, I.H-3.35d “ .Z-1 to I.H-3.35d “ .Z-1504, I.H- 4.35d “ .Z-1 to I.H-4.35d “ .Z-1504).
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.38d “ .Z-1 to I.G-1.38d ” .Z-1504, I.G-2.38d ” .Z-1 to I.G-2.38d “ .Z-1504, I.G- 3.38d ” .Z-1 to I. G-3.38d “ . Z-1504, I.G-4.38d “ .Z-1 to I.G-4.38d “ .Z-1504; I.H-38d " .Z-1 to I.H- 1 38d ” .
  • Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.42d “ . Z-1 to I.G-1 42d ” .Z-1504, I.G-2.42d ” .Z-1 to I.G-2.42d “ . Z-1504, I.G-
  • Table 1d ' Compounds of the formula I. G-1, I.G-2, I.G-3, I.G-4; I.H-1, I.H-2, I.H-3, I.H-4, in which Y is C(Y a1 Y a2 )-C(Y a3 Y a4 ), R 8 is H and the meaning for the combination of Y a1 Y a2 Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I. G-1.1d '" . Z-1 to I. G-1.1d '" .
  • Table 2d ' Compounds of the formula I. G-1, I.G-2, I.G-3, I.G-4; I.H-1, I.H-2, I.H-3, I.H-4, in which Y is C(Y a1 Y a2 )-C(Y a3 Y a4 ), R 8 is CH3 and the meaning for the combination of Y a1 Y a2 Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.2d '" .Z-1 to I.G-1.2d '" .Z-1504, I.G-2.2d '" .Z-1 to I.G-2.2d '" .Z-1504, I.G- 3.2d '" .
  • Table 3d '" Compounds of the formula I. G-1, I.G-2, I.G-3, I.G-4; I.H-1, I.H-2, I.H-3, I.H-4, in which Y is C(Y a1 Y a2 )-C(Y a3 Y a4 ), R 8 is CF 3 and the meaning for the combination of Y a1 Y a2 Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.3d '" .Z-1 to I.G-1.3d '" .Z-1504, I.G-2.3d '" .Z-1 to I.G-2.3d '" .Z-1504, I.G- 3.3d '" .
  • Table 4d '" Compounds of the formula I. G-1, I.G-2, I.G-3, I.G-4; I.H-1, I.H-2, I.H-3, I.H-4, in which Y is C(Y a1 Y a2 )-C(Y a3 Y a4 ), R 8 is CH2CF 3 and the meaning for the combination of Y a1 Y a2 Y a3 and Y a4 for each individual compound corresponds in each case to one line of Table Z (compounds I.G-1.4d '" .Z-1 to I.G-1.4d '" .Z-1504, I.G-2.4d '" .Z-1 to I.G-2.4d '" .Z-1504, I.G- 3.4d '" .Z-1 to I.
  • Preferred embodiments of the present invention are the following compounds 1.1-1 , 1.1-2, 1.1-3, l.l- 4; compounds I.J-1 , I.J-2, I.J-3, I.J-4.
  • the substituents R 8 and Y are independently as defined above or preferably defined herein:
  • preference is given to the compounds of the compounds 1.1-1, I.I-2, 1.1-3, 1.1-4; compounds I.J-1 , I.J-2, I.J-3, I.J-4, that are compiled in the Tables 1d to 49e.
  • Table 1e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4 in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclo-C3H5 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds U-1.1e.AB- 1 to 1.1-1.1 e.AB-528, I . I-2.1 e.
  • Table 2e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclo-C H and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds 1.1-1 2e.AB- 1 to l.l-1.2e.AB-528, l.l-2.2e.AB-1 to l.l-2.2e.AB-528, l.l-3.2e.AB-1 to l.l-3.2e.AB-528, l.l- 4.2e.AB-1 to l.l-4.2e.AB-528; I.J-1 2e.AB-1 to I.J-1.2e.AB-528, I.J-2.2e.AB-1 to I.J-2.2e.AB-528, I.J-3.2e.
  • Table 3e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclo-CsHgand the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l-1.3e.AB- 1 to l.l-1.3e.AB-528, l.l-2.3e.AB-1 to l.l-2.3e.AB-528, l.l-3.3e.AB-1 to l.l-3.3e.AB-528, l.l- 4.3e.AB-1 to l.l-4.3e.AB-528; I.J-1.3e.AB-1 to I.J-1.3e.AB-528, I.J-2.3e.AB-1 to I.J-2.3e.AB-528, I.J
  • Table 4e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclo-C 6 Hii and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds 1.1-1 4e.AB- 1 to l.l-1.4e.AB-528, l.l-2.4e.AB-1 to l.l-2.4e.AB-528, l.l-3.4e.AB-1 to l.l-3.4e.AB-528, l.l- 4.4e.AB-1 to l.l-4.4e.AB-528; I.J-1 4e.AB-1 to I.J-1.4e.AB-528, I.J-2.4e.AB-1 to I.J-2.4e.AB-528, I.J-3.4
  • R 8 is and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l-1.5e.AB- 1 to l.l-1.5e.AB-528, l.l-2.5e.AB-1 to l.l-2.5e.AB-528, l.l-3.5e.AB-1 to l.l-3.5e.AB-528, l.l- 4.5e.AB-1 to l.l-4.5e.AB-528; I.J-1.5e.AB-1 to I.J-1.5e.AB-528, I.J-2.5e.AB-1 to I.J-2.5e.AB-528, I.J-3.5e.AB-1 to I.J-3.5e.AB-528, I.J-4.5e.AB-1 to I.J-4.5e.AB-528).
  • Table 6e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is CeHsand the meaning for the combination of R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds 1.1-1 6e.AB- 1 to l.l-1.6e.AB-528, l.l-2.6e.AB-1 to l.l-2.6e.AB-528, l.l-3.6e.AB-1 to l.l-3.6e.AB-528, l.l- 4.6e.AB-1 to l.l-4.6e.AB-528; I.J-1 6e.AB-1 to I.J-1.6e.AB-528, I.J-2.6e.AB-1 to I.J-2.6e.AB-528, I.J-3.6e.AB-1
  • Table 7e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2-F-CeH 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.39e.AB-1 to l.l-1.39e.AB-528, l.l-2.39e.AB-1 to l.l-2.39e.AB-528, l.l-3.39e.AB-1 to l.l- 3.39e.AB-528, l.l-4.39e.AB-1 to l.l-4.39e.AB-528; I.J-1.39e.AB-1 to I.J-1.39e.AB-528, I.J- 2.39e.AB-1 to I.J-2.39
  • Table 8e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3-F-CeH 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l-1.8e.AB- 1 to l.l-1.8e.AB-528, l.l-2.8e.AB-1 to l.l-2.8e.AB-528, l.l-3.8e.AB-1 to l.l-3.8e.AB-528, l.l- 4.8e.AB-1 to l.l-4.8e.AB-528; I.J-1.8e.AB-1 to I.J-1.8e.AB-528, I.J-2.8e.AB-1 to I.J-2.8e.AB-528, I.J-
  • Table 9e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 4-F-CeH 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l-1.8e.AB- 1 to l.l-1.8e.AB-528, l.l-2.8e.AB-1 to l.l-2.8e.AB-528, l.l-3.8e.AB-1 to l.l-3.8e.AB-528, l.l- 4.8e.AB-1 to l.l-4.8e.AB-528; I.J-1.8e.AB-1 to I.J-1.8e.AB-528, I.J-2.8e.AB-1 to I.J-2.8e.AB-528, I.J-
  • Table 10e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2-CI-C 6 H 4 and the meaning for the combination of R 5 , Y A3 and Y M each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.10e.AB-1 to l.l-1.10e.AB-528, l.l-2.10e.AB-1 to l.l-2.10e.AB-528, l.l-3.10e.AB-1 to l.l- 3.10e.AB-528, l.l-4.10e.AB-1 to l.l-4.10e.AB-528; I.J-1.10e.AB-1 to I.J-1.10e.AB-528, I.J- 2.10e.AB-1 to I.J-2.10
  • Table 11e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3-CI-C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.11e.AB-1 to 1.1-1.11e.AB-528, U-2.11e.AB-1 to 1.1-2.11e.AB-528, 1.1-3.11e.AB-1 to l.l- 3.11e.AB-528, I .
  • Table 12e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 4-CI-C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.12e.AB-1 to l.l-1.12e.AB-528, l.l-2.12e.AB-1 to l.l-2.12e.AB-528, l.l-3.12e.AB-1 to l.l- 3.12e.AB-528, l.l-4.12e.AB-1 to l.l-4.12e.AB-528; I.J-1.12e.AB-1 to I.J-1.12e.AB-528, I.J- 2.12e.AB-1 to I.J-2.12
  • Table 13e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2-OCH 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.13e.AB-1 to l.l-1.13e.AB-528, l.l-2.13e.AB-1 to l.l-2.13e.AB-528, l.l-3.13e.AB-1 to l.l- 3.13e.AB-528, l.l-4.13e.AB-1 to l.l-4.13e.AB-528; I.J-1.13e.AB-1 to I.J-1.13e.AB-528, I.J- 2.13e.AB-1 to I.J
  • Table 14e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3-OCH 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.14e.AB-1 to l.l-1.14e.AB-528, l.l-2.14e.AB-1 to l.l-2.14e.AB-528, l.l-3.14e.AB-1 to l.l- 3.14e.AB-528, l.l-4.14e.AB-1 to l.l-4.14e.AB-528; I.J-1.14e.AB-1 to I.J-1.14e.AB-528, I.J- 2.14e.AB-1 to I.J
  • Table 15e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 4-OCH 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.15e.AB-1 to l.l-1.15e.AB-528, l.l-2.15e.AB-1 to l.l-2.15e.AB-528, l.l-3.15e.AB-1 to l.l- 3.15e.AB-528, l.l-4.15e.AB-1 to l.l-4.15e.AB-528; I.J-1.15e.AB-1 to I.J-1.15e.AB-528, I.J- 2.15e.AB-1 to I.J
  • Table 16e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2-OCHF 2 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.16e.AB-1 to l.l-1.16e.AB-528, l.l-2.16e.AB-1 to l.l-2.16e.AB-528, l.l-3.16e.AB-1 to l.l- 3.16e.AB-528, l.l-4.16e.AB-1 to l.l-4.16e.AB-528; I.J-1.16e.AB-1 to I.J-1.16e.AB-528, I.J- 2.16e.AB-1 to I.J
  • Table 17e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3-OCHF 2 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.17e.AB-1 to l.l-1.17e.AB-528, l.l-2.17e.AB-1 to l.l-2.17e.AB-528, l.l-3.17e.AB-1 to l.l- 3.17e.AB-528, l.l-4.17e.AB-1 to l.l-4.17e.AB-528; I.J-1.17e.AB-1 to I.J-1.17e.AB-528, I.J- 2.17e.AB-1 to I.J
  • Table 18e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y A4 ),R 8 is 4-OCHF 2 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.18e.AB-1 to l.l-1.18e.AB-528, l.l-2.18e.AB-1 to l.l-2.18e.AB-528, l.l-3.18e.AB-1 to l.l- 3.18e.AB-528, l.l-4.18e.AB-1 to l.l-4.18e.AB-528; I.J-1.18e.AB-1 to I.J-1.18e.AB-528, I.J- 2.18e.AB-1 to I.
  • Table 19e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2-CH 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.19e.AB-1 to l.l-1.19e.AB-528, l.l-2.19e.AB-1 to l.l-2.19e.AB-528, l.l-3.19e.AB-1 to l.l- 3.19e.AB-528, l.l-4.19e.AB-1 to l.l-4.19e.AB-528; I.J-1.19e.AB-1 to I.J-1.19e.AB-528, I.J- 2.19e.AB-1 to I.J-2
  • Table 20e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3-CH 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.20e.AB-1 to l.l-1.20e.AB-528, l.l-2.20e.AB-1 to l.l-2.20e.AB-528, l.l-3.20e.AB-1 to l.l- 3.20e.AB-528, l.l-4.20e.AB-1 to l.l-4.20e.AB-528; I.J-1.20e.AB-1 to I.J-1.20e.AB-528, I.J- 2.20e.AB-1 to I.J-2
  • Table 21e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 4-CH 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.21e.AB-1 to l.l-1.21e.AB-528, l.l-2.21e.AB-1 to l.l-2.21e.AB-528, l.l-3.21e.AB-1 to l.l- 3.21e.AB-528, l.l-4.21e.AB-1 to l.l-4.21e.AB-528; I.J-1.21e.AB-1 to I.J-1.21e.AB-528, I.J- 2.21e.AB-1 to I.J-2
  • Table 22e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2-CF 3 -C 6 H 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.22e.AB-1 to 1.1-1 22e.AB-528, U-2.22e.AB-1 to l.l-2.22e.AB-528, l.l-3.22e.AB-1 to l.l- 3.22e.AB-528, l.l-4.22e.AB-1 to l.l-4.22e.AB-528; I.J-1.22e.AB-1 to I.J-1.22e.AB-528, I.J- 2.22e.AB-1 to I.J-2.22e.AB-5
  • Table 23e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3-CF 3 -CeH 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.23e.AB-1 to l.l-1.23e.AB-528, l.l-2.23e.AB-1 to l.l-2.23e.AB-528, l.l-3.23e.AB-1 to l.l- 3.23e.AB-528, l.l-4.23e.AB-1 to l.l-4.23e.AB-528; I.J-1.23e.AB-1 to I.J-1.23e.AB-528, I.J- 2.23e.AB-1 to I.J-2
  • Table 24e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 4-CF 3 -CeH 4 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.24e.AB-1 to l.l-1.24e.AB-528, l.l-2.24e.AB-1 to l.l-2.24e.AB-528, l.l-3.24e.AB-1 to l.l- 3.24e.AB-528, l.l-4.24e.AB-1 to l.l-4.24e.AB-528; I.J-1.24e.AB-1 to I.J-1.24e.AB-528, I.J- 2.24e.AB-1 to I.J-2
  • Table 25e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,3-F 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.25e.AB-1 to l.l-1.25e.AB-528, l.l-2.25e.AB-1 to l.l-2.25e.AB-528, l.l-3.25e.AB-1 to l.l- 3.25e.AB-528, l.l-4.25e.AB-1 to l.l-4.25e.AB-528; I.J-1.25e.AB-1 to I.J-1.25e.AB-528, I.J- 2.25e.AB-1 to I.
  • Table 26e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,4-F 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.26e.AB-1 to l.l-1.26e.AB-528, l.l-2.26e.AB-1 to l.l-2.26e.AB-528, l.l-3.26e.AB-1 to l.l- 3.26e.AB-528, l.l-4.26e.AB-1 to l.l-4.26e.AB-528; I.J-1.26e.AB-1 to I.J-1.26e.AB-528, I.J- 2.26e.AB-1 to I.
  • Table 27e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,5-F 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.27e.AB-1 to l.l-1.27e.AB-528, l.l-2.27e.AB-1 to l.l-2.27e.AB-528, l.l-3.27e.AB-1 to l.l- 3.27e.AB-528, l.l-4.27e.AB-1 to l.l-4.27e.AB-528; I.J-1.27e.AB-1 to I.J-1.27e.AB-528, I.J- 2.27e.AB-1 to I.
  • Table 28e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,6-F 2 -CeH 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.28e.AB-1 to l.l-1.28e.AB-528, l.l-2.28e.AB-1 to l.l-2.28e.AB-528, l.l-3.28e.AB-1 to l.l- 3.28e.AB-528, l.l-4.28e.AB-1 to l.l-4.28e.AB-528; I.J-1.28e.AB-1 to I.J-1.28e.AB-528, I.J- 2.28e.AB-1 to I.
  • Table 29e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3,4-F 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.29e.AB-1 to l.l-1.29e.AB-528, U-2.29e.AB-1 to l.l-2.29e.AB-528, l.l-3.29e.AB-1 to l.l- 3.29e.AB-528, l.l-4.29e.AB-1 to l.l-4.29e.AB-528; I.J-1.29e.AB-1 to I.J-1.29e.AB-528, I.J- 2.29e.AB-1 to I.J-2.
  • Table 30e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3,5-F 2 -CeH 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.30e.AB-1 to l.l-1.30e.AB-528, l.l-2.30e.AB-1 to l.l-2.30e.AB-528, l.l-3.30e.AB-1 to l.l- 3.30e.AB-528, l.l-4.30e.AB-1 to l.l-4.30e.AB-528; I.J-1.30e.AB-1 to I.J-1.30e.AB-528, I.J- 2.30e.AB-1 to I.J
  • Table 31e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,3-Cl 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.31e.AB-1 to l.l-1.31e.AB-528, l.l-2.31e.AB-1 to l.l-2.31e.AB-528, l.l-3.31e.AB-1 to l.l- 3.31e.AB-528, l.l-4.31e.AB-1 to l.l-4.31e.AB-528; I.J-1.31e.AB-1 to I.J-1.31e.AB-528, I.J- 2.31e.AB-1 to I
  • Table 32e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,4-Cl 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.32e.AB-1 to l.l-1.32e.AB-528, l.l-2.32e.AB-1 to l.l-2.32e.AB-528, l.l-3.32e.AB-1 to l.l- 3.32e.AB-528, l.l-4.32e.AB-1 to l.l-4.32e.AB-528; I.J-1.32e.AB-1 to I.J-1.32e.AB-528, I.J- 2.32e.AB-1 to I
  • Table 33e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,5-Cl 2 -C 6 H 3 and the meaning for the combination of R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.33e.AB-1 to l.l-1.33e.AB-528, l.l-2.33e.AB-1 to l.l-2.33e.AB-528, l.l-3.33e.AB-1 to l.l- 3.33e.AB-528, l.l-4.33e.AB-1 to l.l-4.33e.AB-528; I.J-1.33e.AB-1 to I.J-1.33e.AB-528, I.J- 2.33e.AB-1 to
  • Table 34e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,6-Cl 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table (compounds l.l- 1.34e.AB-1 to l.l-1.34e.AB-528, l.l-2.34e.AB-1 to l.l-2.34e.AB-528, l.l-3.34e.AB-1 to l.l- 3.34e.AB-528, l.l-4.34e.AB-1 to l.l-4.34e.AB-528; I.J-1.34e.AB-1 to I.J-1.34e.AB-528, I.J- 2.34e.AB-1 to I.J
  • Table 35e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3,4-Cl 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.35e.AB-1 to l.l-1.35e.AB-528, l.l-2.35e.AB-1 to l.l-2.35e.AB-528, l.l-3.35e.AB-1 to l.l- 3.35e.AB-528, l.l-4.35e.AB-1 to l.l-4.35e.AB-528; I.J-1.35e.AB-1 to I.J-1.35e.AB-528, I.J- 2.35e.AB-1 to I
  • Table 36e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3,5-Cl 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB ((compounds l.l- 1.36e.AB-1 to l.l-1.36e.AB-528, l.l-2.36e.AB-1 to l.l-2.36e.AB-528, l.l-3.36e.AB-1 to l.l- 3.36e.AB-528, l.l-4.36e.AB-1 to l.l-4.36e.AB-528; I.J-1.36e.AB-1 to I.J-1.36e.AB-528, I.J- 2.36e.AB-1 to I
  • Table 37e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,3-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.37e.AB-1 to l.l-1.37e.AB-528, l.l-2.37e.AB-1 to l.l-2.37e.AB-528, l.l-3.37e.AB-1 to l.l- 3.37e.AB-528, l.l-4.37e.AB-1 to l.l-4.37e.AB-528; I.J-1.37e.AB-1 to I.J-1.37e.AB-528, I.J- 2.37e.AB
  • Table 38e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.39e.AB-1 to l.l-1.39e.AB-528, l.l-2.39e.AB-1 to l.l-2.39e.AB-528, l.l-3.39e.AB-1 to l.l- 3.39e.AB-528, l.l-4.39e.AB-1 to l.l-4.39e.AB-528; I.J-1.39e.AB-1 to I.J-1.39e.AB-528, I.J- 2.39e.AB
  • Table 39e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.39e.AB-1 to l.l-1.39e.AB-528, l.l-2.39e.AB-1 to l.l-2.39e.AB-528, l.l-3.39e.AB-1 to l.l- 3.39e.AB-528, l.l-4.39e.AB-1 to l.l-4.39e.AB-528; I.J-1.39e.AB-1 to I.J-1.39e.AB-528, I.J- 2.39e.AB
  • Table 40e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 2,6-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.40e.AB-1 to l.l-1.40e.AB-528, l.l-2.40e.AB-1 to l.l-2.40e.AB-528, l.l-3.40e.AB-1 to l.l- 3.40e.AB-528, l.l-4.40e.AB-1 to l.l-4.40e.AB-528; I.J-1.40e.AB-1 to I.J-1.40e.AB-528, I.J- 2.40e.AB
  • Table 41e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.41e.AB-1 to l.l-1.41e.AB-528, l.l-2.41e.AB-1 to l.l-2.41e.AB-528, l.l-3.41e.AB-1 to l.l- 3.41e.AB-528, l.l-4.41e.AB-1 to l.l-4.41e.AB-528; I.J-1.41e.AB-1 to I.J-1.41e.AB-528, I.J- 2.41e.AB
  • Table 42e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is 3,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.42e.AB-1 to l.l-1.42e.AB-528, l.l-2.42e.AB-1 to l.l-2.42e.AB-528, l.l-3.42e.AB-1 to 1.1- 3.42e.AB-528, l.l-4.42e.AB-1 to l.l-4.42e.AB-528; IJ-1.42e.AB-1 to I.J-1.42e.AB-528, I.J- 2.42e.AB-1 to I.
  • R 8 is and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.43e.AB-1 to l.l-1.43e.AB-528, l.l-2.43e.AB-1 to l.l-2.43e.AB-528, l.l-3.43e.AB-1 to l.l- 3.43e.AB-528, l.l-4.43e.AB-1 to l.l-4.43e.AB-528; I.J-1.43e.AB-1 to I.J-1.43e.AB-528, I.J- 2.43e.AB-1 to I.J-2.43e.AB-528, I.J-3.43e.AB-1 to I.J-3.43e.AB-528, I.J-4.43e.AB-1 to I.J- 4.43e.AB-528).
  • Table 44e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclo-pent-(1)-en and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.44e.AB-1 to l.l-1.44e.AB-528, l.l-2.44e.AB-1 to l.l-2.44e.AB-528, l.l-3.44e.AB-1 to l.l- 3.44e.AB-528, l.l-4.44e.AB-1 to l.l-4.44e.AB-528; I.J-1.44e.AB-1 to I.J-1.44e.AB-528, I.J- 2.44e.AB-1 to I.J
  • Table 45e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclopent-(2)-en and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.45e.AB-1 to l.l-1.45e.AB-528, l.l-2.45e.AB-1 to l.l-2.45e.AB-528, l.l-3.45e.AB-1 to l.l- 3.45e.AB-528, l.l-4.45e.AB-1 to l.l-4.45e.AB-528; I.J-1.45e.AB-1 to I.J-1.45e.AB-528, I.J- 2.45e.AB-1 to I.J-2.
  • Table 46e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclo-pent-(3)-en and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.46e.AB-1 to l.l-1.46e.AB-528, l.l-2.46e.AB-1 to l.l-2.46e.AB-528, l.l-3.46e.AB-1 to l.l- 3.46e.AB-528, l.l-4.46e.AB-1 to l.l-4.46e.AB-528; I.J-1.46e.AB-1 to I.J-1.46e.AB-528, I.J- 2.46e.AB-1 to I.J
  • Table 47e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclohex-(1)-en and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.47e.AB-1 to l.l-1.47e.AB-528, l.l-2.47e.AB-1 to l.l-2.47e.AB-528, l.l-3.47e.AB-1 to l.l- 3.47e.AB-528, l.l-4.47e.AB-1 to l.l-4.47e.AB-528; I.J-1.47e.AB-1 to I.J-1.47e.AB-528, I.J- 2.47e.AB-1 to I.J-2
  • Table 48e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclohex-(2)-en and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.48e.AB-1 to l.l-1.48e.AB-528, l.l-2.48e.AB-1 to l.l-2.48e.AB-528, l.l-3.48e.AB-1 to l.l- 3.48e.AB-528, l.l-4.48e.AB-1 to l.l-4.48e.AB-528; I.J-1.48e.AB-1 to I.J-1.48e.AB-528, I.J- 2.48e.AB-1 to I.J-2
  • Table 49e Compounds of the formula 1.1-1 , 1.1-2, 1.1-3, 1.1-4; I.J-1 , I.J-2, I.J-3, I.J-4, in which Y is N(R 5 )-C(Y A3 Y M ), R 8 is cyclohex-(3)-en and the meaning for the combination R 5 , Y A3 and Y M for each individual compound corresponds in each case to one line of Table AB (compounds l.l- 1.49e.AB-1 to l.l-1.49e.AB-528, l.l-2.49e.AB-1 to l.l-2.49e.AB-528, l.l-3.49e.AB-1 to l.l- 3.49e.AB-528, l.l-4.49e.AB-1 to l.l-4.49e.AB-528; I.J-1.49e.AB-1 to I.J-1.49e.AB-528, I.J-
  • Preferred embodiments of the present invention are the following compounds I.K-1 , I.K-2, I.K-3, I.K-4; compounds I.L-1, I.L-2, I.L-3, I.L-4.
  • the substituents R 8 and Y are independently as defined above or preferably defined herein:
  • Table 1f Compounds of the formula I.K-1 , I.K-2, I.K-3, I.K-4; I.L-1 , I.L-2, I.L-3, I.L-4 in which Y is C(Y a1 Y a2 ), R 8 is 0-cyclo-C 3 H 5 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.1f.X-1 to I.K-1.1f.CD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclo-C 4 H 7 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.2f.X-1 to I.K-1.2f.CD-42, I.K-2.2f.X-1 to I. K-2.2f.
  • CD-42 I.K-3.2f.X-1 to I.K-3.2f.CD-42, I.K-4.2f.X-1 to I.K-4.2f.CD-42; I.L-1.2f.X-1 to I.L-1 2f.CD-42, I.L-2.2f.X-1 to I.L-2.2f.CD-42, I.L-3.2f.X-1 to I.L- 3.2f.CD-42, I.L-4.2f.X-1 to I.L-4.2f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is O-cyclo-CsHg and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.3f.X-1 to I.K-1.3f.CD-42, I.K-2.3f.X-1 to I. K-2.3f. CD-42, I.K-3.3f.X-1 to I.K-3.3f.CD-42, I.K-4.3f.X-1 to I.K-4.3f.CD-42; I.L-1.3f.X-1 to I.L-1 3f.CD-42, I.L-2.3f.X-1 to I. L-2.3f. CD-42, I.L-3.3f.X-1 to I.L-
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclo-C 6 Hii and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.4f.X-1 to I.K-1.4f.CD-42, I.K-2.4f.X-1 to I. K-2.4f.
  • CD-42 I.K-3.4f.X-1 to I.K-3.4f.CD-42, I.K-4.4f.X-1 to I.K-4.4f.CD-42; I.L-1.4f.X-1 to I.L-1 4f.CD-42, I.L-2.4f.X-1 to I.L-2.4f.CD-42, I.L-3.4f.X-1 to I.L- 3.4f.CD-42, I.L-4.4f.X-1 to I. L-4.4f. CD-42).
  • Table 5f Compounds of the formula I.K-1, I.K-2, I.K-3, I.K-4; I.L-1 , I.L-2, I.L-3, I.L-4, in which
  • Y is C(Y a1 Y a2 ), R 8 is O- and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.5f.X-1 to I.K-1.5f.CD-42, I.K-2.5f.X-1 to I. K-2.5f. CD-42, I.K-3.5f.X-1 to I.K-3.5f.CD-42, I.K-4.5f.X-1 to I.K-4.5f.CD-42; I.L-1.5f.X-1 to I.L-1 5f. CD-42, I.L-2.5f.X-1 to I. L-2.5f. CD-42, I.L-3.5f.X-1 to I.L-
  • Y is C(Y a1 Y a2 ), R 8 is 0-C 6 H 5 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.6f.X-1 to I.K-1.6f.CD-42, I.K-2.6f.X-1 to I. K-2.6f.
  • CD-42 I.K-3.6f.X-1 to I.K-3.6f.CD-42, I.K-4.6f.X-1 to I.K-4.6f.CD-42; I.L-1.6f.X-1 to I.L-1 6f.CD-42, I.L-2.6f.X-1 to I.L-2.6f.CD-42, I.L-3.6f.X-1 to I.L- 3.6f.CD-42, I.L-4.6f.X-1 to I.L-4.6f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is O-2-F-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.39f.X- 1 to I.K-1.39f.CD-42, I.K-2.39f.X-1 to I. K-2.39f. CD-42, I.K-3.39f.X-1 to I. K-3.39f. CD-42, I.K- 4.39LX-1 to I.K-4.39f.CD-42; I.L-1 39f.X-1 to I.L-1.39LCD-42, I.L-2.39f.X-1 to I. L-2.39L CD-42, I.L-3.39f.X-1 to I. L-3.39f. CD-42, I.L-4.39f.X-1 to I.L-4.39f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is O-3-F-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.8f.X-1 to I.K-1.8f.CD-42, I.K-2.8f.X-1 to I. K-2.8f. CD-42, I.K-3.8f.X-1 to I.K-3.8f.CD-42, I.K-4.8f.X-1 to I.K-4.8f.CD-42; I.L-1.8f.X-1 to I.L-1 8f. CD-42, I.L-2.8f.X-1 to I. L-2.8f. CD-42, I.L-3.8f.X-1 to I.L-
  • Y is C(Y a1 Y a2 ), R 8 is C -F-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.8f.X-1 to I.K-1.8f.CD-42, I.K-2.8f.X-1 to I. K-2.8f. CD-42, I.K-3.8f.X-1 to I.K-3.8f.CD-42, I.K-4.8f.X-1 to I.K-4.8f.CD-42; I.L-1.8f.X-1 to I.L-1 8f.CD-42, I.L-2.8f.X-1 to I. L-2.8f. CD-42, I.L-3.8f.X-1 to I.L-3.8f.X-1 to I.L-
  • Y is C(Y a1 Y a2 ), R 8 is 0-2-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.10f.X- 1 to I.K-1 10f.CD-42, I.K-2.10f.X-1 to I.K-2.10f.CD-42, I.K-3.10f.X-1 to I.K-3.10f.CD-42, I.K- 4.10f.X-1 to I.K-4.10f.CD-42; I.L-1 10f.X-1 to I.L-1 10f.CD-42, I . L-2.10f.X-1 to I.L-2.10f.CD-42,
  • Y is C(Y a1 Y a2 ), R 8 is O-3-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.11f.X- 1 to I.K-1.11f.CD-42, I.K-2.11f.X-1 to I.K-2.11f.CD-42, I.K-3.11f.X-1 to I.K-3.11f.CD-42, I.K-
  • Y is C(Y a1 Y a2 ), R 8 is O-4-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.12f.X- 1 to I.K-1 12f.CD-42, I.K-2.12f.X-1 to I.K-2.12f.CD-42, I.K-3.12f.X-1 to I.K-3.12f.CD-42, I.K- 4.12f.X-1 to I.K-4.12f.CD-42; I.L-1 12f.X-1 to I.L-1.12LCD-42, I . L-2.12f.X-1 to I.L-2.12f.CD-42,
  • Y is C(Y a1 Y a2 ), R 8 is 0-2-0CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.13LX-1 to I.K-1 13f.CD-42, I.K-2.13f.X-1 to I.K-2.13f.CD-42, I.K-3.13f.X-1 to I.K-3.13f.CD-42, I.K-4.13f.X-1 to I.K-4.13f.CD-42; I.L-1 13f.X-1 to I.L-1.13LCD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is 0-3-0CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.14f.X-1 to I.K-1 14f.CD-42, I.K-2.14f.X-1 to I.K-2.14f.CD-42, I.K-3.14f.X-1 to I.K-3.14f.CD-42, I.K-4.14f.X-1 to I.K-4.14f.CD-42; I.L-1 14f.X-1 to I.L-1 14f.CD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is 0-4-0CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.15f.X-1 to I.K-1 15f.CD-42, I.K-2.15f.X-1 to I.K-2.15f.CD-42, I.K-3.15f.X-1 to I.K-3.15f.CD-42, I.K-4.15f.X-1 to I.K-4.15f.CD-42; I.L-1 15f.X-1 to I.L-1 15f.CD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is 0-2-0CHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.16f.X-1 to I.K-1 16f.CD-42, I.K-2.16f.X-1 to I.K-2.16f.CD-42, I.K-3.16f.X-1 to I.K-3.16f.CD-42, I.K-4.16f.X-1 to I.K-4.16f.CD-42; I.L-1 16f.X-1 to I.L-1 16f.CD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is 0-3-0CHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.17f.X-1 to I.K-1 17f.CD-42, I.K-2.17f.X-1 to I.K-2.17f.CD-42, I.K-3.17f.X-1 to I.K-3.17f.CD-42, I.K-4.17f.X-1 to I.K-4.17f.CD-42; I.L-1 17f.X-1 to I.L-1 17f.CD-42, I .
  • Y is C(Y a1 Y a2 ),R 8 is 0-4-0CHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.18f.X-1 to I.K-1 18f.CD-42, I.K-2.18f.X-1 to I.K-2.18f.CD-42, I.K-3.18f.X-1 to I.K-3.18f.CD-42, I.K-4.18f.X-1 to I.K-4.18f.CD-42; I.L-1 18f.X-1 to I.L-1 18f.CD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is O-2-CH3-C6H4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.19f.X- 1 to I.K-1 19f.CD-42, I.K-2.19f.X-1 to I.K-2.19f.CD-42, I.K-3.19f.X-1 to I.K-3.19f.CD-42, I.K- 4.19LX-1 to I.K-4.19f.CD-42; I.L-1 19f.X-1 to I.L-1.19LCD-42, I . L-2.19f.X-1 to I.L-2.19f.CD-42,
  • Table 20f Compounds of the formula I.K-1, I.K-2, I.K-3, I.K-4; I.L-1 , I. L-2, I. L-3, I. L-4, in which Y is C(Y a1 Y a2 ), R 8 is O-3-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.20f.X- 1 to I.K-1 20f.CD-42, I.K-2.20f.X-1 to I.K-2.20f.CD-42, I.K-3.20f.X-1 to I.K-3.20f.CD-42, I.K- 4.20f.X-1 to I.K-4.20f.CD-42; I.L-1 20f.X-1 to I.L-1 20f.CD-42, I.L-2.20f.X-1 to I.L-2.20f.CD-42
  • Y is C(Y a1 Y a2 ), R 8 is 0-4-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.21f.X- 1 to I.K-1 21f.CD-42, I.K-2.21f.X-1 to I.K-2.21f.CD-42, I.K-3.21f.X-1 to I.K-3.21f.CD-42, I.K- 4.21f.X-1 to I.K-4.21 f.CD-42; I.L-1 21f.X-1 to I.L-1 21f.CD-42, I .
  • Y is C(Y a1 Y a2 ), R 8 is O-2-CF 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.22f.X- 1 to I.K-1 22f.CD-42, I.K-2.22f.X-1 to I.K-2.22f.CD-42, I.K-3.22f.X-1 to I.K-3.22f.CD-42, I.K- 4.22LX-1 to I.K-4.22f.CD-42; I.L-1 22f.X-1 to I.L-1.22LCD-42, I.L-2.22f.X-1 to I.L-2.22f.CD-42, I.L-3.22f.X-1 to I.L-3.22f.CD-42, I.L-4.22f.X-1 to I.L-4.22f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is O-3-CF 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.23f.X- 1 to I.K-1 23f.CD-42, I.K-2.23f.X-1 to I.K-2.23f.CD-42, I.K-3.23f.X-1 to I.K-3.23f.CD-42, I.K- 4.23LX-1 to I.K-4.23f.CD-42; I.L-1 23f.X-1 to I.L-1.23LCD-42, I.L-2.23f.X-1 to I.L-2.23f.CD-42, I.L-3.23f.X-1 to I.L-3.23f.CD-42, I.L-4.23f.X-1 to I.L-4.23f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is O-4-CF 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.24f.X- 1 to I.K-1 24f.CD-42, I.K-2.24f.X-1 to I.K-2.24f.CD-42, I.K-3.24f.X-1 to I.K-3.24f.CD-42, I.K- 4.24LX-1 to I.K-4.24f.CD-42; I.L-1 24f.X-1 to I.L-1.24LCD-42, I.L-2.24f.X-1 to I.L-2.24f.CD-42, I.L-3.24f.X-1 to I.L-3.24f.CD-42, I.L-4.24f.X-1 to I.L-4.24f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,3-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.25f.X- 1 to I.K-1 25f.CD-42, I.K-2.25f.X-1 to I.K-2.25f.CD-42, I.K-3.25f.X-1 to I.K-3.25f.CD-42, I.K- 4.25f.X-1 to I.K-4.25f.CD-42; I.L-1 25f.X-1 to I.L-1 25f.CD-42, I.L-2.25f.X-1 to I.L-2.25f.CD-42, I.L-3.25f.X-1 to I.L-3.25f.CD-42, I.L-4.25f.X-1 to I.L-4.25f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2.4-F 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.26f.X- 1 to I.K-1 26f.CD-42, I.K-2.26f.X-1 to I.K-2.26f.CD-42, I.K-3.26f.X-1 to I.K-3.26f.CD-42, I.K- 4.26f.X-1 to I.K-4.26f.CD-42; I.L-1 26f.X-1 to I.L-1.26LCD-42, I.L-2.26f.X-1 to I.L-2.26f.CD-42, I.L-3.26f.X-1 to I.L-3.26f.CD-42, I.L-4.26f.X-1 to I.L-4.26f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2.5-F 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.27f.X- 1 to I.K-1 27f.CD-42, I.K-2.27f.X-1 to I.K-2.27f.CD-42, I.K-3.27f.X-1 to I.K-3.27f.CD-42, I.K- 4.27LX-1 to I.K-4.27f.CD-42; I.L-1 27f.X-1 to I.L-1.27LCD-42, I.L-2.27f.X-1 to I.L-2.27f.CD-42, I.L-3.27f.X-1 to I.L-3.27f.CD-42, I.L-4.27f.X-1 to I.L-4.27f.CD-42).
  • Table 28f Com
  • Y is C(Y a1 Y a2 ), R 8 is 0-2.6-F 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.28f.X- 1 to I.K-1 28f.CD-42, I.K-2.28f.X-1 to I.K-2.28f.CD-42, I.K-3.28f.X-1 to I.K-3.28f.CD-42, I.K- 4.28f.X-1 to I.K-4.28f.CD-42; I.L-1 28f.X-1 to I.L-1 28f.CD-42, I.L-2.28f.X-1 to I.L-2.28f.CD-42, I.L-3.28f.X-1 to I.L-3.28f.CD-42, I.L-4.28f.X-1 to I.L-4.28f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-3.4-F 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.29f.X- 1 to I.K-1 29f.CD-42, I.K-2.29LX-1 to I.K-2.29f.CD-42, I.K-3.29f.X-1 to I.K-3.29f.CD-42, I.K- 4.29LX-1 to I.K-4.29f.CD-42; I.L-1 29f.X-1 to I.L-1.29LCD-42, I.L-2.29f.X-1 to I.L-2.29f.CD-42, I.L-3.29f.X-1 to I.L-3.29f.CD-42, I.L-4.29f.X-1 to I.L-4.29f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-3.5-F 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.30f.X- 1 to I.K-1 30f.CD-42, I.K-2.30f.X-1 to I. K-2.30L CD-42, I.K-3.30f.X-1 to I. K-3.30L CD-42, I.K- 4.30f.X-1 to I.K-4.30f.CD-42; I.L-1 30f.X-1 to I.L-1 30f.CD-42, I.L-2.30f.X-1 to I. L-2.30L CD-42, I.L-3.30f.X-1 to I. L-3.30f. CD-42, I.L-4.30f.X-1 to I.L-4.30f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,3-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.31f.X- 1 to I.K-1 31f.CD-42, I.K-2.31f.X-1 to I.K-2.31f.CD-42, I.K-3.31f.X-1 to I.K-3.31f.CD-42, I.K- 4.31LX-1 to I.K-4.31 f.CD-42; I.L-1 31f.X-1 to I.L-1.31LCD-42, I.
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,4-CI 2-C6H3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.32f.X- 1 to I.K-1 32f.CD-42, I.K-2.32f.X-1 to I. K-2.32L CD-42, I.K-3.32f.X-1 to I. K-3.32L CD-42, I.K- 4.32f.X-1 to I.K-4.32f.CD-42; I.L-1 32f.X-1 to I.L-1.32LCD-42, I.L-2.32f.X-1 to I. L-2.32L CD-42, I.L-3.32f.X-1 to I. L-3.32f. CD-42, I.L-4.32f.X-1 to I.L-4.32f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,5-Cl 2 -C 6 H 3 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.33f.X- 1 to I.K-1 33f.CD-42, I.K-2.33f.X-1 to I. K-2.33L CD-42, I.K-3.33f.X-1 to I. K-3.33L CD-42, I.K- 4.33f.X-1 to I.K-4.33f.CD-42; I.L-1 33f.X-1 to I.L-1.33LCD-42, I.L-2.33f.X-1 to I. L-2.33L CD-42, I.L-3.33f.X-1 to I. L-3.33f. CD-42, I.L-4.33f.X-1 to I.L-4.33f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,6-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table (compounds I.K-1 34f.X-1 to I.K-1 34f.CD-42, I.K-2.34f.X-1 to I. K-2.34L CD-42, I.K-3.34f.X-1 to I. K-3.34L CD-42, I.K-4.34f.X-1 to I.K-4.34f.CD-42; I.L-1 34f.X-1 to I.L-1.34LCD-42, I.L-2.34f.X-1 to I. L-2.34L CD-42, I.L-3.34f.X- 1 to I. L-3.34f. CD-42, I.L-4.34f.X-1 to I.L-4.34f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-3,4-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.35f.X- 1 to I.K-1 35f.CD-42, I.K-2.35f.X-1 to I. K-2.35L CD-42, I.K-3.35f.X-1 to I.
  • K-3.35L CD-42 I.K- 4.35f.X-1 to I.K-4.35f.CD-42; I.L-1 35f.X-1 to I.L-1 35f.CD-42, I.L-2.35f.X-1 to I. L-2.35L CD-42, I.L-3.35f.X-1 to I. L-3.35f. CD-42, I.L-4.35f.X-1 to I.L-4.35f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-3,5-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD ((compounds I.K-
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,3-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.37LX-1 to I.K-1 37f.CD-42, I.K-2.37f.X-1 to I. K-2.37L CD-42, I.K-3.37f.X-1 to I.
  • K-3.37L CD-42 I.K-4.37f.X-1 to I.K-4.37f.CD-42; I.L-1 37f.X-1 to I.L-1.37LCD-42, I.L-2.37f.X-1 to I.L-2.37f.CD- 42, I.L-3.37f.X-1 to I. L-3.37L CD-42, I.L-4.37f.X-1 to I.L-4.37f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.39LX-1 to I.K-1 39f.CD-42, I.K-2.39f.X-1 to I. K-2.39L CD-42, I.K-3.39f.X-1 to I.
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.39LX-1 to I.K-1 39f.CD-42, I.K-2.39f.X-1 to I. K-2.39L CD-42, I.K-3.39f.X-1 to I.
  • Y is C(Y a1 Y a2 ), R 8 is 0-2,6-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.40f.X-1 to I.K-1 40f.CD-42, I.K-2.40f.X-1 to I.K-2.40f.CD-42, I.K-3.40f.X-1 to I.K-3.40f.CD-42, I.K-4.40f.X-1 to I.K-4.40f.CD-42; I.L-1 40f.X-1 to I.L-1 40f.CD-42, I.L-2.40f.X-1 to I.L-2.40f.CD- 42, I.L-3.40f.X-1 to I.L-3.40f.CD-42, I.L-4.40f.X-1 to I.L-4.40f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-3,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.41LX-1 to I.K-1.41LCD-42, I.K-2.41f.X-1 to I.K-2.41f.CD-42, I.K-3.41f.X-1 to I.K-3.41f.CD-42, I.K-4.41f.X-1 to I.K-4.41f.CD-42; I.L-1 41f.X-1 to I.L-1.41LCD-42, I.
  • Y is C(Y a1 Y a2 ), R 8 is 0-3,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.42LX-1 to I.K-1.42LCD-42, I.K-2.42f.X-1 to I.K-2.42f.CD-42, I.K-3.42f.X-1 to I.K-3.42f.CD-42, I.K-4.42f.X-1 to I.K-4.42f.CD-42; I.L-1 42f.X-1 to I.L-1.42LCD-42, I.L-2.42f.X-1 to I.L-2.42f.CD- 42, I.L-3.42f.X-1 to I.L-3.42f.CD-42, I.L-4.42f.X-1 to I.L-4.42f.CD-42).
  • Table 43f Compounds of the formula I.K-1, I.K-2, I.K-3, I.K-4; I.L-1 , I.L-2, I.L-3, I.L-4, in which Y is C(Y a1 Y a2 ), R 8 is O- and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.43f.X- 1 to I.K-1 43f.CD-42, I.K-2.43f.X-1 to I.K-2.43f.CD-42, I.K-3.43f.X-1 to I.K-3.43f.CD-42, I.K- 4.43f.X-1 to I.K-4.43f.CD-42; I.L-1 43f.X-1 to I.L-1.43LCD-42, I.L-2.43f.X-1 to I.L-2.43f.CD-42, I.L-3.43f.
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclo-pent-(1)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.44f.X-1 to I.K-1 44f.CD-42, I.K-2.44f.X-1 to I.K-2.44f.CD-42, I.K-3.44f.X-1 to I.K-3.44f.CD-42, I.K-4.44f.X-1 to I.K-4.44f.CD-42; I.L-1 44f.X-1 to I.L-1 44f.CD-42, I.L-2.44f.X-1 to I.L-2.44f.CD- 42, I.L-3.44f.X-1 to I.L-3.44f.CD-42, I.L-4.44f.X-1 to I.L-4.44f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclopent-(2)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.45f.X-1 to I.K-1 45f.CD-42, I.K-2.45f.X-1 to I.K-2.45f.CD-42, I.K-3.45f.X-1 to I.K-3.45f.CD-42, I.K-4.45f.X-1 to I.K-4.45f.CD-42; I.L-1 45f.X-1 to I.L-1 45f.CD-42, I.L-2.45f.X-1 to I.L-2.45f.CD- 42, I.L-3.45f.X-1 to I.L-3.45f.CD-42, I.L-4.45f.X-1 to I.L-4.45f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclo-pent-(3)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.46LX-1 to I.K-1.46LCD-42, I.K-2.46f.X-1 to I.K-2.46f.CD-42, I.K-3.46f.X-1 to I.K-3.46f.CD-42, I.K-4.46f.X-1 to I.K-4.46f.CD-42; I.L-1 46f.X-1 to I.L-1.46LCD-42, I.L-2.46f.X-1 to I.L-2.46f.CD- 42, I.L-3.46f.X-1 to I.L-3.46f.CD-42, I.L-4.46f.X-1 to I.L-4.46f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclohex-(1)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.47LX-1 to I.K-1.47LCD-42, I.K-2.47f.X-1 to I.K-2.47f.CD-42, I.K-3.47f.X-1 to I.K-3.47f.CD-42, I.K-4.47f.X-1 to I.K-4.47f.CD-42; I.L-1 47f.X-1 to I.L-1.47LCD-42, I.L-2.47f.X-1 to I.L-2.47f.CD- 42, I.L-3.47f.X-1 to I.L-3.47f.CD-42, I.L-4.47f.X-1 to I.L-4.47f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclohex-(2)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.48f.X-1 to I.K-1 48f.CD-42, I.K-2.48f.X-1 to I.K-2.48f.CD-42, I.K-3.48f.X-1 to I.K-3.48f.CD-42, I.K-4.48f.X-1 to I.K-4.48f.CD-42; I.L-1 48f.X-1 to I.L-1 48f.CD-42, I.L-2.48f.X-1 to I.L-2.48f.CD- 42, I.L-3.48f.X-1 to I.L-3.48f.CD-42, I.L-4.48f.X-1 to I.L-4.48f.CD-42).
  • Y is C(Y a1 Y a2 ), R 8 is 0-cyclohex-(3)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.49LX-1 to I.K-1.49LCD-42, I.K-2.49f.X-1 to I.K-2.49f.CD-42, I.K-3.49f.X-1 to I.K-3.49f.CD-42, I.K-4.49f.X-1 to I.K-4.49f.CD-42; I.L-1 49f.X-1 to I.L-1.49LCD-42, I.L-2.49f.X-1 to I.L-2.49f.CD- 42, I.L-3.49f.X-1 to I.L-3.49f.CD-42, I.L-4.49f.X-1 to I.L-4.49f.CD-42).
  • Table 1f Compounds of the formula I.K-1, I.K-2, I.K-3, I.K-4; I.L-1 , I.L-2, I.L-3, I.L-4 in which Y is C(Y a1 Y a2 )-CH2-CEC, R 8 is cyclo-CsHs and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.1G.C-1 to I. K-1.1G. CD-42, I.K-2.1G.C-1 to I. K-2.1G. CD-42, I.K-3.1G.C-1 to I. K-3.1G.
  • CD-42 I.K- 4.1G.C-1 to I.K-4.1f ' .CD-42; I.L-1.1G.C-1 to I . L-1.1 f ' .CD-42, I.L-2.1f ' .X-1 to I. L-2.1f .CD-42, I.L- 3.1G.C-1 to I. L-3.1f ' . CD-42, I.L-4.1f ' .X-1 to I.L-4.1f ' .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclo-C4H7and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.2G.C-1 to I. K-1.2G. CD-42, I.K-2.2G.C-1 to I. K-2.2G. CD-42, I.K-3.2G.C-1 to I. K-3.2G.
  • CD-42 I.K- 4.2G.C-1 to I.K-4.2f ' .CD-42; I.L-1.2G.C-1 to I.L-1.2f ' .CD-42, I.L-2.2f ' .X-1 to I. L-2.2f. CD-42, I.L- 3.2G.C-1 to I. L-3.2f ' . CD-42, I.L-4.2f ' .X-1 to I.L-4.2f ' .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclo-CsHgand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.3G.C-1 to I.K-1 3f. CD-42, I.K-2.3G.C-1 to I. K-2.3G. CD-42, I.K-3.3G.C-1 to I. K-3.3G. CD-42, I.K-4.3G.C-1 to I.K-4.3f ' .CD-42; I.L-1.3G.C-1 to I.L-1 3f. CD-42, I.L-2.3f.X-1 to I. L-2.3f. CD-42, I.L-3.3T.X-1 to I. L-3.3f. CD-42, I.L-4.3T.X-1 to I.L-4.3f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclo-CeHn and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.4G.C-1 to I.K-1 4f. CD-42, I.K-2.4G.C-1 to I. K-2.4G. CD-42, I.K-3.4G.C-1 to I. K-3.4G. CD-42, I.K-4.4G.C-1 to I.K-4.4f ' .CD-42; I.L-1.4G.C-1 to I.L-1 4f. CD-42, I.L-2.4f.X-1 to I. L-2.4f. CD-42, I.L-3.4T.X-1 to I. L-3.4f ' . CD-42, I.L-4.4T.X-1 to I.L-4.4f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-C-C
  • R 8 is and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.5G.C-1 to I.K-1 5f. CD-42, I.K-2.5G.C-1 to I. K-2.5G. CD-42, I.K-3.5G.C-1 to I. K-3.5G. CD-42, I.K-4.5G.C-1 to I.K-4.5f ' .CD-42; I.L-1.5G.C-1 to I.L-1 5f. CD-42, I.L-2.5f.X-1 to I. L-2.5f .CD-42, I.L-3.5T.X-1 to I. L-3.5f ' . CD-42, I.L-4.5T.X-1 to I.L-4.5f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is CeHsand the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.6G.C- 1 to I. K-1.6G. CD-42, I.K-2.6G.C-1 to I. K-2.6G. CD-42, I.K-3.6G.C-1 to I. K-3.6G. CD-42, I.K-4.6G.C- 1 to I.K-4.6G .CD-42; I.L-1.6G.C-1 to I.L-1 6f. CD-42, I.L-2.6T.X-1 to I. L-2.6f .CD-42, I.L-3.6T.X-1 to I. L-3.6f ' . CD-42, I.L-4.6f.X-1 to I.L-4.6f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2-F-CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.39G.C-1 to I. K-1.39G. CD-42, I.K-2.39G.C-1 to I. K-2.39G. CD-42, I.K-3.39G.C-1 to I.K-3.39G .CD- 42, I.K-4.39G.C-1 to I.K-4.39G .CD-42; I.L-1.39G.C-1 to I.L-1 39f.
  • CD-42 I.L-2.39f .X-1 to I.L- 2.39G. CD-42, I.L-3.39f .X-1 to I. L-3.39f. CD-42, I.L-4.39f .X-1 to I.L-4.39f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is S-F-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.8G.C-1 to I. K-1.8G. CD-42, I.K-2.8G.C-1 to I. K-2.8G. CD-42, I.K-3.8G.C-1 to I. K-3.8G.
  • CD-42 I.K- 4.8G.C-1 to I.K-4.8f ' .CD-42; I.L-1.8G.C-1 to I.L-1.8f ' .CD-42, I.L-2.8f ' .X-1 to I. L-2.8f .CD-42, I.L- 3.8G.C-1 to I. L-3.8f. CD-42, I.L-4.8f ' .X-1 to I.L-4.8f ' .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 4-F-CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.8G.C-1 to I. K-1.8G. CD-42, I.K-2.8G.C-1 to I.K-2.8T.CD-42, I.K-3.8G.C-1 to I. K-3.8G. CD-42, I.K- 4.8G.C-1 to I.K-4.8G .CD-42; I.L-1.8G.C-1 to I.L-1.8f ' .CD-42, I.L-2.8T.X-1 to I. L-2.8f .CD-42, I.L- 3.8G.C-1 to I. L-3.8f .CD-42, I.L-4.8T.X-1 to I.L-4.8f .CD-42, I.L- 3.8
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.10G.C-1 to I.K-1.1 Of ' . CD-42, I.K-2.10G.C-1 to I. K-2.10f .CD-42, I.K-3.10G.C-1 to I. K-3.10G. CD- 42, I.K-4.10G.C-1 to I.K-4.10f ' .CD-42; I.L-1.10G.C-1 to I.L-1 10f. CD-42, I.L-2.10f ' .X-1 to I.L-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is S-CI-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.11G.C-1 to I. K-1.11G. CD-42, I.K-2.11G.C-1 to I. K-2.11f. CD-42, I.K-3.11G.C-1 to I.K-3.1 If ' .CD- 42, I.K-4.11f ' .X-1 to I.K-4.11f .CD-42; I.L-1.11G.C-1 to I.L-1.11f. CD-42, I.L-2.11G.C-1 to I.L-L-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 4-CI-C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.12G.C-1 to I. K-1.12G. CD-42, I.K-2.12G.C-1 to I. K-2.12f .CD-42, I.K-3.12G.C-1 to I. K-3.12G.
  • CD- 42 I.K-4.12G.C-1 to I.K-4.12f ' .CD-42; I.L-1.12G.C-1 to I.L-1 12f ' .CD-42, I.L-2.12f ' .X-1 to I.L-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2-OCH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.13G.C-1 to I. K-1.13G. CD-42, I.K-2.13G.C-1 to I. K-2.13f .CD-42, I.K-3.13G.C-1 to I.K- 3.13G. CD-42, I.K-4.13G.C-1 to I.K-4.13f ' .CD-42; I.L-1.13G.C-1 to I.L-1 13f.
  • CD-42 I.L-2.13f ' .X-1 to I. L-2.13f. CD-42, I.L-3.13f ' .X-1 to I.L-3.13f ' .CD-42, I.L-4.13f ' .X-1 to I.L-4.13f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3-OCH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.14G.C-1 to I. K-1.14G. CD-42, I.K-2.14G.C-1 to I. K-2.14f .CD-42, I.K-3.14G.C-1 to I.K- 3.14G.
  • CD-42 I.K-4.14G.C-1 to I.K-4.14f ' .CD-42; I.L-1.14G.C-1 to I.L-1 14f ' .CD-42, I.L-2.14f ' .X-1 to I. L-2.14f. CD-42, I.L-3.14f ' .X-1 to I.L-3.14f ' .CD-42, I.L-4.14f ' .X-1 to I.L-4.14f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 4-OCH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.15G.C-1 to I. K-1.15G. CD-42, I.K-2.15G.C-1 to I. K-2.15f .CD-42, I.K-3.15G.C-1 to I.K- 3.15G. CD-42, I.K-4.15G.C-1 to I.K-4.15f ' .CD-42; I.L-1.15G.C-1 to I.L-1 15f.
  • CD-42 I.L-2.15f ' .X-1 to I. L-2.15f. CD-42, I.L-3.15f ' .X-1 to I.L-3.15f ' .CD-42, I.L-4.15f ' .X-1 to I.L-4.15f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2-OCHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.16G.C-1 to I. K-1.16G. CD-42, I.K-2.16G.C-1 to I. K-2.16f .CD-42, I.K-3.16G.C-1 to I. K-3.16G. CD-42, I.K-4.16G.C-1 to I.K-4.16G .CD-42; I.L-1.16G.C-1 to I.L-1 16f.
  • CD-42 I.L- 2.16G.C-1 to I. L-2.16f ' . CD-42, I.L-3.16f .X-1 to I. L-3.16f .CD-42, I.L-4.16f .X-1 to I. L-4.16f .CD- 42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3-OCHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.17G.C-1 to I. K-1.17G. CD-42, I.K-2.17G.C-1 to I. K-2.17f .CD-42, I.K-3.17G.C-1 to I. K-3.17f ' . CD-42, I.K-4.17G.C-1 to I.K-4.17G .CD-42; I.L-1.17G.C-1 to I.
  • Y is C(Y a1 Y a2 ),R 8 is 4-OCHF 2 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K- 1.18G.C-1 to I. K-1.18G. CD-42, I.K-2.18G.C-1 to I. K-2.18f .CD-42, I.K-3.18G.C-1 to I. K-3.18G. CD- 42, I.K-4.18G.C-1 to I.K-4.18G .CD-42; I.L-1.18G.C-1 to I.L-1 18f. CD-42, I.L-2.18f .X-1 to I.L-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1 19f. X-1 to I. K-1.19G. CD-42, I.K-2.19G.C-1 to I. K-2.19f .CD-42, I.K-3.19G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is S-CFL-CeFUand the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1 20f .X-1 to I. K-1.20G. CD-42, I.K-2.20G.C-1 to I. K-2.20G. CD-42, I.K-3.20G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 4-CH 3 -C 6 H 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.21G.C-1 to I. K-1.21G. CD-42, I.K-2.21G.C-1 to I. K-2.21G. CD-42, I.K-3.21G .X-1 to I.K- 3.21G. CD-42, I.K-4.21G.C-1 to I.K-4.21G .CD-42; I.L-1.21G.C-1 to I.L-1 21f.
  • CD-42 I.L-2.21f .X-1 to I. L-2.21f. CD-42, I . L-3.21 f ' .X-1 to I. L-3.21f. CD-42, I. L-4.21f ' .X-1 to I.L-4.21f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2-CF 3 -CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.22G.C-1 to I. K-1.22G. CD-42, I.K-2.22G.C-1 to I. K-2.22G. CD-42, I.K-3.22G.C-1 to I.K- 3.22G. CD-42, I.K-4.22G.C-1 to I.K-4.22G .CD-42; I.L-1.22G.C-1 to I.L-1 22f.
  • CD-42 I.L-2.22f .X-1 to I. L-2.22f. CD-42, I.L-3.22f .X-1 to I. L-3.22f. CD-42, I.L-4.22f .X-1 to I.L-4.22f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3-CF 3 -CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.23G.C-1 to I. K-1.23G. CD-42, I.K-2.23G.C-1 to I. K-2.23G. CD-42, I.K-3.23G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 4-CF 3 -CeH 4 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.24G.C-1 to I.K-1.24G. CD-42, I.K-2.24G.C-1 to I. K-2.24G. CD-42, I.K-3.24G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,3-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.25G.C-1 to I. K-1.25G. CD-42, I.K-2.25G.C-1 to I. K-2.25G. CD-42, I.K-3.25G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,4-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.26G.C-1 to I. K-1.26G. CD-42, I.K-2.26G.C-1 to I. K-2.26G. CD-42, I.K-3.26G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,5-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.27G.C-1 to I. K-1.27G. CD-42, I.K-2.27G.C-1 to I. K-2.27G. CD-42, I.K-3.27G.C-1 to I.K- 3.27G. CD-42, I.K-4.27G.C-1 to I.K-4.27G .CD-42; I.L-1.27G.C-1 to I.L-1 27f.
  • CD-42 I.L-2.27f .X-1 to I. L-2.27f. CD-42, I.L-3.27f .X-1 to I. L-3.27f. CD-42, I.L-4.27f .X-1 to I.L-4.27f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,6-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.28G.C-1 to I. K-1.28G. CD-42, I.K-2.28G.C-1 to I. K-2.28G. CD-42, I.K-3.28G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3,4-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.29G.C-1 to I. K-1.29G. CD-42, I.K-2.29G.C-1 to I. K-2.29G. CD-42, I.K-3.29G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3,5-F 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1 30f .X-1 to I. K-1.30G. CD-42, I.K-2.30G.C-1 to I. K-2.30G. CD-42, I.K-3.30G.C-1 to I.K- 3.30G. CD-42, I.K-4.30G.C-1 to I.K-4.30G .CD-42; I.L-1.30G.C-1 to I.L-1 30f.
  • CD-42 I.L-2.30f .X-1 to I. L-2.30T .CD-42, I.L-3.30f .X-1 to I. L-3.30f .CD-42, I.L-4.30f .X-1 to I.L-4.30f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,3-Cl 2 -CeH 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.31G.C-1 to I. K-1.31G. CD-42, I.K-2.31G .X-1 to I. K-2.31G. CD-42, I.K-3.31G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,4-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.32G.C-1 to I. K-1.32G. CD-42, I.K-2.32G.C-1 to I. K-2.32G. CD-42, I.K-3.32G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,5-Cl 2 -C 6 H 3 and the meaning for the combination of R 5 and R 9 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.33G.C-1 to I. K-1.33G. CD-42, I.K-2.33G.C-1 to I. K-2.33G. CD-42, I.K-3.33G.C-1 to I.K- 3.33G. CD-42, I.K-4.33G.C-1 to I.K-4.33G .CD-42; I.L-1.33G.C-1 to I.L-1 33f.
  • CD-42 I.L-2.33f .X-1 to I. L-2.33f ' . CD-42, I.L-3.33f .X-1 to I. L-3.33f. CD-42, I.L-4.33f .X-1 to I.L-4.33f .CD-42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,6-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table (compounds I.K- 1.34G.C-1 to I. K-1.34G. CD-42, I.K-2.34G.C-1 to I. K-2.34G. CD-42, I.K-3.34G.C-1 to I.K-3.34G .CD- 42, I.K-4.34G.C-1 to I.K-4.34G .CD-42; I.L-1.34G.C-1 to I.L-1 34f. CD-42, I.L-2.34f .X-1 to I.L-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3,4-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.35G.C-1 to I. K-1.35G. CD-42, I.K-2.35G.C-1 to I. K-2.35G. CD-42, I.K-3.35G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3,5-Cl 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD ((compounds I.K-1.36G.C-1 to I. K-1.36G. CD-42, I.K-2.36G.C-1 to I. K-2.36G. CD-42, I.K-3.36G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,3-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.37G.C-1 to I. K-1.37G. CD-42, I.K-2.37G.C-1 to I. K-2.37G. CD-42, I.K-3.37G.C-1 to I. K-3.37G. CD-42, I.K-4.37G.C-1 to I.K-4.37G .CD-42; I.L-1.37G.C-1 to I.L-1 37f.
  • CD-42 I.L- 2.37G.C-1 to I. L-2.37f. CD-42, I.L-3.37f .X-1 to I. L-3.37f. CD-42, I.L-4.37f .X-1 to I.L-4.37f ' .CD- 42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.39G.C-1 to I. K-1.39G. CD-42, I.K-2.39G.C-1 to I. K-2.39G. CD-42, I.K-3.39G.C-1 to I. K-3.39G. CD-42, I.K-4.39G.C-1 to I.K-4.39G .CD-42; I.L-1.39G.C-1 to I.L-1 39f.
  • CD-42 I.L- 2.39G.C-1 to I. L-2.39T .CD-42, I.L-3.39f .X-1 to I. L-3.39f. CD-42, I.L-4.39f .X-1 to I.L-4.39f ' .CD- 42).
  • Table 39G Compounds of the formula I.K-1, I.K-2, I.K-3, I.K-4; I.L-1 , I.L-2, I.L-3, I.L-4, in which Y is C(Y a1 Y a2 )-CH2-CEC, R 8 is 2,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.39G.C-1 to I. K-1.39G. CD-42, I.K-2.39G.C-1 to I. K-2.39G. CD-42, I.K-3.39G.C-1 to I.
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 2,6-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.40G.C-1 to I. K-1.40G. CD-42, I.K-2.40G.C-1 to I. K-2.40G. CD-42, I.K-3.40G.C-1 to I. K-3.40f ' . CD-42, I.K-4.40G.C-1 to I.K-4.40G .CD-42; I.L-1.40G.C-1 to I.
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3,4-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.41G.C-1 to I. K-1.41G. CD-42, I.K-2.41G.C-1 to I. K-2.41G. CD-42, I.K-3.41G.C-1 to I. K-3.41f ' . CD-42, I.K-4.41G.C-1 to I.K-4.41G .CD-42; I.L-1.41G.C-1 to I.L-1 41f.
  • CD-42 I.L- 2.41G.C-1 to I. L-2.41f. CD-42, I.L-3.41f .X-1 to I. L-3.41f. CD-42,
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is 3,5-(CH 3 ) 2 -C 6 H 3 and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.42G.C-1 to I. K-1.42G. CD-42, I.K-2.42G.C-1 to I. K-2.42G. CD-42, I.K-3.42G.C-1 to I. K-3.42f ' . CD-42, I.K-4.42G.C-1 to I.K-4.42G .CD-42; I.L-1.42G.C-1 to I.L-1 42f.
  • CD-42 I.L- 2.42G.C-1 to I. L-2.42f. CD-42, I.L-3.42f .X-1 to I. L-3.42f. CD-42, I.L-4.42f .X-1 to I.L-4.42f ' .CD- 42).
  • Y is C(Y a1 Y a2 )-CH2-C-C
  • R 8 is and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.43G.C-1 to I. K-1.43G. CD-42, I.K-2.43G.C-1 to I. K-2.43G. CD-42, I.K-3.43G.C-1 to I.K-
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclo-pent-(1)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.44G.C-1 to I. K-1.44G. CD-42, I.K-2.44G.C-1 to I. K-2.44G. CD-42, I.K-3.44G.C-1 to I. K-3.44f ' . CD-42, I.K-4.44G.C-1 to I.K-4.44G .CD-42; I.L-1.44G.C-1 to I.L-1 44f.
  • CD-42 I.L- 2.44G.C-1 to I. L-2.44f ' .
  • CD-42 I.L-3.44f .X-1 to I. L-3.44f.
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclopent-(2)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.45G.C-1 to I. K-1.45G. CD-42, I.K-2.45G.C-1 to I. K-2.45G. CD-42, I.K-3.45G.C-1 to I. K-3.45f ' . CD-42, I.K-4.45G.C-1 to I.K-4.45G .CD-42; I.L-1.45G.C-1 to I.L-1 45f.
  • CD-42 I.L- 2.45G.C-1 to I. L-2.45f. CD-42, I.L-3.45f .X-1 to I. L-3.45f .CD-42, I.L-4.45f .X-1 to I. L-4.45f .CD- 42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclo-pent-(3)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.46G.C-1 to I. K-1.46G. CD-42, I.K-2.46G.C-1 to I. K-2.46G. CD-42, I.K-3.46G.C-1 to I. K-3.46G. CD-42, I.K-4.46G.C-1 to I.K-4.46G .CD-42; I.L-1.46G.C-1 to I.
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclohex-(1)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.47G.C-1 to I. K-1.47G. CD-42, I.K-2.47G.C-1 to I. K-2.47G. CD-42, I.K-3.47G.C-1 to I. K-3.47f ' . CD-42, I.K-4.47G.C-1 to I.K-4.47G .CD-42; I.L-1.47G.C-1 to I.L-1 47f.
  • CD-42 I.L- 2.47G.C-1 to I. L-2.47f. CD-42, I.L-3.47f .X-1 to I. L-3.47f. CD-42,
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclohex-(2)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.48G.C-1 to I. K-1.48G. CD-42, I.K-2.48G.C-1 to I. K-2.48G. CD-42, I.K-3.48G.C-1 to I. K-3.48G. CD-42, I.K-4.48G.C-1 to I.K-4.48G .CD-42; I.L-1.48G.C-1 to I.L-1 48f.
  • CD-42 I.L- 2.48G.C-1 to I. L-2.48f ' .
  • CD-42 I.L-3.48f .X-1 to I. L-3.48f .CD-42, I.L-4.48f .X-1 to I.L-4.48f ' .CD- 42).
  • Y is C(Y a1 Y a2 )-CH2-CEC
  • R 8 is cyclohex-(3)-en and the meaning for the combination of Y a1 and Y a2 for each individual compound corresponds in each case to one line of Table CD (compounds I.K-1.49G.C-1 to I. K-1.49G. CD-42, I.K-2.49G.C-1 to I. K-2.49G. CD-42, I.K-3.49G.C-1 to I. K-3.49f ' . CD-42, I.K-4.49G.C-1 to I.K-4.49G .CD-42; I.L-1.49G.C-1 to I.L-1 49f.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne l'utilisation de composés de formule I, dans laquelle les variables sont telles que définies dans la description et les revendications. L'invention concerne en outre les composés I et une composition pour des composés de formule I.
PCT/EP2020/076363 2019-10-02 2020-09-22 Nouveaux dérivés pyridines bicycliques WO2021063735A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19201072 2019-10-02
EP19201072.6 2019-10-02

Publications (1)

Publication Number Publication Date
WO2021063735A1 true WO2021063735A1 (fr) 2021-04-08

Family

ID=68136243

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2020/076363 WO2021063735A1 (fr) 2019-10-02 2020-09-22 Nouveaux dérivés pyridines bicycliques

Country Status (1)

Country Link
WO (1) WO2021063735A1 (fr)

Citations (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3296272A (en) 1965-04-01 1967-01-03 Dow Chemical Co Sulfinyl- and sulfonylpyridines
US3325503A (en) 1965-02-18 1967-06-13 Diamond Alkali Co Polychloro derivatives of mono- and dicyano pyridines and a method for their preparation
EP0141317A2 (fr) 1983-10-21 1985-05-15 BASF Aktiengesellschaft 7-Amino-azolo[1,5-a]pyrimidines et fongicides les contenant
EP0152031A2 (fr) 1984-02-03 1985-08-21 Shionogi & Co., Ltd. Dérivés azolyl cycloalkanols et fongicides agricoles
EP0226917A1 (fr) 1985-12-20 1987-07-01 BASF Aktiengesellschaft Esters acryliques et fongicides contenant ces composés
EP0243970A1 (fr) 1986-05-02 1987-11-04 Stauffer Chemical Company Imidates de pyridyle fongicides
EP0256503A2 (fr) 1986-08-12 1988-02-24 Mitsubishi Kasei Corporation Dérivés de pyridinecarboxamide et leur utilisation comme fongicides
EP0428941A1 (fr) 1989-11-10 1991-05-29 Agro-Kanesho Co., Ltd. Dérivés de l'hexahydrotriazine et insecticides
EP0532022A1 (fr) 1991-09-13 1993-03-17 Ube Industries, Ltd. Composés acryliques, procédé pour leur préparation et fongicides les contenant
WO1994001546A1 (fr) 1992-07-01 1994-01-20 Cornell Research Foundation, Inc. Inducteur de la reponse hypersensible chez des plantes
DE19650197A1 (de) 1996-12-04 1998-06-10 Bayer Ag 3-Thiocarbamoylpyrazol-Derivate
WO1998044140A1 (fr) 1997-04-03 1998-10-08 Dekalb Genetics Corporation Lignees de mais resistantes aux glyphosates
WO1998046608A1 (fr) 1997-04-14 1998-10-22 American Cyanamid Company Trifluoromethylalkylamino-triazolopyrimidines fongicides
WO1999014187A1 (fr) 1997-09-18 1999-03-25 Basf Aktiengesellschaft Derives de benzamidoxime, produits intermediaires et procedes pour les preparer et les utiliser comme fongicides
WO1999024413A2 (fr) 1997-11-12 1999-05-20 Bayer Aktiengesellschaft Amides d'acide isothiazol carboxylique et leur utilisation pour la protection de plantes
WO1999027783A1 (fr) 1997-12-04 1999-06-10 Dow Agrosciences Llc Compositions fongicides, procedes correspondants, composes et procedes concourant a leur elaboration
WO2000026356A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N. V. Riz tolerant au glufosinate
WO2000026345A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N.V. Riz tolerant au glufosinate
WO2000029404A1 (fr) 1998-11-17 2000-05-25 Kumiai Chemical Industry Co., Ltd. Derives de pyrimidinylbenzimidazole et de triazinylbenzimidazole et bactericides agricoles/horticoles
WO2000046148A1 (fr) 1999-02-02 2000-08-10 Sintokogio, Ltd. Gel de silice a photocatalyseur fortement concentre a base d'oxyde de titane et procede de fabrication correspondant
EP1028125A1 (fr) 1998-11-30 2000-08-16 Isagro Ricerca S.r.l. Dipeptides ayant une activité fungizide et leur utilisation agronomique
EP1035122A1 (fr) 1999-03-11 2000-09-13 Rohm And Haas Company Isoxazolidines substituées par des hétérocycles et leur utilisation comme fongicides
WO2000065913A1 (fr) 1999-04-28 2000-11-09 Takeda Chemical Industries, Ltd. Derives de sulfamide
WO2001031042A2 (fr) 1999-10-29 2001-05-03 Aventis Cropscience N.V. Plantes brassica male sterile et procedes de production de ces plantes
WO2001041558A1 (fr) 1999-12-08 2001-06-14 Aventis Cropscience N.V. Colza oleagineux d'hiver hybrides et son procede de production
DE10021412A1 (de) 1999-12-13 2001-06-21 Bayer Ag Fungizide Wirkstoffkombinationen
WO2001054501A2 (fr) 2000-01-25 2001-08-02 Syngenta Participations Ag Composition herbicide
EP1122244A1 (fr) 2000-02-04 2001-08-08 Sumitomo Chemical Company, Limited Composés d'uracile et leur usage
WO2001056358A2 (fr) 2000-01-28 2001-08-09 Rohm And Haas Company Pesticides dotes de proprietes accrues
CN1309897A (zh) 2000-02-24 2001-08-29 沈阳化工研究院 不饱和肟醚类杀菌剂
WO2002022583A2 (fr) 2000-09-18 2002-03-21 E. I. Du Pont De Nemours And Company Pyridinyl-amides et pyridinyl-imides utilisés comme fongicides
WO2002034946A2 (fr) 2000-10-25 2002-05-02 Monsanto Technology Llc Mecanisme biochimique de plant de coton pv-ghgt07(1445), compositions et techniques de detection de celui-ci
EP1201648A1 (fr) 1999-08-05 2002-05-02 Kumiai Chemical Industry Co., Ltd. Derives de carbamate et bactericides destines a l'agriculture et a l'horticulture
WO2002036831A2 (fr) 2000-10-30 2002-05-10 Monsanto Technology Llc Colza canola pv-bngt(rt73), compositions et procedes de detection correspondants
WO2002040431A2 (fr) 2000-11-17 2002-05-23 Dow Agrosciences Llc Composes presentant une activite fongicide et leurs procedes de preparation et d'utilisation
US20020102582A1 (en) 2000-09-13 2002-08-01 Levine Elaine B. Corn event MON810 and compositions and methods for detection thereof
JP2002316902A (ja) 2001-04-20 2002-10-31 Sumitomo Chem Co Ltd 植物病害防除剤組成物
WO2002100163A2 (fr) 2001-06-11 2002-12-19 Monsanto Technology Llc Evenement mon15985 du coton et compositions et procedes servant a sa detection
WO2003010149A1 (fr) 2001-07-25 2003-02-06 Bayer Cropscience Ag Carboxanilides de pyrazolyle utilises comme fongicides
WO2003011853A1 (fr) 2001-07-30 2003-02-13 Dow Agrosciences Llc 6-aryl-4-aminopicolinates et leur utilisation comme herbicides
WO2003013224A2 (fr) 2001-08-06 2003-02-20 Bayer Bioscience N.V. Cotonniers avec tolerance aux herbicides et procedes de production et d'identification de ces cotonniers
WO2003014103A1 (fr) 2001-08-03 2003-02-20 Bayer Cropscience S.A. Derives de iodobenzopyran-4-one presentant une activite fongicide
WO2003016286A1 (fr) 2001-08-17 2003-02-27 Sankyo Agro Company, Limited Derive de 3-phenoxy-4-pyridazinol et composition herbicide le contenant
WO2003016303A1 (fr) 2001-08-20 2003-02-27 Dainippon Ink And Chemicals, Inc. Derive de tetrazoyle oxime et produit chimique agricole contenant ledit derive comme principe actif
WO2003053145A1 (fr) 2001-12-21 2003-07-03 Nissan Chemical Industries, Ltd. Composition bactericide
US20030126634A1 (en) 1990-08-09 2003-07-03 Dekalb Genetics Corporation Methods and compositions for the increase of yield in plants
WO2003061388A1 (fr) 2002-01-18 2003-07-31 Sumitomo Chemical Takeda Agro Company, Limited Compose de sulfonyluree heterocyclique fusionne, herbicide contenant ce compose et procede de controle de plantes nuisibles au moyen de cet herbicide
WO2003064572A1 (fr) 2002-01-31 2003-08-07 Exxonmobil Research And Engineering Company Compositions d'huile lubrifiante a proprietes de reduction du frottement ameliorees
WO2003066609A1 (fr) 2002-02-04 2003-08-14 Bayer Cropscience Aktiengesellschaft Thiazolylcarboxanilides disubstitues et leur utilisation comme microbicides
WO2003074491A1 (fr) 2002-03-05 2003-09-12 Syngenta Participations Ag O-cyclopropyle-carboxanilides et leur utilisation comme fongicides
CN1456054A (zh) 2003-03-25 2003-11-19 浙江省化工研究院 甲氧基丙烯酸甲酯类化合物杀菌剂
WO2004011601A2 (fr) 2002-07-29 2004-02-05 Monsanto Technology, Llc Mais pv-zmir13 designe mon863, composition et procedes de detection
WO2004039986A1 (fr) 2002-10-29 2004-05-13 Syngenta Participations Ag Coton insecticide cot102
WO2004049804A2 (fr) 2002-11-29 2004-06-17 Syngenta Participations Ag Combinaisons fongicides pour proteger des cultures
WO2004072235A2 (fr) 2003-02-12 2004-08-26 Monsanto Technology Llc Evenement mon 88913 de plant de coton et procedes de detection correspondants
WO2004074492A1 (fr) 2003-02-20 2004-09-02 Kws Saat Ag Betteraves sucrieres tolerant le glyphosate
WO2004083193A1 (fr) 2003-03-17 2004-09-30 Sumitomo Chemical Company, Limited Compose amide et composition bactericide contenant ledit compose
WO2004099447A2 (fr) 2003-05-02 2004-11-18 Dow Agrosciences Llc Mais tc1507 et procedes de detection de celui-ci
WO2005059103A2 (fr) 2003-12-15 2005-06-30 Monsanto Technology Llc Plant de mais mon88017, compositions et procedes de detection associes
WO2005061720A2 (fr) 2003-12-11 2005-07-07 Monsanto Technology Llc Compositions de mais a haute teneur en lysine et methodes de detection correspondantes
WO2005063721A1 (fr) 2003-12-19 2005-07-14 E.I. Dupont De Nemours And Company Pyrimidines herbicides
WO2005087772A1 (fr) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, procedes pour leur production, leur utilisation pour lutter contre des champignons nuisibles, ainsi qu'agents les contenant
WO2005087773A1 (fr) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, procedes pour leur production, leur utilisation pour lutter contre des champignons nuisibles, ainsi qu'agents les contenant
WO2005103301A2 (fr) 2004-03-25 2005-11-03 Syngenta Participations Ag Mais mir604
WO2005103266A1 (fr) 2004-03-26 2005-11-03 Dow Agrosciences Llc Lignees de coton transgeniques cry1f et cry1ac et leur identification specifique a l'evenement
WO2005120234A2 (fr) 2004-06-03 2005-12-22 E.I. Dupont De Nemours And Company Melanges fongicides de composes d'amidinylphenyle
WO2005123690A1 (fr) 2004-06-18 2005-12-29 Basf Aktiengesellschaft (ortho-phenyl)-anilides d'acide 1-methyl-3-difluormethyl-pyrazol-4-carboxylique et leur utilisation comme fongicides
WO2005123689A1 (fr) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-trifluoromethyl-pyrazol-4-acide carboxylique-(ortho-phenyl)-anilides et leur utilisation comme fongicides
WO2006015866A1 (fr) 2004-08-12 2006-02-16 Syngenta Participations Ag Procédé servant à protéger des plantes utiles ou une matière de propagation de plante
WO2006039376A2 (fr) 2004-09-29 2006-04-13 Pioneer Hi-Bred International, Inc. Evenement de mais das-59122-7, et procedes de detection correspondants
WO2006087343A1 (fr) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Anilides d'acide carboxylique pyrazole, procedes de production associes et agents les contenant pour la lutte antifongique
WO2006087325A1 (fr) 2005-02-16 2006-08-24 Basf Aktiengesellschaft 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, procede de fabrication de ces composes, utilisation dans la lutte contre des champignons parasites et agents les contenant
DE102005009458A1 (de) 2005-03-02 2006-09-07 Bayer Cropscience Ag Pyrazolylcarboxanilide
WO2006098952A2 (fr) 2005-03-16 2006-09-21 Syngenta Participations Ag Mais 3272 et procedes pour le detecter
WO2006108675A2 (fr) 2005-04-11 2006-10-19 Bayer Bioscience N.V. Evenement elite a5547-127 et procedes et trousses pour l'identification d'un tel evenement dans des echantillons biologiques
WO2006108674A2 (fr) 2005-04-08 2006-10-19 Bayer Bioscience N.V. Evenement elite a2704-12 et procedes et trousses permettant d'identifier cet evenement dans des prelevements biologiques
WO2006128573A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce43-67b
WO2006130436A2 (fr) 2005-05-27 2006-12-07 Monsanto Technology Llc Evenement de soja mon89788 et procedes de detection de celui-ci
WO2007006670A1 (fr) 2005-07-07 2007-01-18 Basf Aktiengesellschaft Composes de n-thio-anthranilamide et utilisations comme pesticides
CN1907024A (zh) 2005-08-03 2007-02-07 浙江化工科技集团有限公司 取代甲氧基丙烯酸甲酯类化合物杀菌剂
WO2007017186A1 (fr) 2005-08-08 2007-02-15 Bayer Bioscience N.V. Cotonniers tolerants aux herbicides et leurs procedes d'identification
WO2007082098A2 (fr) 2006-01-13 2007-07-19 Dow Agrosciences Llc 6-(poly-aryl substituté)-4-aminopicolinates et utilisations de ceux-ci comme herbicides
WO2007090624A2 (fr) 2006-02-09 2007-08-16 Syngenta Participations Ag Procede de protection d'une matiere de propagation vegetale, d'un vegetal et/ou d'un organisme vegetal
WO2007129454A1 (fr) 2006-05-08 2007-11-15 Kumiai Chemical Industry Co., Ltd. Derive 1,2-benzisothiazole et agent luttant contre une maladie de plante agricole ou horticole
WO2007140256A1 (fr) 2006-05-26 2007-12-06 Monsanto Technology, Llc Plant et semence de maïs correspondant au produit transgénique mon89034, procédés de détection et utilisation associés
WO2007142840A2 (fr) 2006-06-03 2007-12-13 Syngenta Participations Ag Événement de transformation de maïs mir162
US20070292854A1 (en) 2000-06-22 2007-12-20 Behr Carl F Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof
WO2008002872A2 (fr) 2006-06-28 2008-01-03 Pioneer Hi-Bred International, Inc. Événement de soja 3560.4.3.5 et compositions et procedes d'identification et/ou de détection de celui-ci
WO2008013622A2 (fr) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Amides azocycliques fongicides
WO2008054747A2 (fr) 2006-10-31 2008-05-08 E. I. Du Pont De Nemours And Company Événement de soja dp-305423-1, leurs compositions et leurs procédés d'identification et/ou de détection
WO2008112019A2 (fr) 2006-10-30 2008-09-18 Pioneer Hi-Bred International, Inc. Evènement dp-098140-6 du maïs et compositions et procédés pour son identification et/ou sa détection
WO2008122406A1 (fr) 2007-04-05 2008-10-16 Bayer Bioscience N.V. Plants de coton résistant aux insectes et leurs procédés d'identification
JP2008255018A (ja) * 2007-04-02 2008-10-23 Hokko Chem Ind Co Ltd １，３‐ジオキソラン誘導体、１，３‐ジチオラン誘導体または１，３‐オキサチオラン誘導体および農園芸用殺菌剤。
JP2008280274A (ja) * 2007-05-09 2008-11-20 Hokko Chem Ind Co Ltd シクロヘキサンカルボキサミド誘導体および農園芸用殺菌剤
WO2008151780A1 (fr) 2007-06-11 2008-12-18 Bayer Bioscience N.V. Cotonniers résistant aux insectes comprenant un événement élite ee-gh6 et leurs procédés d'identification
WO2009064652A1 (fr) 2007-11-15 2009-05-22 Monsanto Technology Llc Plante et graine de soja correspondant à l'événement transgénique mon87701 et procédés pour les détecter
WO2009090181A2 (fr) 2008-01-15 2009-07-23 Bayer Cropscience Sa Composition pesticide comprenant un dérivé de tétrazolyloxime et une substance active fongicide ou insecticide
WO2009094442A2 (fr) 2008-01-22 2009-07-30 Dow Agrosciences Llc Dérivés de 5-fluoropyrimidine
WO2009103049A2 (fr) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Evénement spt flanquant l'adn génomique végétal et procédés d'identification de l'événement spt
WO2009102873A1 (fr) 2008-02-15 2009-08-20 Monsanto Technology Llc Plante de soja et graine correspondant à l’évènement transgénique mon87769 et leurs procédés de détection
WO2009111263A1 (fr) 2008-02-29 2009-09-11 Monsanto Technology Llc Plant de maïs correspondant au produit transgénique mon87460 et compositions et procédés de détection associés
WO2010037016A1 (fr) 2008-09-29 2010-04-01 Monsanto Technology Llc Événement transgénique de soja t mon87705 et procédés pour la détection de celui-ci
WO2010069882A1 (fr) 2008-12-17 2010-06-24 Syngenta Participations Ag Dérivés d'isoxazole en tant que fongicides
WO2010075200A1 (fr) 2008-12-22 2010-07-01 Array Biopharma Inc. Dérivés d'acide 7-phénoxychromanecarboxylique
WO2010077816A1 (fr) 2008-12-16 2010-07-08 Syngenta Participations Ag Evénement transgénique du maïs 5307
WO2010080829A1 (fr) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Évènement de soja 127 et procédés apparentés
WO2010139271A1 (fr) 2009-06-05 2010-12-09 中国中化股份有限公司 Composés ester phénylacrylique de type e contenant un groupe anilinopyrimidine substitué et leurs utilisations
WO2011022469A2 (fr) 2009-08-19 2011-02-24 Dow Agrosciences Llc Événement das-40278-9 d'aad-1, lignées transgéniques de maïs connexes et identification spécifique d'événement de celui-ci
WO2011028657A1 (fr) 2009-09-01 2011-03-10 Dow Agrosciences Llc Compositions fongicides synergiques contenant un dérivé de 5-fluoropyrimidine pour la lutte contre les champignons dans des céréales
WO2011034704A1 (fr) 2009-09-17 2011-03-24 Monsanto Technology Llc Variété transgénique mon 87708 du soja et ses méthodes d'utilisation
WO2011062904A1 (fr) 2009-11-23 2011-05-26 Monsanto Technology Llc Événement du maïs transgénique mon 87427 et échelle de développement relative
WO2011066384A1 (fr) 2009-11-24 2011-06-03 Dow Agrosciences Llc Événement 416 de la transformation aad-12, lignées de soja transgéniques associées, et leur identification spécifique à l'événement
WO2011077514A1 (fr) 2009-12-22 2011-06-30 三井化学アグロ株式会社 Composition permettant de lutter contre des maladies végétales et procédé de lutte contre des maladies végétales par application de la composition
WO2011081174A1 (fr) 2010-01-04 2011-07-07 日本曹達株式会社 Compose heterocyclique contenant de l'azote et germicide agricole/horticole
WO2011084621A1 (fr) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Evénement de transformation dp-004114-3 du maïs et son procédé de détection
WO2011092140A1 (fr) 2010-01-27 2011-08-04 Boehringer Ingelheim International Gmbh Composés pyrazole comme antagonistes du crth2
WO2011135827A1 (fr) 2010-04-27 2011-11-03 Sumitomo Chemical Company, Limited Composition pesticide et utilisation associée
WO2011135833A1 (fr) 2010-04-28 2011-11-03 Sumitomo Chemical Company, Limited Composition phytosanitaire et utilisation associée
WO2011153186A1 (fr) 2010-06-04 2011-12-08 Monsanto Technology Llc Evénement mon 88032 d'une plante transgénique du genre brassica et ses procédés d'utilisation
WO2012051199A2 (fr) 2010-10-12 2012-04-19 Monsanto Technology Llc Plante et semence de soja correspondant à l'événement transgénique mon87712 et procédé pour les détecter
WO2012082548A2 (fr) 2010-12-15 2012-06-21 Syngenta Participations Ag Soja comprenant le mécanisme de transformation syht04r, et compositions et procédés de détection de ce mécanisme
WO2012084812A1 (fr) 2010-12-20 2012-06-28 Isagro Ricerca S.R.L. Amides d'aminoindanes présentant une forte activité fongicide et leurs compositions phytosanitaires
WO2012134808A1 (fr) 2011-03-30 2012-10-04 Monsanto Technology Llc Événement transgénique mon 88701 du coton et ses procédés d'utilisation
WO2012165511A1 (fr) 2011-05-31 2012-12-06 クミアイ化学工業株式会社 Procédé de lutte contre des maladies dans une plante de riz
WO2012168188A1 (fr) 2011-06-07 2012-12-13 Bayer Intellectual Property Gmbh Combinaisons de composés actifs
WO2013003558A1 (fr) 2011-06-30 2013-01-03 Monsanto Technology Llc Plante et graine de luzerne correspondant à l'événement transgénique kk 179-2 et procédés pour la détection de celui-ci
WO2013007767A1 (fr) 2011-07-13 2013-01-17 Basf Se Composés fongicides 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol substitués
WO2013010862A1 (fr) 2011-07-15 2013-01-24 Basf Se Composés fongicides de 2-[2-chloro-4-(4-chloro-phénoxy)-phényl]-1-[1,2,4]triazol-1-yl-éthanol substitué par alkyle
WO2013016516A1 (fr) 2011-07-26 2013-01-31 Dow Agrosciences Llc Evénement combiné de sélection résistant aux insectes et tolérant à un herbicide d'un événement de soja pdab9582.814.19.1 et pdab4468.04.16.1
WO2013024009A1 (fr) 2011-08-12 2013-02-21 Basf Se Composés n-thio-anthranilamides et leur utilisation comme pesticides
WO2013024010A1 (fr) 2011-08-12 2013-02-21 Basf Se Composés n-thio-anthranilamides et leur utilisation comme pesticides
WO2013047749A1 (fr) 2011-09-29 2013-04-04 三井化学アグロ株式会社 Procédé de fabrication de dérivé de 4,4-difluoro-3,4-dihydroisoquinoléine
WO2013047441A1 (fr) 2011-09-26 2013-04-04 日本曹達株式会社 Composition bactéricide pour l'agriculture et l'horticulture
WO2013092224A1 (fr) 2011-12-21 2013-06-27 Basf Se Utilisation de composés de type strobilurine pour combattre des champignons phytopathogènes résistants aux inhibiteurs du site qo
WO2013112527A1 (fr) 2012-01-23 2013-08-01 Dow Agrosciences Llc Coton résistant aux herbicides évènement pdab4468.19.10.3
WO2013116251A2 (fr) 2012-02-01 2013-08-08 E. I. Du Pont De Nemours And Company Mélanges de pyrazole fongicides
WO2013127704A1 (fr) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Associations de composés actifs contenant une thiazoylisoxazoline et un fongicide
WO2013162072A1 (fr) 2012-04-27 2013-10-31 Sumitomo Chemical Company, Limited Composés de tétrazolinone et leur utilisation en tant que pesticides
WO2013164773A1 (fr) 2012-05-02 2013-11-07 Lupin Limited Composés substitués de pyrazole en tant que modulateurs de crac
CN103387541A (zh) 2012-05-10 2013-11-13 中国中化股份有限公司 一种取代吡唑醚类化合物的制备方法
WO2013169923A2 (fr) 2012-05-08 2013-11-14 Monsanto Technology Llc Événement de maïs mon 87411
WO2014060177A1 (fr) 2012-10-16 2014-04-24 Syngenta Participations Ag Compositions fongicides
WO2014116854A1 (fr) 2013-01-25 2014-07-31 Pioneer Hi-Bred International, Inc. Événement de maïs dp-033121-3 et ses procédés de détection
WO2014178913A1 (fr) 2013-05-02 2014-11-06 J.R. Simplot Company Cultivar de pomme de terre f10
WO2014201235A2 (fr) 2013-06-14 2014-12-18 Monsanto Technology Llc Événement transgénique de soja mon87751 et procédés de détection et d'utilisation de celui-ci
WO2015053998A1 (fr) 2013-10-09 2015-04-16 Monsanto Technology Llc Événement de maïs transgénique mon87403 et procédés pour la détection de celui-ci
EP2865265A1 (fr) 2014-02-13 2015-04-29 Bayer CropScience AG Combinaisons de composés actifs comprenant des composés phénylamidine et agents de lutte biologique
WO2015065922A1 (fr) 2013-10-28 2015-05-07 Dexcom, Inc. Dispositifs utilisés en relation avec une surveillance continue de substances à analyser pour fournir une ou plusieurs notifications à un utilisateur, et procédés associés
JP2015089883A (ja) 2013-11-06 2015-05-11 アグロカネショウ株式会社 ２−アミノニコチン酸ベンジルエステル誘導体およびこれを有効成分とする殺菌剤
JP2015120675A (ja) 2013-12-25 2015-07-02 アグロカネショウ株式会社 ６−置換ニコチン酸エステル誘導体およびこれを有効成分とする殺菌剤
WO2015119246A1 (fr) 2014-02-07 2015-08-13 日産化学工業株式会社 Composition bactéricide ou de stérilisation et méthode de lutte contre les maladies
WO2015142571A1 (fr) 2014-03-20 2015-09-24 Monsanto Technology Llc Événement transgénique de maïs mon 87419 et méthodes d'utilisation de celui-ci
WO2016183445A1 (fr) 2015-05-14 2016-11-17 J.R. Simplot Company Cultivar de pomme de terre v11
WO2017062831A1 (fr) 2015-10-08 2017-04-13 J.R. Simplot Company Cultivar de pomme de terre x17
WO2017062825A1 (fr) 2015-10-08 2017-04-13 J.R. Simplot Company Cultivar de pomme de terre y9
WO2018020474A1 (fr) * 2016-07-29 2018-02-01 Lupin Limited Composés de thiazolo-pyridine substitués en tant qu'inhibiteurs de malt1
WO2018172133A1 (fr) 2017-03-20 2018-09-27 Syngenta Participations Ag Dérivés microbiocides de quinoléine (thio)carboxamide

Patent Citations (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325503A (en) 1965-02-18 1967-06-13 Diamond Alkali Co Polychloro derivatives of mono- and dicyano pyridines and a method for their preparation
US3296272A (en) 1965-04-01 1967-01-03 Dow Chemical Co Sulfinyl- and sulfonylpyridines
EP0141317A2 (fr) 1983-10-21 1985-05-15 BASF Aktiengesellschaft 7-Amino-azolo[1,5-a]pyrimidines et fongicides les contenant
EP0152031A2 (fr) 1984-02-03 1985-08-21 Shionogi & Co., Ltd. Dérivés azolyl cycloalkanols et fongicides agricoles
EP0226917A1 (fr) 1985-12-20 1987-07-01 BASF Aktiengesellschaft Esters acryliques et fongicides contenant ces composés
EP0243970A1 (fr) 1986-05-02 1987-11-04 Stauffer Chemical Company Imidates de pyridyle fongicides
EP0256503A2 (fr) 1986-08-12 1988-02-24 Mitsubishi Kasei Corporation Dérivés de pyridinecarboxamide et leur utilisation comme fongicides
EP0428941A1 (fr) 1989-11-10 1991-05-29 Agro-Kanesho Co., Ltd. Dérivés de l'hexahydrotriazine et insecticides
US20030126634A1 (en) 1990-08-09 2003-07-03 Dekalb Genetics Corporation Methods and compositions for the increase of yield in plants
EP0532022A1 (fr) 1991-09-13 1993-03-17 Ube Industries, Ltd. Composés acryliques, procédé pour leur préparation et fongicides les contenant
WO1994001546A1 (fr) 1992-07-01 1994-01-20 Cornell Research Foundation, Inc. Inducteur de la reponse hypersensible chez des plantes
DE19650197A1 (de) 1996-12-04 1998-06-10 Bayer Ag 3-Thiocarbamoylpyrazol-Derivate
WO1998044140A1 (fr) 1997-04-03 1998-10-08 Dekalb Genetics Corporation Lignees de mais resistantes aux glyphosates
WO1998046608A1 (fr) 1997-04-14 1998-10-22 American Cyanamid Company Trifluoromethylalkylamino-triazolopyrimidines fongicides
WO1999014187A1 (fr) 1997-09-18 1999-03-25 Basf Aktiengesellschaft Derives de benzamidoxime, produits intermediaires et procedes pour les preparer et les utiliser comme fongicides
WO1999024413A2 (fr) 1997-11-12 1999-05-20 Bayer Aktiengesellschaft Amides d'acide isothiazol carboxylique et leur utilisation pour la protection de plantes
WO1999027783A1 (fr) 1997-12-04 1999-06-10 Dow Agrosciences Llc Compositions fongicides, procedes correspondants, composes et procedes concourant a leur elaboration
WO2000026356A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N. V. Riz tolerant au glufosinate
WO2000026345A1 (fr) 1998-11-03 2000-05-11 Aventis Cropscience N.V. Riz tolerant au glufosinate
WO2000029404A1 (fr) 1998-11-17 2000-05-25 Kumiai Chemical Industry Co., Ltd. Derives de pyrimidinylbenzimidazole et de triazinylbenzimidazole et bactericides agricoles/horticoles
EP1028125A1 (fr) 1998-11-30 2000-08-16 Isagro Ricerca S.r.l. Dipeptides ayant une activité fungizide et leur utilisation agronomique
WO2000046148A1 (fr) 1999-02-02 2000-08-10 Sintokogio, Ltd. Gel de silice a photocatalyseur fortement concentre a base d'oxyde de titane et procede de fabrication correspondant
EP1035122A1 (fr) 1999-03-11 2000-09-13 Rohm And Haas Company Isoxazolidines substituées par des hétérocycles et leur utilisation comme fongicides
WO2000065913A1 (fr) 1999-04-28 2000-11-09 Takeda Chemical Industries, Ltd. Derives de sulfamide
EP1201648A1 (fr) 1999-08-05 2002-05-02 Kumiai Chemical Industry Co., Ltd. Derives de carbamate et bactericides destines a l'agriculture et a l'horticulture
WO2001031042A2 (fr) 1999-10-29 2001-05-03 Aventis Cropscience N.V. Plantes brassica male sterile et procedes de production de ces plantes
WO2001041558A1 (fr) 1999-12-08 2001-06-14 Aventis Cropscience N.V. Colza oleagineux d'hiver hybrides et son procede de production
DE10021412A1 (de) 1999-12-13 2001-06-21 Bayer Ag Fungizide Wirkstoffkombinationen
WO2001054501A2 (fr) 2000-01-25 2001-08-02 Syngenta Participations Ag Composition herbicide
WO2001056358A2 (fr) 2000-01-28 2001-08-09 Rohm And Haas Company Pesticides dotes de proprietes accrues
EP1122244A1 (fr) 2000-02-04 2001-08-08 Sumitomo Chemical Company, Limited Composés d'uracile et leur usage
CN1309897A (zh) 2000-02-24 2001-08-29 沈阳化工研究院 不饱和肟醚类杀菌剂
US20070292854A1 (en) 2000-06-22 2007-12-20 Behr Carl F Corn event PV-ZMGT32(nk603) and compositions and methods for detection thereof
US20020102582A1 (en) 2000-09-13 2002-08-01 Levine Elaine B. Corn event MON810 and compositions and methods for detection thereof
WO2002022583A2 (fr) 2000-09-18 2002-03-21 E. I. Du Pont De Nemours And Company Pyridinyl-amides et pyridinyl-imides utilisés comme fongicides
WO2002034946A2 (fr) 2000-10-25 2002-05-02 Monsanto Technology Llc Mecanisme biochimique de plant de coton pv-ghgt07(1445), compositions et techniques de detection de celui-ci
WO2002036831A2 (fr) 2000-10-30 2002-05-10 Monsanto Technology Llc Colza canola pv-bngt(rt73), compositions et procedes de detection correspondants
WO2002040431A2 (fr) 2000-11-17 2002-05-23 Dow Agrosciences Llc Composes presentant une activite fongicide et leurs procedes de preparation et d'utilisation
JP2002316902A (ja) 2001-04-20 2002-10-31 Sumitomo Chem Co Ltd 植物病害防除剤組成物
WO2002100163A2 (fr) 2001-06-11 2002-12-19 Monsanto Technology Llc Evenement mon15985 du coton et compositions et procedes servant a sa detection
WO2003010149A1 (fr) 2001-07-25 2003-02-06 Bayer Cropscience Ag Carboxanilides de pyrazolyle utilises comme fongicides
WO2003011853A1 (fr) 2001-07-30 2003-02-13 Dow Agrosciences Llc 6-aryl-4-aminopicolinates et leur utilisation comme herbicides
WO2003014103A1 (fr) 2001-08-03 2003-02-20 Bayer Cropscience S.A. Derives de iodobenzopyran-4-one presentant une activite fongicide
WO2003013224A2 (fr) 2001-08-06 2003-02-20 Bayer Bioscience N.V. Cotonniers avec tolerance aux herbicides et procedes de production et d'identification de ces cotonniers
WO2003016286A1 (fr) 2001-08-17 2003-02-27 Sankyo Agro Company, Limited Derive de 3-phenoxy-4-pyridazinol et composition herbicide le contenant
WO2003016303A1 (fr) 2001-08-20 2003-02-27 Dainippon Ink And Chemicals, Inc. Derive de tetrazoyle oxime et produit chimique agricole contenant ledit derive comme principe actif
WO2003053145A1 (fr) 2001-12-21 2003-07-03 Nissan Chemical Industries, Ltd. Composition bactericide
WO2003061388A1 (fr) 2002-01-18 2003-07-31 Sumitomo Chemical Takeda Agro Company, Limited Compose de sulfonyluree heterocyclique fusionne, herbicide contenant ce compose et procede de controle de plantes nuisibles au moyen de cet herbicide
WO2003064572A1 (fr) 2002-01-31 2003-08-07 Exxonmobil Research And Engineering Company Compositions d'huile lubrifiante a proprietes de reduction du frottement ameliorees
WO2003066609A1 (fr) 2002-02-04 2003-08-14 Bayer Cropscience Aktiengesellschaft Thiazolylcarboxanilides disubstitues et leur utilisation comme microbicides
WO2003074491A1 (fr) 2002-03-05 2003-09-12 Syngenta Participations Ag O-cyclopropyle-carboxanilides et leur utilisation comme fongicides
WO2004011601A2 (fr) 2002-07-29 2004-02-05 Monsanto Technology, Llc Mais pv-zmir13 designe mon863, composition et procedes de detection
WO2004039986A1 (fr) 2002-10-29 2004-05-13 Syngenta Participations Ag Coton insecticide cot102
WO2004049804A2 (fr) 2002-11-29 2004-06-17 Syngenta Participations Ag Combinaisons fongicides pour proteger des cultures
WO2004072235A2 (fr) 2003-02-12 2004-08-26 Monsanto Technology Llc Evenement mon 88913 de plant de coton et procedes de detection correspondants
WO2004074492A1 (fr) 2003-02-20 2004-09-02 Kws Saat Ag Betteraves sucrieres tolerant le glyphosate
WO2004083193A1 (fr) 2003-03-17 2004-09-30 Sumitomo Chemical Company, Limited Compose amide et composition bactericide contenant ledit compose
CN1456054A (zh) 2003-03-25 2003-11-19 浙江省化工研究院 甲氧基丙烯酸甲酯类化合物杀菌剂
WO2004099447A2 (fr) 2003-05-02 2004-11-18 Dow Agrosciences Llc Mais tc1507 et procedes de detection de celui-ci
WO2005061720A2 (fr) 2003-12-11 2005-07-07 Monsanto Technology Llc Compositions de mais a haute teneur en lysine et methodes de detection correspondantes
WO2005059103A2 (fr) 2003-12-15 2005-06-30 Monsanto Technology Llc Plant de mais mon88017, compositions et procedes de detection associes
WO2005063721A1 (fr) 2003-12-19 2005-07-14 E.I. Dupont De Nemours And Company Pyrimidines herbicides
WO2005087772A1 (fr) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, procedes pour leur production, leur utilisation pour lutter contre des champignons nuisibles, ainsi qu'agents les contenant
WO2005087773A1 (fr) 2004-03-10 2005-09-22 Basf Aktiengesellschaft 5,6-dialkyl-7-amino-triazolopyrimidines, procedes pour leur production, leur utilisation pour lutter contre des champignons nuisibles, ainsi qu'agents les contenant
WO2005103301A2 (fr) 2004-03-25 2005-11-03 Syngenta Participations Ag Mais mir604
WO2005103266A1 (fr) 2004-03-26 2005-11-03 Dow Agrosciences Llc Lignees de coton transgeniques cry1f et cry1ac et leur identification specifique a l'evenement
WO2005120234A2 (fr) 2004-06-03 2005-12-22 E.I. Dupont De Nemours And Company Melanges fongicides de composes d'amidinylphenyle
WO2005123690A1 (fr) 2004-06-18 2005-12-29 Basf Aktiengesellschaft (ortho-phenyl)-anilides d'acide 1-methyl-3-difluormethyl-pyrazol-4-carboxylique et leur utilisation comme fongicides
WO2005123689A1 (fr) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-trifluoromethyl-pyrazol-4-acide carboxylique-(ortho-phenyl)-anilides et leur utilisation comme fongicides
WO2006015866A1 (fr) 2004-08-12 2006-02-16 Syngenta Participations Ag Procédé servant à protéger des plantes utiles ou une matière de propagation de plante
WO2006039376A2 (fr) 2004-09-29 2006-04-13 Pioneer Hi-Bred International, Inc. Evenement de mais das-59122-7, et procedes de detection correspondants
WO2006087325A1 (fr) 2005-02-16 2006-08-24 Basf Aktiengesellschaft 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, procede de fabrication de ces composes, utilisation dans la lutte contre des champignons parasites et agents les contenant
WO2006087343A1 (fr) 2005-02-16 2006-08-24 Basf Aktiengesellschaft Anilides d'acide carboxylique pyrazole, procedes de production associes et agents les contenant pour la lutte antifongique
DE102005009458A1 (de) 2005-03-02 2006-09-07 Bayer Cropscience Ag Pyrazolylcarboxanilide
WO2006098952A2 (fr) 2005-03-16 2006-09-21 Syngenta Participations Ag Mais 3272 et procedes pour le detecter
WO2006108674A2 (fr) 2005-04-08 2006-10-19 Bayer Bioscience N.V. Evenement elite a2704-12 et procedes et trousses permettant d'identifier cet evenement dans des prelevements biologiques
WO2006108675A2 (fr) 2005-04-11 2006-10-19 Bayer Bioscience N.V. Evenement elite a5547-127 et procedes et trousses pour l'identification d'un tel evenement dans des echantillons biologiques
WO2006130436A2 (fr) 2005-05-27 2006-12-07 Monsanto Technology Llc Evenement de soja mon89788 et procedes de detection de celui-ci
WO2006128573A2 (fr) 2005-06-02 2006-12-07 Syngenta Participations Ag Coton insecticide ce43-67b
WO2007006670A1 (fr) 2005-07-07 2007-01-18 Basf Aktiengesellschaft Composes de n-thio-anthranilamide et utilisations comme pesticides
CN1907024A (zh) 2005-08-03 2007-02-07 浙江化工科技集团有限公司 取代甲氧基丙烯酸甲酯类化合物杀菌剂
WO2007017186A1 (fr) 2005-08-08 2007-02-15 Bayer Bioscience N.V. Cotonniers tolerants aux herbicides et leurs procedes d'identification
WO2007082098A2 (fr) 2006-01-13 2007-07-19 Dow Agrosciences Llc 6-(poly-aryl substituté)-4-aminopicolinates et utilisations de ceux-ci comme herbicides
WO2007090624A2 (fr) 2006-02-09 2007-08-16 Syngenta Participations Ag Procede de protection d'une matiere de propagation vegetale, d'un vegetal et/ou d'un organisme vegetal
WO2007129454A1 (fr) 2006-05-08 2007-11-15 Kumiai Chemical Industry Co., Ltd. Derive 1,2-benzisothiazole et agent luttant contre une maladie de plante agricole ou horticole
WO2007140256A1 (fr) 2006-05-26 2007-12-06 Monsanto Technology, Llc Plant et semence de maïs correspondant au produit transgénique mon89034, procédés de détection et utilisation associés
WO2007142840A2 (fr) 2006-06-03 2007-12-13 Syngenta Participations Ag Événement de transformation de maïs mir162
WO2008002872A2 (fr) 2006-06-28 2008-01-03 Pioneer Hi-Bred International, Inc. Événement de soja 3560.4.3.5 et compositions et procedes d'identification et/ou de détection de celui-ci
WO2008013622A2 (fr) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Amides azocycliques fongicides
WO2008112019A2 (fr) 2006-10-30 2008-09-18 Pioneer Hi-Bred International, Inc. Evènement dp-098140-6 du maïs et compositions et procédés pour son identification et/ou sa détection
WO2008054747A2 (fr) 2006-10-31 2008-05-08 E. I. Du Pont De Nemours And Company Événement de soja dp-305423-1, leurs compositions et leurs procédés d'identification et/ou de détection
JP2008255018A (ja) * 2007-04-02 2008-10-23 Hokko Chem Ind Co Ltd １，３‐ジオキソラン誘導体、１，３‐ジチオラン誘導体または１，３‐オキサチオラン誘導体および農園芸用殺菌剤。
WO2008122406A1 (fr) 2007-04-05 2008-10-16 Bayer Bioscience N.V. Plants de coton résistant aux insectes et leurs procédés d'identification
JP2008280274A (ja) * 2007-05-09 2008-11-20 Hokko Chem Ind Co Ltd シクロヘキサンカルボキサミド誘導体および農園芸用殺菌剤
WO2008151780A1 (fr) 2007-06-11 2008-12-18 Bayer Bioscience N.V. Cotonniers résistant aux insectes comprenant un événement élite ee-gh6 et leurs procédés d'identification
WO2009064652A1 (fr) 2007-11-15 2009-05-22 Monsanto Technology Llc Plante et graine de soja correspondant à l'événement transgénique mon87701 et procédés pour les détecter
WO2009090181A2 (fr) 2008-01-15 2009-07-23 Bayer Cropscience Sa Composition pesticide comprenant un dérivé de tétrazolyloxime et une substance active fongicide ou insecticide
WO2009094442A2 (fr) 2008-01-22 2009-07-30 Dow Agrosciences Llc Dérivés de 5-fluoropyrimidine
WO2009103049A2 (fr) 2008-02-14 2009-08-20 Pioneer Hi-Bred International, Inc. Evénement spt flanquant l'adn génomique végétal et procédés d'identification de l'événement spt
WO2009102873A1 (fr) 2008-02-15 2009-08-20 Monsanto Technology Llc Plante de soja et graine correspondant à l’évènement transgénique mon87769 et leurs procédés de détection
WO2009111263A1 (fr) 2008-02-29 2009-09-11 Monsanto Technology Llc Plant de maïs correspondant au produit transgénique mon87460 et compositions et procédés de détection associés
WO2010037016A1 (fr) 2008-09-29 2010-04-01 Monsanto Technology Llc Événement transgénique de soja t mon87705 et procédés pour la détection de celui-ci
WO2010077816A1 (fr) 2008-12-16 2010-07-08 Syngenta Participations Ag Evénement transgénique du maïs 5307
WO2010069882A1 (fr) 2008-12-17 2010-06-24 Syngenta Participations Ag Dérivés d'isoxazole en tant que fongicides
WO2010075200A1 (fr) 2008-12-22 2010-07-01 Array Biopharma Inc. Dérivés d'acide 7-phénoxychromanecarboxylique
WO2010080829A1 (fr) 2009-01-07 2010-07-15 Basf Agrochemical Products B.V. Évènement de soja 127 et procédés apparentés
WO2010139271A1 (fr) 2009-06-05 2010-12-09 中国中化股份有限公司 Composés ester phénylacrylique de type e contenant un groupe anilinopyrimidine substitué et leurs utilisations
WO2011022469A2 (fr) 2009-08-19 2011-02-24 Dow Agrosciences Llc Événement das-40278-9 d'aad-1, lignées transgéniques de maïs connexes et identification spécifique d'événement de celui-ci
WO2011028657A1 (fr) 2009-09-01 2011-03-10 Dow Agrosciences Llc Compositions fongicides synergiques contenant un dérivé de 5-fluoropyrimidine pour la lutte contre les champignons dans des céréales
WO2011034704A1 (fr) 2009-09-17 2011-03-24 Monsanto Technology Llc Variété transgénique mon 87708 du soja et ses méthodes d'utilisation
WO2011062904A1 (fr) 2009-11-23 2011-05-26 Monsanto Technology Llc Événement du maïs transgénique mon 87427 et échelle de développement relative
WO2011066384A1 (fr) 2009-11-24 2011-06-03 Dow Agrosciences Llc Événement 416 de la transformation aad-12, lignées de soja transgéniques associées, et leur identification spécifique à l'événement
WO2011084621A1 (fr) 2009-12-17 2011-07-14 Pioneer Hi-Bred International, Inc. Evénement de transformation dp-004114-3 du maïs et son procédé de détection
WO2011077514A1 (fr) 2009-12-22 2011-06-30 三井化学アグロ株式会社 Composition permettant de lutter contre des maladies végétales et procédé de lutte contre des maladies végétales par application de la composition
WO2011081174A1 (fr) 2010-01-04 2011-07-07 日本曹達株式会社 Compose heterocyclique contenant de l'azote et germicide agricole/horticole
WO2011092140A1 (fr) 2010-01-27 2011-08-04 Boehringer Ingelheim International Gmbh Composés pyrazole comme antagonistes du crth2
WO2011135827A1 (fr) 2010-04-27 2011-11-03 Sumitomo Chemical Company, Limited Composition pesticide et utilisation associée
WO2011135833A1 (fr) 2010-04-28 2011-11-03 Sumitomo Chemical Company, Limited Composition phytosanitaire et utilisation associée
WO2011153186A1 (fr) 2010-06-04 2011-12-08 Monsanto Technology Llc Evénement mon 88032 d'une plante transgénique du genre brassica et ses procédés d'utilisation
WO2012051199A2 (fr) 2010-10-12 2012-04-19 Monsanto Technology Llc Plante et semence de soja correspondant à l'événement transgénique mon87712 et procédé pour les détecter
WO2012082548A2 (fr) 2010-12-15 2012-06-21 Syngenta Participations Ag Soja comprenant le mécanisme de transformation syht04r, et compositions et procédés de détection de ce mécanisme
WO2012084812A1 (fr) 2010-12-20 2012-06-28 Isagro Ricerca S.R.L. Amides d'aminoindanes présentant une forte activité fongicide et leurs compositions phytosanitaires
WO2012134808A1 (fr) 2011-03-30 2012-10-04 Monsanto Technology Llc Événement transgénique mon 88701 du coton et ses procédés d'utilisation
WO2012165511A1 (fr) 2011-05-31 2012-12-06 クミアイ化学工業株式会社 Procédé de lutte contre des maladies dans une plante de riz
WO2012168188A1 (fr) 2011-06-07 2012-12-13 Bayer Intellectual Property Gmbh Combinaisons de composés actifs
WO2013003558A1 (fr) 2011-06-30 2013-01-03 Monsanto Technology Llc Plante et graine de luzerne correspondant à l'événement transgénique kk 179-2 et procédés pour la détection de celui-ci
WO2013007767A1 (fr) 2011-07-13 2013-01-17 Basf Se Composés fongicides 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol substitués
WO2013010862A1 (fr) 2011-07-15 2013-01-24 Basf Se Composés fongicides de 2-[2-chloro-4-(4-chloro-phénoxy)-phényl]-1-[1,2,4]triazol-1-yl-éthanol substitué par alkyle
WO2013016527A1 (fr) 2011-07-26 2013-01-31 Dow Agrosciences Llc Evénement de soja 9582.814.19.1 résistant aux insectes et tolérant aux herbicides
WO2013016516A1 (fr) 2011-07-26 2013-01-31 Dow Agrosciences Llc Evénement combiné de sélection résistant aux insectes et tolérant à un herbicide d'un événement de soja pdab9582.814.19.1 et pdab4468.04.16.1
WO2013024009A1 (fr) 2011-08-12 2013-02-21 Basf Se Composés n-thio-anthranilamides et leur utilisation comme pesticides
WO2013024010A1 (fr) 2011-08-12 2013-02-21 Basf Se Composés n-thio-anthranilamides et leur utilisation comme pesticides
WO2013047441A1 (fr) 2011-09-26 2013-04-04 日本曹達株式会社 Composition bactéricide pour l'agriculture et l'horticulture
WO2013047749A1 (fr) 2011-09-29 2013-04-04 三井化学アグロ株式会社 Procédé de fabrication de dérivé de 4,4-difluoro-3,4-dihydroisoquinoléine
WO2013092224A1 (fr) 2011-12-21 2013-06-27 Basf Se Utilisation de composés de type strobilurine pour combattre des champignons phytopathogènes résistants aux inhibiteurs du site qo
WO2013112527A1 (fr) 2012-01-23 2013-08-01 Dow Agrosciences Llc Coton résistant aux herbicides évènement pdab4468.19.10.3
WO2013116251A2 (fr) 2012-02-01 2013-08-08 E. I. Du Pont De Nemours And Company Mélanges de pyrazole fongicides
WO2013127704A1 (fr) 2012-02-27 2013-09-06 Bayer Intellectual Property Gmbh Associations de composés actifs contenant une thiazoylisoxazoline et un fongicide
WO2013162072A1 (fr) 2012-04-27 2013-10-31 Sumitomo Chemical Company, Limited Composés de tétrazolinone et leur utilisation en tant que pesticides
WO2013164773A1 (fr) 2012-05-02 2013-11-07 Lupin Limited Composés substitués de pyrazole en tant que modulateurs de crac
WO2013169923A2 (fr) 2012-05-08 2013-11-14 Monsanto Technology Llc Événement de maïs mon 87411
CN103387541A (zh) 2012-05-10 2013-11-13 中国中化股份有限公司 一种取代吡唑醚类化合物的制备方法
WO2014060177A1 (fr) 2012-10-16 2014-04-24 Syngenta Participations Ag Compositions fongicides
WO2014116854A1 (fr) 2013-01-25 2014-07-31 Pioneer Hi-Bred International, Inc. Événement de maïs dp-033121-3 et ses procédés de détection
WO2014178913A1 (fr) 2013-05-02 2014-11-06 J.R. Simplot Company Cultivar de pomme de terre f10
WO2014178910A1 (fr) 2013-05-02 2014-11-06 J.R. Simplot Company Cultivar de pomme de terre e12
WO2014179276A1 (fr) 2013-05-02 2014-11-06 J.R. Simplot Company Cultivar de pomme de terre j55
WO2014178941A1 (fr) 2013-05-02 2014-11-06 J.R. Simplot Company Cultivar de pomme de terre j3
WO2014201235A2 (fr) 2013-06-14 2014-12-18 Monsanto Technology Llc Événement transgénique de soja mon87751 et procédés de détection et d'utilisation de celui-ci
WO2015053998A1 (fr) 2013-10-09 2015-04-16 Monsanto Technology Llc Événement de maïs transgénique mon87403 et procédés pour la détection de celui-ci
WO2015065922A1 (fr) 2013-10-28 2015-05-07 Dexcom, Inc. Dispositifs utilisés en relation avec une surveillance continue de substances à analyser pour fournir une ou plusieurs notifications à un utilisateur, et procédés associés
JP2015089883A (ja) 2013-11-06 2015-05-11 アグロカネショウ株式会社 ２−アミノニコチン酸ベンジルエステル誘導体およびこれを有効成分とする殺菌剤
JP2015120675A (ja) 2013-12-25 2015-07-02 アグロカネショウ株式会社 ６−置換ニコチン酸エステル誘導体およびこれを有効成分とする殺菌剤
WO2015119246A1 (fr) 2014-02-07 2015-08-13 日産化学工業株式会社 Composition bactéricide ou de stérilisation et méthode de lutte contre les maladies
EP2865265A1 (fr) 2014-02-13 2015-04-29 Bayer CropScience AG Combinaisons de composés actifs comprenant des composés phénylamidine et agents de lutte biologique
WO2015142571A1 (fr) 2014-03-20 2015-09-24 Monsanto Technology Llc Événement transgénique de maïs mon 87419 et méthodes d'utilisation de celui-ci
WO2016183445A1 (fr) 2015-05-14 2016-11-17 J.R. Simplot Company Cultivar de pomme de terre v11
WO2017062831A1 (fr) 2015-10-08 2017-04-13 J.R. Simplot Company Cultivar de pomme de terre x17
WO2017062825A1 (fr) 2015-10-08 2017-04-13 J.R. Simplot Company Cultivar de pomme de terre y9
WO2018020474A1 (fr) * 2016-07-29 2018-02-01 Lupin Limited Composés de thiazolo-pyridine substitués en tant qu'inhibiteurs de malt1
WO2018172133A1 (fr) 2017-03-20 2018-09-27 Syngenta Participations Ag Dérivés microbiocides de quinoléine (thio)carboxamide

Non-Patent Citations (27)

* Cited by examiner, † Cited by third party
Title
"Section B: Organic Chemistry Including Medicinal Chemistry", INDIAN JOURNAL OF CHEMISTRY, vol. 52B, no. 6, 2013, pages 776 - 786
"Technical Monograph", May 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide formulation types and international coding system"
BULL. SOC. CHIM. BELGE, vol. 87, 1978, pages 223
CAN. J., PLANT SCI, vol. 48, no. 6, 1968, pages 587 - 94
CHEMICAL ABSTRACTS, Columbus, Ohio, US; abstract no. 148893-10-1
ENVIRON MICROBIOL, vol. 16, 2014, pages 2253 - 66
J. AM. CHEM. SOC., vol. 123, no. 25, 2001, pages 5962 - 5973
J. HETEROCYC. CHEM., vol. 18, no. 7, 1981, pages 1305 - 8
J. MED. CHEM., vol. 38, no. 11, 1995, pages 1892 - 903
JACS, vol. 124, 2002, pages 6043 - 6048
JMEDCHEM, vol. 54, 2011, pages 6342 - 6363
JOURNAL OF PLANT DISEASES AND PROTECTION, vol. 125, pages 21 - 26
KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, vol. 11, 1988, pages 1515 - 17
KNOWLES: "Agrow Reports DS243", 2005, T&F INFORMA, article "New developments in crop protection product formulation"
KNOWLES: "Agrow Reports DS256", 2006, T&F INFORMA, article "Adjuvants and additives"
MCCUTCHEON'S: "Emulsifiers & Detergents", vol. 1, 2008, MCCUTCHEON'S DIRECTORIES
MOLLETGRUBEMANN: "Formulation technology", 2001, WILEY VCH
ORGLETT, vol. 5, 2003, pages 4611 - 4614
PEST MANAG SCI, vol. 70, 2014, pages 378 - 388
PEST MANAG SCI, vol. 72, no. 121, 2016, pages 1 - 1215
PEST MANAG SCI, vol. 74, 2018, pages 672 - 681
PHYTOPATHOL, vol. 106, 2016, pages 1278 - 1284
PHYTOPATHOL, vol. 93, 2003, pages 891 - 900
PHYTOPATHOL, vol. 98, 2008, pages 397 - 404
RSC ADVANCES, vol. 3, 2013, pages 18787 - 18790
SYNTHESIS, vol. 149, 1973
TETRAHEDRON, vol. 71, no. 48, 2015, pages 9101 - 9111

Similar Documents

Publication Publication Date Title
JP7160487B2 (ja) 植物病原菌を駆除するための置換５－（ハロアルキル）－５－ヒドロキシ－イソオキサゾール
JP2019502661A (ja) 植物病原菌を駆除するための置換オキサジアゾール
JP2018537457A (ja) 植物病原菌を駆除するための置換オキサジアゾール
JP2018536025A (ja) 植物病原菌を駆除するための置換オキサジアゾール
WO2018202491A1 (fr) Trifluorométhyloxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes
BR112019015338B1 (pt) Compostos de fórmula i, composição agroquímica, semente revestida, uso dos compostos e método para combater fungos nocivos fitopatogênicos
WO2018114393A1 (fr) Oxadiazoles substitués pour lutter contre des champignons phytopathogènes
WO2018073110A1 (fr) Composés de quinoléine en tant que fongicides
US20200190043A1 (en) 2-[[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]aryloxy](thio)acetamides for combating phytopathogenic fungi
WO2018054711A1 (fr) Composés de pyridine pour lutter contre des champignons nocifs phytopathogènes
WO2018188962A1 (fr) Oxadiazoles substitués utilisés pour lutter contre des champignons phytopathogènes
WO2019154665A1 (fr) Nouveaux pyridine carboxamides
WO2020244968A1 (fr) N-(pyrid-3-yl)carboxamides fongicides
WO2019154663A1 (fr) Nouveaux pyridine carboxamides
WO2018054721A1 (fr) Composés de pyridine pour lutter contre des champignons phytopathogenes nocifs
WO2018065182A1 (fr) Composés de quinoléine réduits en tant qu'agents antifuni
WO2021063736A1 (fr) Dérivés de pyridine bicycliques
WO2018149754A1 (fr) Composés de pyridine
WO2020244970A1 (fr) Nouveaux carboxamides de pyridine carbocycliques
US11147275B2 (en) Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
US11076596B2 (en) Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
AU2018278714B2 (en) Pyridine and pyrazine compounds
WO2021063735A1 (fr) Nouveaux dérivés pyridines bicycliques
WO2019025250A1 (fr) Trifluorométhyloxadiazoles substitués permettant de lutter contre des champignons phytopathogènes
WO2020244969A1 (fr) Dérivés de pyridine et leur utilisation comme fongicides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20788993

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20788993

Country of ref document: EP

Kind code of ref document: A1